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Chapter 1 
General introduction 
1. Hyperthermia 
Hyperthermia is the elevation of tissue temperatures to 40-45 °C and is mainly 
applied as a cancer therapy in combination with other treatment modalities, 
such as radiotherapy or chemotherapy. A detailed introduction to the biology, 
physics and clinical application of hyperthermia is given in: An introduction to 
the practical aspects of clinical hyperthermia, edited by Field and Hand and in: 
Thermoradiotherapy and Thermochemotherapy (volumes 1 and 2), edited by 
Seegenschmiedt, Fessenden and Vernon (Springer-Verlag, Berlin, Heidelberg 
1995). 
1.1. Biological rationale 
At temperatures of 39°C and higher, direct cell kill is possible if this tempera-
ture is maintained sufficiently long. Most in vitro and in vivo studies of the 
biological effect of a single hyperthermia treatment show similar iso-effect 
time-temperature curves, for a broad range of different tumour and normal 
tissues (Field and Morris, 1983). Above a certain transition temperature, 
between 42 and 43°C, a temperature rise of 1°C allows a reduction of the 
heating time, of about a factor 2, while maintaining the same level of cell-kill. 
However, below the transition temperature, decreasing the temperature with 
1°C, requires a sixfold longer heating period to maintain the effect. 
The basic mechanism behind heat-induced cell kill is considered protein 
denaturation, which already starts at 39°C. Whether cytotoxicity is the result 
of damage of plasma membranes, cytoplasm or nucleus is still a point of dis-
cussion. The cell kill achieved depends on many factors. For example, the 
degree of proliferation, phase of the cell cycle (Westra and Dewey, 1971) and 
the physlologica[conditions (josH"c! the heat sensitivity. A lowpRTRaveman, 
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1979) and deprivation of oxygen and/or nutrients (Haveman and Hahn, 1981) 
often the result of a poor blood perfusion, are factors which increase the 
effect of hyperthermia. Furthermore, cells may become thermo-resistant after 
a certain period of temperature elevation (Li and Hahn, 1980). On the other 
hand the effect of heat can be increased through socalled step-down heating, 
i.e. a short interval at a high temperature followed by a longer period at a 
lower temperature (Field and Morris, 1984). 
With hyperthermia alone, it appears not possible to achieve local tumour 
control. In vivo experiments with rhabdomyosarcoma's implanted in the flank 
of Wag/Rij rats show that the surviving fraction of the tumour after 0.5 hours 
at 44°C was still 0.24, resulting in a grow-delay of only several days (Van 
Geel et al., 1994). 
Hyperthermia as an adjuvant to other therapies has been found to be far more 
effective. At present, adding hyperthermia to radiotherapy is considered as 
most effective. The interaction consists of two basic mechanisms. Firstly both 
therapies are almost complementary. In contrast with hyperthermia, the 
cytotoxicity of radiotherapy is enhanced in a well oxygenated 
microenvironment, with sufficient nutrients and a normal pH. In addition, the 
highest heat sensitivity during a cell cycle is observed in the S-phase while 
radiation is more toxic during the Gl-phase. Secondly, hyperthermia works as 
a radiosensitizer by inhibiting repair of sub-lethal DNA-damage caused by 
radiation (Ben-Hur et al., 1974) and, at lower temperatures «41°C), by 
reoxygenation of tissue through an increase of blood flow . Mechanisms of 
sensitisation of chemotherapy by heat are an increased uptake of the 
chemotherapeutic drugs, an increased sensitivity of the cells for the drugs, or 
a combination of both (Meyn et al., 1980). Transport to and into the cells of 
some drugs can be improved by heat-induced increased blood perfusion and 
permeability of the membranes. Furthermore hyperthermia can alter the struc-
ture of proteins and DNA which in some cases enhances the effect of chemo-
therapy. The large variety of available drugs and their different working 
mechanisms makes it very difficult to find the optimum temperature, timing 
and sequence for thermo-chemotherapy treatments. 
1.2. Clinical rationale 
Because hyperthermia alone is not effective as cancer therapy, it is generally 
combined with one or more other treatment modalities. In most clinical 
applications of hyperthermia the primary treatment goal is improving local 
tumour control. For those cancers where local control is expected to improve 
survival, hyperthermia can be used with a curative intent. If cure is not 
possible, e.g. due to metastatic disease, hyperthermia can still have an import-
ant palliative function, enhancing the quality of life. In general, the aim of 
hyperthermia is to sensitize other treatment modalities with two possible 
purposes. Firstly, hyperthermia can be added if the response to a certain 
standard therapy is insufficient and an increase of the standard therapy dose 
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would lead to unacceptable side effects. For example in case of previously 
irradiated persistent or recurrent tumours. Secondly, the reason for the 
addition of heat could be, maintaining the efficacy of the original treatment, 
while using a lower dose and in this way reducing the side effects. 
Since the 1970s many clinical studies demonstrated benefit of hyperthermia 
(Seegenschmiedt et al., 1995b). More recently, the results of a number of 
randomized studies showed that hyperthermia can be very effective as an 
adjuvant to radiotherapy. The outcome of these well controlled, socalled phase 
III studies are generally considered more valuable than the phase "" studies. 
In a randomized trial by the European Society for Hyperthermic Oncology 
(ESHO) the value of hyperthermia as an adjuvant to radiotherapy of recurrent 
or metastatic malignant melanoma was investigated. The results of this study 
(Overgaard et al., 1996) showed a significantly higher local tumour control 
after 2 year with hyperthermia (46%) than with radiotherapy alone (28%). A 
large difference in the 5-years survival rate was found between patients with 
a locally controlled disease (38%) and those with a still active disease. 
Another study which showed a benefit of hyperthermia was the multi-centre 
trial which compared radiotherapy alone with the combined treatment of 
primary or recurrent breast cancer (Vernon et al., 1996). 
The results of a Dutch phase III trial were presented at the Internal Congress 
on Hyperthermic Oncology in Rome (Van der Zee et al., 1996). The effect of 
additional hyperthermia for inoperable pelvic tumours, originating from the 
urinary bladder, the uterine cervix or rectum was investigated. The overall 
complete response rates were 58% an 37% for respectively 
thermoradiotherapy and irradiation alone. 
Acute heat-related toxicity was limited to 2nd or 3rd grade skin burns and 
subcutaneous burns. Furthermore no enhancement of radiation-induced 
complications was found. 
So far it has been demonstrated that hyperthermia can improve the response 
rate and the survival with a acceptably heat-induced toxicity. Possibly, 
hyperthermia can also be beneficial in those situations where radiotherapy 
already is effective but it is desirable to reduce normal tissue toxicity, I.e. the 
addition of heat might decrease the required effective radiotherapy dose and 
therefore the irradiation-induced toxicity. 
1.3. Technology of hyperthermia 
It took a long time before the potential of hyperthermia was demonstrated in 
randomized studies. The main reason for this is that it appears difficult to 
satisfy the requirements for an good hyperthermia treatment (Oleson et ai, 
1993, Emami et al., 1996, Hand et ai, 1997). Basically, the aim is to achieve 
an elevated homogeneous temperature distribution within the target volume 
and no heating of the surrounding tissue. Although, hot spots leading to 
localized necrotic regions might cause unwanted side-effects, the requirement 
dfhdmdgeheTtV has·rathefapract1Calfhanablological··grolifid:ln clinical 
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practice, power deposition is often limited because of temperature-related 
pain. In a heterogeneous temperature distribution, this may result in 
insufficient heating in the colder regions. 
To reach the heating goal, firstly the hyperthermia equipment must be 
appropriate for the job. The power which can be deposited in the tissue must 
be sufficient to reach therapeutic temperatures(40-45°C),the temperature 
measurements must be accurate (±O.2 °C) and the spatial resolution of both 
power deposition and temperature measurement must correspond with the 
inhomogeneity of tissue cooling, mainly by blood flow (Lagendijk et al., 1994) 
For example, it is obvious that in case of an higher blood temperature in the 
clinical target volume, e.g due to a systemic temperature rise or because the 
heated volume is sufficiently larger than the target volume, the necessity of 
spatial control is reduced. Sometimes, e.g. if many applicators and 
thermometers are used, automatic temperature control is needed. 
Secondly, good treatment planning is required to assure adequate applicator 
and thermometer placement and a proper use of extra treatment tools such as 
(absorbing/perfused) waterboli or electric field probes. For treatment planning, 
various computer models are available to estimate power absorption and 
temperature distributions for a certain treatment set-up. Both for treatment 
planning and treatment control, the experience obtained from previous treat-
ments is very important. 
In general, the choice for a certain heating method depends on the position, 
size and shape of the clinical target volume and on the treatment modality 
with which hyperthermia is combined. Furthermore patient-specific criteria, 
e.g. the presence of a pacemaker or metal parts, can playa role in this matter. 
The heating targets can be divided in four categories: superficial (less than 
about 4 cm from the skin), loco-regional or deep (at a depth of more than 4 
cm), regional (organ or extremity, such as an arm or a leg) and whole body. 
The various heating methods differ regarding the physics behind the energy 
deposition in tissue. Most straightforward is to use hot sources and rely on 
heat conduction. This hot source can be extracorporeal heated blood (regional 
and whole body hyperthermia), ferromagnetic seeds or fluids heated with an 
external electromagnet, or simply hot water. Other methods for energy 
deposition in case of superficial or loco-regional hyperthermia are electro-
magnetic or ultrasound waves. 
Further classification of the heating method is possible using the position of 
the applicators which can lay outside the body (external), in the tissue 
(interstitial) or in cavities of the body (intracavitary). 
After the heating system is chosen, the decision about the type of thermom-
eter to be used has to be taken. Accuracy, precision and stability must be 
sufficient in combination with the heating method. The main distinction that 
can be made is between invasive and non-invasive thermometry. The most 
frequently used invasive thermometers are thermocouples, thermistors and 
fiberoptic thermometers, each with its specific advantages and disadvantages 
(Cetas,T987).I!Y ·rrioslsiWaliohs, ferriperalUres dLliing·· <ihypeitherrriia 
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treatment can be measured within ±0.2°C, using invasive thermometers. Only 
in case of ultrasound hyperthermia this accuracy can not always be reached. 
However because of serious discomfort for the patient the spatial resolution 
of invasive temperature measurements is generally poor. Therefore, presently 
great effort is being put in the development of non-invasive techniques, which 
can be either passive or active. The passive techniques are based on measure-
ment of electromagnetic or acoustic radiation, spontaneously emitted by a 
body at a certain temperature. In case of the active method the object of 
interest is irradiated first, before it sends some temperature-related information 
back. Examples of passive and the active technique are microwave radiometry 
(Leroy et al., 1998) and magnetic resonance imaging respectively (Samulski 
et ai, 1992). At present the accuracy, precision and spatial/temporal resolution 
of these and other non-invasive thermometry systems are still insufficient for 
most clinical situations. Despite all the sophisticated thermometry systems 
available at the moment, the patient remains an important thermometer in 
clinical practice. 
Detailed information about physics and technology of various heating tech-
niques, thermometry systems, and methods to calculate power absorption or 
temperature distributions can be found in above mentioned handbooks. 
For a optimal choice and use of hyperthermia equipment there are a number 
of quality assurance guidelines available, e.g. Hand et al. (1989) for external 
hyperthermia and Emami et al.(1991) or Visser et al. (1993b) for interstitial 
hyperthermia, based on the experience of specialists of the different fields of 
hyperthermia. 
2.27 MHz multi-electrode current-source interstitial hyperthermia. 
2.1 Interstitial hyperthermia 
Interstitial hyperthermia systems were primarily developed to be used in 
combination with interstitial radiotherapy (lRT) and so far IHT is usually not 
performed without IRT. Generally, interstitial treatment is chosen, when 
sparing of normal tissue is very important, e.g. when the clinical target is 
located near critical organ or in a previously irradiated area. Furthermore 
interstitial applicators might be advantageous if a target is difficult to access 
with external applicators, e.g. because of a irregular patient contour or body 
cavities close to the target volume. Because of patient tolerance, the number 
of brachytherapy needles or plastic catheters that can be used is limited and 
therefore the target has to be relatively small, i.e. with a diameters in the 
range 1-10 cm. Regions which are often treated interstitially are head & neck, 
pelvis and brain. 
An important advantage of interstitial hyperthermia is a high spatial density of 
applicators and thermometers which makes compensation for local cooling by 
bloodflow possible. In theory, this should make it possible to deliver a high 
hear dOset6 tnaTUma,,!· Witflo"foViliheatin 9 the su irou ridiil gUss uil.H ow"ll"r 
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in practice this appears to be rather difficult. Despite the large number of 
applicators, temperature distributions obtained with IHT are often quite 
inhomogeneous and hot-spot-induced pain causes insufficient heating at other 
places. Two reasons for this problem are firstly, that power absorption 
decreases rapidly with increasing distance from the applicators and secondly, 
cooling by blood perfusion is large because only small volumes are heated and 
incoming blood is not pre-heated. 
This inhomogeneous heating is one of the reasons for the disappointing results 
of some interstitial clinical trials (Emami et al., 1996). An exception to this are 
treatments of brain tumours which do not have the problem of high-tempera-
ture-induced pain (Sneed et al., 1998). A general introduction to interstitial 
hyperthermia can be found in: Interstitial and intracavitary thermoradiotherapy, 
edited by Seegenschmiedt and Sauer (Springer-Verlag, Berlin, Heidelberg 
1993) and in the handbooks mentioned above. One of the, relatively large 
number of different IHT systems is the 27 MHz multi-electrode current-source 
(MECS) IHT-system, which has been developed during the past 15 years. 
2.2. History 
In the middle eighties Marchal demonstrated to Visser and Van Rhoon that 
electrodes operating at 27 MHz, inserted in plastic catheters (as frequently 
used in brachyherapy) could be used for hyperthermia. After that, both in 
Centre Alexis Vautrin in Nancy and in the Daniel den Hoed Cancer Centre in 
Rotterdam research was started to test this heating method (Marchal et al. 
1989, Visser et al., 1989). In Rotterdam, the early investigation was 
supported by the Dutch Cancer Society (grant RRTI 87-3). Deurloo et al. 
(1991) demonstrated the advantage of the capacitive coupling between 
electrodes and tissue over galvanic coupling via metallic needles in case of the 
older local-current radio-frequency method. A more extensive comparison 
between various RF-IHT systems has been given by Visser et al. (1993a). The 
27 MHz capacitively-coupled method was applied in a rat-tumour model to 
investigate the effect of the combination of IHT and low-dose-rate IRT (Ruifrok 
et al., 1991) and photo dynamic therapy (Levendag et al., 1989). Furthermore, 
the research resulted in a 12-channel prototype of a clinical capacitive-coupled 
IHT-system. In a feasibility study 11 patients with advanced andlor recurrent 
cancers in head and neck were treated. (Levendag etal., 1993). However the 
temperature distributions obtained were rather inhomogeneous and the mini-
mum tumour temperatures were low. Reasons for this were the relatively large 
spacing between the afterloading catheters (1.5 to more than 2 cm) and 
absorption of electromagnetic energy in the catheter wall. Furthermore, cross-
coupling between electrodes made adequate control of applicator power, 
which had to be performed manually, very difficult. 
In a collaboration between the University Hospital Utrecht and the Daniel den 
Hoed Cancer Centre, the IHT-system was improved on several points. Firstly 
the hlJrl'loef ofhe"tingchahnelswasincreasedto 2 groups of each 32 
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channels with opposite phase. This made the use of multi-electrode applicators 
and thus a better spatial control of the power deposition possible. 
Furthermore, the inconvenient external ground at the patient skin could now 
be omitted and a more localized current pattern was obtained. In the new 
system both power steering and temperature measurement were computer 
controlled, which made automatic temperature control possible. At this point 
the name of the system changed from capacitive-coupled IHT-system to multi-
electrode current-source (abbreviated as MECS) IHT-system. Furthermore, the 
development of IHT-treatment planning software and a search for catheter 
materials with lower dielectric loss were started. A general description about 
the technical features of the MECS-IHT system has been given by Lagendijk 
etal. (1995). 
3. Study objectives and outline of this thesis 
The work presented in this thesis was part of a project which was supported 
by the Dutch Cancer Society (grant DDHK 91-13). Two main sub-projects 
could be distinguished: 1) investigation of the effectiveness of IHT in 
combination with brachytherapy in a rat tumour model, 2) physical 
development of IHT equipment. The main objective of the technical part, the 
subject of this thesis, was to prepare the MECS-system for clinical introduction 
and to inVestigate the performance in clinical practice. Furthermore, the 
available IHT-system for small animals had to be improved. 
With this latter system, the effect of high-dose-rate and low-dose-rate IRT in 
combination with IHT was investigated in solid tumours transplanted in the 
flank of rats. The design and the performance of a 4-channel IHT-system for 
small animals are described in chapter 2. 
Regarding the clinicallHT -system the main concerns were the efficiency of the 
power deposition in the tissue and the optimization of the homogeneity of the 
temperature distributions. 
The part of the generator power which is actually absorbed by the tissue is 
called the effective power (P,,,). P,,, depends on the method used to match 
the impedance of the applicator and afterloading catheter in the tissue with the 
generator impedance. Chapter 3, gives a detailed description of electrical 
aspects of impedance matching, applicator design, afterloading catheter choice 
and tissue to heat. Furthermore, a model is presented with which the required 
power absorption density can be estimated for a certain tumour size, 
applicator density and effective heat conductivity of the tissue. Calculations 
and measurements of P ,If are compared with each other and evaluated in 
respect of the power requirements. 
Several aspects of thermocouple thermometry in combination with the 27 MHz 
current source IHT are discussed in the chapters 4 an 5. If a thermocouple 
probe is inserted in a afterloading catheter, the thermal conductivity along the 
thermocouple wires is considerably larger than this in radial direction. This, in 
combination ·witll·largetemperaturegradients ·inthetissue, ··1: 2 bernini are 
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typical for IHT, is a potential source of measurement errors. Furthermore, the 
fact that thermometers are used inside applicators and are not directly in the 
tissue in combination with power dissipation in the afterloading catheter wall 
and/or in the applicator itself causes a difference in the measured temperature 
and the tissue temperature to be known. These two facets are illuminated in 
chapter 4. Implications of thermocouple probes inside applicators for Po" and 
for the applicator impedance, and thus the impedance matching, are discussed 
in chapter 5. 
Features of the MECS-IHT system which affect the temperature homogeneity 
have been evaluated in chapter 6. 
Finally in chapter 7, the feasibility of heating brain tumours, using the MECS-
IHT system and methods of thermometry use are discussed. 
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Abstract 
Temperature distribution is an important factor in thermo-radiotherapy and it 
is greatly dependent on the applied heating technique. Consistency of the 
heating method is therefore important in translating in vivo experimental data 
to the clinical situation. 
To further evaluate the combination of interstitial hyperthermia and interstitial 
radiotherapy, an experimental interstitial hyperthermia system has been 
developed for small (500-2000 mm3 ) tumours growing in the flank of a rat. 
The system used reproduces the properties of our clinical current source 
interstitial hyperthermia system. The heating system consists of four 
applicators, each with independent tuning and power control. The applicators 
are situated inside plastic afterloading catheters and are capacitively coupled 
with the surrounding tissue. The tumour is heated through dissipation of a 27 
MHz current flowing to an external ground plane. 
An effective RF-filter allows reliable thermocouple temperature measurements 
when the power is switched on. The tumour temperature is easily controlled 
by means of a continuous temperature read-out and a clear temperature 
display. A minimum temperature up to 46°C can be reached within 4-10 
minutes and maintained (± O. 5°C) throughout the treatment period. 
Modelling calculations performed for this heating system indicate that the 
applicatorternperaturesshouldbekeptequal in order to minimize the 
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difference between maximum and minimum tumour temperature. Significantly 
higher applicator currents are needed at larger distances from the ground 
plane. In addition, the homogeneity of the temperature distribution is improved 
when either the tumour is isolated or when the environmental temperature is 
increased. The calculations also show that temperature distribution is strongly 
dependant on effective heat conductivity. 
A description of the system and its performance is presented. 
1. Introduction 
The experiments of Ben-Hur et al. (1974), and numerous other subsequent in 
vitro and in vivo studies have demonstrated the radiosensitizing effect of 
hyperthermia (HT). However, specific research is needed to determine optimal 
clinical conditions for combined treatment. Detailed clinical study of the most 
optimal clinical set up has often not been possible because of the limited 
number of patients in clinical studies. Despite the differences between animal 
tumours and human tumours (Hahn et al., 1989), an in vivo tumour model is 
more likely to approximate the clinical situation than an in vitro experiment, 
even if cell lines of human origin are studied in the latter. As dose distribution, 
and ultimately, the outcome of treatment, is dependent on the applied heating 
and irradiation techniques, in vivo experiments should be carried out, using the 
same techniques as during a clinical treatment. An animal model is, therefore, 
invaluable for investigating the effects of dose and sequencing of multiple 
radiotherapy (RT) and HT treatment sessions. 
Whilst available clinical data on the combination of interstitial or intracavitary 
radiotherapy (IRT), i.e. brachytherapy and interstitial hyperthermia (IHT)' were 
recently summarized by Seegenschmiedt and Sauer (1992), limited experimen-
tal in vivo studies (Miller et al., 1978; Papadopoulos et al., 1989; Mieler et al., 
1989; Ruifrok et al., 1991; Van Geel et al., 1994) have been published to 
date. To gain an insight in the combined treatment, e.g. regarding the effect 
of treatment sequence when IHT is combined with either low-dose-rate (LDR), 
pulsed-dose-rate (PDR) or high-dose-rate (HDR) brachytherapy or regarding the 
relation between thermal dose (temperature, treatment time) and tumour 
response, a 27 MHz current source IHT-system for small animals has been 
developed. It is able to heat adequately small (1500-2000 mm3 ) solid tumours, 
growing in the flank of a rat. This paper describes the heating system, the 
thermometry and their performance. 
2. Materials and methods 
2.1. Tumour model 
Small experimental tumours (1500-2000 mm3), growing in the flank of a rat, 
"reimplanted withlollr paraflefriylon catheTers (inner diamefer (d;l""f.l mm, 
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outer diameter (do) = 1.6 mm) in a square geometry (7x7 mm) using a stainless 
steel template (Levendag et al., 1989). Several different tumours in different 
rats (R1 m in female WagRij, L27 in female Brown Norwegian and CC531 in 
male WagRij) have been studied. 
2.2. The heating system 
The heating system is based on the 27 MHz current source heating method 
(Marchal et al., 1985; Visser et al., 1989). A schematic design is shown in 
Figure 1. Applicators, which are constructed of flexible nylon catheters 
(d;=0.75 mm, do=0.96 mm) covered over 15 mm from the tip with a 
conducting paint (Electrodag 1415, Acheson Industries). are inserted inside the 
a/terloading catheters. The painted segment serves as an electrode. A thin 
(0.1 mm) copper wire inside the applicator catheter is attached to the paint. 
Each applicator is connected to its own 27 MHz generator (0-10 Watt, SSB 
Electronic). Due to the high frequency, an electrode is capacitively coupled 
with the surrounding tissue, through the wall of the implanted catheter. An 
electrical current can flow to an external ground return below the rat 
(Figure 1). 
tumour / ~Q catheter #~?~~fc6tor ground return 
saline bag 
generator 
coax. cable tuning coil 
t t 
im edance transformers 
Figure 1. Schematic design of the IHT -system, Each applicator is connected to its own generator 
via a matching network, containing a tuning Gail and two 4: 1 impedance transformers, and a 
decoupling transformer. A saline bag is used for a optimal contact between tissue and ground 
return. 
A saline bag is used to avoid hot spots on the surface between rat and ground 
return. The tumour is heated through ohmic losses. About 35% of the 
generator output is actually dissipated in the tissue. The capacitive coupling 
between the copper feeder wire inside the applicator and the tissue is 
negligible, so that the heated region is limited to the painted segment. Due to 
fhe high impedance "ssociajea withth" ·capaciti\ie Goupil n9 ·b"fwe"n·app licalo! 
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and tissue, the current density along the heated region is hardly dependent on 
tissue impedance. This current source character of the applicator leads to a 
homogeneous heating along the catheter, even if the implanted catheters are 
not strictly parallel. These features were described in detail by Deurloo et al. 
(1991 ). 
The small (25x19x9 cm') box below the rat contains a matching network 
and a decoupling transformer for each applicator (Figure 1) to minimize 
reflected power and cross-coupling between applicators. The mainly capacitive 
impedance (Z '" 50-650j ohm) of the applicator inside the tissue is transformed 
to 50 ohms, through a variable air coil (15 turns, do = 3cm) and two 4: 1 
impedance transformers. The decoupling transformers prevent current from 
flowing from one applicator to another. This so called cross-coupling has to be 
avoided to allow a reliable power steering of individual applicators. 
2.3. Thermometry 
The thermometry is based on copper-constantan thermocouples. Temperature 
monitoring is performed with a 40-channel data-acquisition-system (Helios I, 
Fluke). The maximum measurement frequency is 15 times per minute and the 
accuracy is 0.05 °C. Inside each applicator the temperature is measured with 
a single point probe. Furthermore, temperatures are measured every 5 mm 
with a seven point probe inside an extra thermometry catheter (d, = 1 .1 mm, 
do = 1.6 mm) implanted, through the tumour centre, perpendicular to the 
applicator catheters (Figure 2). This is the long axis of the ellipsoidal tumours. 
applicator + single-point thermocouple-probe 
". ":: ":: ··£)'CC~5--l,~~",;;~m_T""'C"7 ______ _ ~ .. ~ '/' 
adge 1 CD 0-1 edge 7 -point thermocouple-probe 
_____ ..!.I~~----
skin 
-------- ----------
Figure 2. Position of applicators and thermocouples in the tumour. The applicators are positioned 
in a square geometry with 7 mm sides. Inside each applicator a single thermocouple thermometer 
is inserted, Furthermore, perpendicular on the applicators a 7-point thermocouple probe is placed, 
The data acquisition system is connected to a PC which provides clear display 
and ... autornaticstorageOn di.sk .... of the .. ternpera(Ure .... da.t" ... 8.nd ..... also ... a 
thermocouple calibration procedure. 
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An RF-filter system (-60dB), constructed with ferrite toroids, allows 
continuous, undisturbed temperature measurements in a 27 MHz environment. 
A schematic design is given in Figure 3. The filter system can be distinguished 
in two identical units, both surrounded by a Faraday cage, one including the 
connectors for the 2 m long thermocouple probes and the other attached to 
the data acquisition system. The copper and constantan extension wires 
between the two filter units are shielded by a stainless steel braid. Each single 
thermocouple wire is wound around two ferrite toroids (fl = 100, 14x9x5 mm, 
ferrox-cube 4C6, Philips) to create a large impedance. Furthermore, each pair 
of wires is coiled around two other toroids to equalize the difference in RF-
current which is due to the different electric resistances of copper and 
constantan. In this way, the junction current error as described by Chakraborty 
and Brezovich (1982) is minimized. 
I Faraday cage 
1- L ___ ~ 
~ -
\ I -\ .~ If .. · .1' co.,o" 
Ihermocoup:e stainless steel braid 
connector 
Figure 3. Diagram of the RF-filter system, The filter has two identical units, both surrounded by 
a Faraday cage, The copper and constantan extension wires in between are shielded by a stainless 
steel braid. Each thermocouple wire is separately wound around two ferrite toroids. Furthermore, 
each pair of wires is coiled around two other toroids. 
2.4. Temperature control 
Generally, the aim of a hyperthermia treatment is to achieve a homogeneous 
temperature distribution inside the tumour, at a chosen elevated temperature, 
without over-heating the surrounding normal tissue. In practice this means: 
aim at temperatures above a chosen minimum temperature (T mi') and keep the 
maximum temperature (T m,') as low as possible. 
If the applicators have been implanted in the centre of the tumour, than the 
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lowest temperature is expected to be at the edge of the tumour. For power 
steering the temperatures measured along the longest axis at the edges of the 
tumour are used as minimum temperatures. One edge temperature can be 
measured directly if the measure point at the tip of the probe is positioned at 
the boundary of the tumour. If there is no measure point at the opposite 
tumour edge, the edge temperature is calculated through interpolation from 
three temperature measurements, two in the tumour and one in the skin, 
around this edge. The "applicator temperatures" are seen as the, power 
limiting, maximum temperatures. 
Due to a continuous read-out and a clear display of minimum and maximum 
temperatures, the tumour temperature is controlled easily by manual power 
steering of the four generators. 
2.5. Model calculations 
The modelling software used for the computations was developed by the 
group of Lagendijk (De Bree et al., 1994; Kotte et al., 1994). Using a quasi-
static approximation of the Maxwell equations, potential and power absorption 
distributions can be computed for a certain volume if the electrical properties 
(electrical conductivity (a), relative permittivity (E,)) and the position of current 
andlor voltage sources are known (SAR model). From the SAR distribution and 
the thermal properties (density (p), specific heat capacity (cp\' thermal conduc-
tivity (k)), the temperature distribution at a certain time can be calculated 
(thermal model). In Figure 4 the volume used for the computations is shown. 
Electric and thermal properties are given in Table 1. The temperature at the 
edges of the rat (Tr) was held at 30°C. 
,--. 
15mm 
30mm , .. 
ground plane 
front view side view 
Figure 4. The volume as it was used for the model calculations, It consists of a block shaped 
tumour on a rectangular rat. In the centre of the tumour, four current sources were positioned in 
a 7 mm square geometry. The tissue is separated from the surrounding air by a transition layer. 
Both air and the edges of the rat were held at a constant temperature (Ta' T/), The ground potential 
was fixed at 0 Volt. 
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The tumour is surrounded by an air layer with a fixed temperature (Ta). To 
bring into account the heat transfer from skin to air, a transition layer with a 
thickness of one voxel (1 mm3 ) was defined. This layer is composed of half air, 
half tissue and the total heat transfer coefficient (h,,) is given by 
the formula 
_1_+~+_1_ (1 ) 
hair hA htissue 
where hair and htissue are the heat transfer coefficients of air and tissue 
respectively and hA represents the heat transfer coefficient of the actual 
transition. The latter can be determined experimentally and is, in case of a 
solid wall and a gas (free convection), in the range of 5-15 Wm-2 K-' (forced 
convection: 10-100 Wm-2 K-'). From equation 1, the effective thermal 
conductivity can be determined with 
(2) 
For the model calculations the default value of hA was set at 10 Wm-2 K-' and 
of d", and d",,,, at 0.5 mm. With these values, the thermal conductivity of the 
transition layer is 0.0083 Wm-1 K-'. The density and the heat capacity are 
chosen equal to the average of these values of air and tissue (Table 1). The 
temperature of the surrounding air (T,) was set at 25°C. 
Table 1. Electric and thermal properties used for the model calculations. 
Medium a E, p cp k 
[0-' m-'] [oO] [kgm-3 ] [Jkg-' K-'] [Wm-'K-'] 
air 0 1 1.29 1000 0.024 
tissue 0.6 80 1020 3500 0.6 
transition layer 0 1 500 2250 0.0083 
applicatorlground 0 1 1020 3500 0.6 
3. Results 
3.1. Model calculations 
The main aim of model calculations was to establish if the temperature at the 
edge of the x-axis (T,_,d,,) and the temperature measured inside the applicators 
T,p,1. vv.ere representative for respectively th.e minimum and .the .maximum 
tumour temperature (T m'o and T m,,) and thus useful as appropriate input 
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parameters for temperature control. 
If the temperature distribution is calculated starting from a tissue 
temperature of 30°C and with a realistic fixed current per applicator (135 mAl 
it takes 330 s to reach a temperature of 46°C at the x-edge of the tumour. 
The temperature distribution along the x-axis as a function of heat exchange 
between the tumour and the surrounding air, is shown in Figure 5a. The effect 
of isolating the tumour (hA=O Wm-2 K- ' ) is small. A relatively cold (20°C) air 
flow around the tumour, i.e. large heat exchange, lowers the tumour 
temperature with about 2°C and increases the difference between the 
temperature at the edge and the temperature in the centre with 0.8°C. 
The temperature distribution is effected more by heat transport through 
blood flow than by heat exchange with the surrounding air. Blood flow through 
small vessels (diameter smaller than O. 5mm) is best described with a enhanced 
effective heat conductivity (Crezee et a/., 1991). The effective heat conductiv-
ity was varied between 0.6, corresponding with no blood flow, and 3 W m- l 
K- l , which is typical for well perfused tissues like the tongue. A lower effective 
heat conductivity gives a less homogeneous temperature distribution 
(Figure 5b). Because of the poor blood flow in most rat tumours, steep 
temperature gradients outside the square implant are often seen. This results, 
especially for larger tumours, in a large difference between T'dg, and T coot" 
(Figure 6). 
To find out if T'_'dg, is representative for the minimum tumour temperature 
the x-edge temperature was elevated to 46°C. If the current is kept the same 
(135 mA/applicator) for each applicator, the temperature distribution along the 
z-axis will be substantially asymmetric around the centre of the implant 
(Figure 5c) which is due to the position of the ground plane. So, in this case, 
the upper side of the tumour (T'_'d9') would be seriously under-dosed if T'~dg, 
were seen as T mio' This error is smaller if the applicator temperatures are 
maintained equal (upper applicators 180 mA, lower applicators 50 mAl as can 
be seen in Figure 5d. However, to get Tl-edga equal to Tx-edge, so that TX-edge 
becomes really the minimum tumour temperature, it is still necessary to 
position the centre of the implant at least 1 mm above the centre of the 
tumour. 
In the equal applicator temperature situation, T m" is located in the centre of 
the implant and is a little higher (56°C) than the temperature inside the 
applicators (54°C). However, in in vivo experiments, the applicator 
temperatures are always higher then the central temperature. This is mainly 
due to the dielectric loss in the nylon catheter wall which is not included in the 
model. Therefore, the highest applicator temperature can be seen as T m,,' 
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Figure 5. Model calculations of the temperature distribution along three orthogonal axes through 
the centre of the implant after 330 s of heating. 
a) Effect of heat exchange between the tumour and the surrounding air on the temperature 
distribution along the x-axis, for three combinations of air temperature and heat transfer 
coefficient. solid line: Ta=25°C, hA= 10Wm-1 K- 1 (normal exchange, dotted line: Ta =25°C, 
hA =OWm-1 K- 1 (isolationL dashed line: Ta= 20°C, hA = 100Wm·1 K· 1 (large exchange). 
b) The temperature distribution along the x-axis as a fUnction of the effective heat conductivity. 
thick solid line: k~ff=O.6, dotted line: keff =l, dashed line: keu=2, thin solid line: kcu =3. 
cJ Temperature distribution along the x(solid), y(dotted) and z(dashed) axes. The current per 
applicator was held the same for each applicator. 
d) As in c) but now the applicator temperatures are equal. 
3.2. In vivo measurements 
Several different tumours (rhabdomyosarcoma (Rl m, n = 14), lung carcinoma 
(L27, n = 4), colon carcinoma (CC531, n = 15» have been treated. All of them 
were solid tumours growing in the flank of a rat (R1 m in female WagRij, L27 
in female Brown Norwegian, CC531 in male WagRij) with tumour volumes in 
the range of 1500-2000 mm'. 
In Figure 6 two typical examples of an IHT-treatment are given. In a colon 
carcinoma the minimum tumour temperature was held at 44°C for 30 minutes 
(upper panels). The second example is a treatment of a rhabdomyosarcoma 
where the aim was Tm;,=46°C for 15 minutes (lower panels). Although the 
tumour volume was the same (1750 mm') for both tumours, the maximum 
tumour dimension of the R 1-tumour was larger (17 mm) than that of the 
CC531-tumour (12 mm), which had a more spherical shape. The left panels 
of Figure6displaythe minimumandmaximum temperatures during the treat-
ment. The charts on the right show the temperature distributions through the 
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tumour, measured with the 7-point thermometer probe just before power off 
at the end of the treatment time. In both treatments T,_.,g. was easily elevated 
to the target temperature and maintained stable (± O. 5°C) during the whole 
treatment time. During the heating-up period about 2-3W was used. If the 
tissue resistance is about 500 and the efficiency is 35% the current per 
applicator was in the range of (120-150 mAl. To maintain T m'O' about 0.6 W 
per applicator (nett generator output) was sufficient for the 44°C treatment 
and about 1W to keep Tm"at 46°C. Further differences are that the target 
temperature was reached more rapidly in the CC531-tumour than in the R1 
and that the temperature distribution in the lower panels of Figure 6 is 
considerably less homogeneous. 
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Figure 6. Typical IHT treatments; The minimum temperature was held at 44°C for 30 minutes 
inside a colon carcinoma (upper panels), and at 46°C for 15 minutes inside a rhabdomyosarcoma 
(lower panels), The temperatures measured at the edges of the tumour and inside the warmest 
applicator, during the treatment (left panels). The figures on the right show the temperature 
distribution through the tumour at the end of the treatment time. 
In general, it was found that treatment characteristics as temperature 
uniformity, applicator power and time before the target temperature was 
reached depend on T m" and the tumour diameter. The reason for this is that 
the absorption of the electromagnetic energy falls steeply with increasing 
distance from the applicator, resulting in a large temperature gradient (10-
15°C/cm) outside the 7 mm square implant. The results are summarized in 
Table 2, where the difference between T m'e and T,pp, is a measure for 
inhomogeneity. For a given implant, T mie and heating rate are limited by the 
maximum tissue temperature allowed (in our case 70°C inside the applicators 
dutingheating) ahdbythll size of the tumour. 
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Tumour type (R1 m, L27, CC531) and mean start temperature (28.8°C, 
SD = 1.2°C, range:26.4°C-31.9°C) did not have a noticeable effect on the 
heating process. The rectal temperature was measured during a number of 
treatments and this revealed a slow (about 0.1 °C/min) decrease of core 
temperature, probably due to anaesthesia with pentobarbital. No correlation 
with the tumour temperature has been seen. To minimize the cooling of the rat 
the saline bag below is warmed up to about 30°C before treatment. During 
the treatment a lamp keeps the environment of the rat warm. 
Table 2. Characteristics of the lHT-treatments (n=33): mean ± SD (range) 
small tumours (0 ,,; 14mm) large tumour (0 > 14 mm) 
Tmin Tapp, - T min thaat-up P steady state Tapp, - T min thaal-uP P steady state 
rOC] rOC] [sl [W] rOC] [s] [W] 
44 3.6±1.4 5.3±1.7 0.68±0.13 9.4±1.5 7.3 ±4.4 0.87 ±0.15 
(n= 12) (n=7) 
46 4.5±1.6 5.2±1.6 0.90±0.00 10.4±2.4 8.4 ± 1.3 1.00±0.11 
(n=6) In=8) 
4. Discussion 
The IHT-system described in this report can reliably heat small tumours in the 
flank of a rat in an uniform manner. In tumours measuring less than 2 cm, a 
minimum tumour temperature of 46°C can be reached and maintained. In 
larger tumours the minimum temperature is be limited by the maximum 
temperature, measured inside the applicators. 
However, these observations do not necessarily imply that the system is not 
suitable for heating larger tumours and at other locations. For the R1 m 
tumours the maximum spacing between the catheters was about 7 mm. It was 
chosen to keep the implant geometry constant. However, in somewhat larger 
tumours a larger spacing between the applicators would improve the 
homogeneity of the temperature distribution. Furthermore, it is possible to use 
longer applicators. The maximum generator power is sufficiently high (lOW) 
to heat the tissue over a length of about 4 cm and the matching network is 
capable to match the impedance of longer applicators. For much larger 
tumours it would be necessary to increase the number of channels. 
If the system is used to investigate the effect of thermal dose on tumour 
response, specially when the treatment time is short (15 min), the 3-10 
minutes heating up time should not be neglected. To minimize the variation in 
thermal dose given before the actual treatment starts, the range in tumour 
diameter (x-axis) must besma(1. 
In vivo studies indicate that the most efficient treatment involves the 
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simultaneous application of heat and radiation (Overgaard, 1980). A limitation 
of the current source system is that IHT and IRT can not be delivered simulta-
neously. However, the time gap between radiotherapy and hyperthermia can 
be short (,,; 5 min). This makes it feasible to study the effects of (quasi) 
simultaneous treatments through alternating (PDR) IRT and IHT sessions. 
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Figure 7. Temperature inhomogeneity due to dissipation in nulon {crosshatched bars) and 
polythene (hatched bars) afterloading catheters, The normalized temperature rise after 1 minute 
heating along the central implant axis, measured in an agar phantom, 
A few points are pertinent when comparing animal experiments and clinical 
treatments. The maximum temperature of almost 70 0 e (Figure 6c) would not 
be acceptable in human tissue. Furthermore, a 7 mm spacing between the 
afterloading catheters is relatively small, compared with clinical practice. 
Dielectric loss in the nylon catheter material is the main reason for the high 
applicator temperatures. Due to the high dielectric loss factor of nylon 
(tgo=0.04) 20 to 50% of the electromagnetic energy is absorbed inside the 
catheter wall. A more homogeneous power distribution can be obtained if 
teflon or polythene catheters, with a negligible loss (tgo=0.0002), are used 
(Figurel)' However. ..... these .c.athe.ters .. h.aYe.110LbeefLJJSedJor .. the. tre'lJrne[1ts 
described in this paper, because of the relatively large energy loss in the impe-
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dance matching circuit which leads to a power shortage. In addition, the 
diameter of the present brachytherapy catheters used with afterloading 
systems (microSelectron HDR/PDR/LDR) is 2.0 mm instead of 1.6 mm used for 
the animal treatments. This improves the homogeneity of the power 
distribution. A pilot study with headlneck tumours (Levendag et al., 1993) 
showed that, using 2 mm nylon catheters and a mean spacing of 15 mm, 
minimum temperatures of about 40°C and mean applicator temperatures of 
45°C are feasible. Present in vivo experiments are done with 2 mm 
polyoxymethylene (POM, tgo = 0.005) brachytherapy catheters. 
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Abstract 
In interstitial heating one of the main requirements to achieve a certain 
elevated temperature in a tumour, is that the effective power per applicator 
(P'If)' i.e. the power which is actually deposited in the tissue, is sufficiently 
high. In this paper this requirement is discussed for the applicators of the 27 
MHz multi-electrode current-source (MECS) interstitial hyperthermia (lHT) 
system. 
To minimize power reflection, the applicator impedance was matched with 
the generator impedance by adjusting the length of the coaxial cable in 
between. Transmission line losses, applicator efficiency and subsequently P,1f 
were computed for several applicator types. The actual P,1f per electrode was 
obtained from calorimetric measurements. Experiments with RC-Ioads, which 
can be seen as perfect applicators, were performed to investigate the effect 
of mismatching on P,If' Applicator losses were measured for clinically used 
applicators, both single- and dual-electrode, utilizing saline phantoms. 
A simple spherical tumour model, using the effective heat conductivity (k'lf) to 
account for heat transport, was used 'to estimate P,1f for a given tumour size, 
implant size, and applicator density. 
Computations .. of P,(f. of .. various .. MECS:.IHT el.eGtro.des.~ere ... i.n ... c.loseagree-
ment with the phantom measurements. Most of the initial generator power 
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was absorbed in the transmission line (60-65%). The efficiency of the 
applicators was about 65%. Both for single-electrode and dual-electrode 
applicators the effective electrode power was found to be about 1 W. 
Model calculations show that P,,, of 1 W is sufficient to reach a minimum 
tumour temperature of 43°C in well perfused tumours (k,,,=3 W m-'°C-'), 
using a typical implant with 2 cm electrodes and 1.5 cm spacing. Mismatching 
can considerably affect P,,,. Both a reduction to almost zero and a two-fold 
increase are possible. However, because the matching theory is well 
understood, mismatching is not a serious problem in clinical practice and can 
even be used to increase P effl if necessary. 
The applicator design and the impedance matching method chosen in the 
MECS-system allow heating to temperatures in the therapeutic range, with 
implants used in clinical practice. 
1. Introduction 
The multi-electrode current-source (MECS) interstitial hyperthermia (IHT) 
system has been developed in a collaboration between the University Hospital 
Utrecht and the Dr Daniel den Hoed Cancer Center Rotterdam. Flexible multi-
electrode applicators can be inserted in standard afterloading catheters, which 
can also be used for brachytherapy. The 27 MHz current-source heating 
method is based on the capacitive coupling of electrodes, through the plastic 
catheter wall, with the surrounding tissue. Electrical current, which flows 
either to an external ground plane or to electrodes with opposite phase, is 
dissipated in the tissue. Because the impedance of the catheter wall, typically 
5-10 pF, is high compared to the tissue impedance (generally less than 100 
0), the current injection into the tissue is independent of the implant geometry 
and quite homogeneous along the electrodes (Marchal et al., 1989; Visser et 
al., 1989a; Deurloo et al., 1991). 
The subject of this paper is the heating efficiency of the MECS-system, i.e. 
the ratio between power effectively deposited in the tissue and the generator 
power. The power per channel is about 5 Wand the system was designed to 
have an efficiency of about 0.2-0.3. The remaining effective power of 1-1.5 
W per channel was considered to be enough to reach therapeutic tumour 
temperatures. However, in practice a large variation in heating rates was 
observed. A study has been performed to investigate which parameters 
influence the effective power per channel and to what extent. Energy loss 
between generator and tissue can be divided in a part which is related to the 
method used to match the electrical impedance of the applicators with the 
generator impedance and a part, associated with the applicator design. 
After a short description of the MECS-system in section 2.1, the theoretical 
models used to calculate the heating efficiency for a certain applicator-
catheter-tissue combination are described in section 2.2. Furthermore, it is 
shown in this section how the power absorption density needed to reach a 
ceitilintemperalure risecanbeestimat"d,using"'simpl,,sphericaThomogene: 
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ous tumour model with an effective heat conductivity to account for heat 
transport. 
The heating efficiency theory has been verified in the section 3. 
In section 4, the predicted efficiency of the MECS-IHT system will be 
discussed in relation to the 
estimated power absorption density. requirements and conclusions will be 
drawn in section 5. 
2. Materials and methods 
2.1. The 27 MHz current source interstitial hyperthermia system 
In Figure 1 a a diagram of the 27 MHz current source hyperthermia system is 
shown. Three units can be distinguished, i.e. a 27 MHz power unit, a 
thermometry system, and a workstation for treatment planning and treatment 
control. 
The power system has 64 coherent channels, divided into two groups with 
a phase difference of 180°. Duty cycle power steering is used to maintain the 
strict phase relation between the channels. The duty cycle switches of four 
channels are grouped in one module. In Figure 1 b a schematic of a switch 
module is shown. The channel power is proportional with the ratio between 
the time that the corresponding switch is closed and the total cycle time (200 
ms). Each of the 16 switch modules has its own power amplifier. The output 
of the power amplifiers contains higher harmonics of 27 MHz (~-10 dB). A 
purer 27 MHz signal of about 20 W is obtained, using low pass absorption 
filters (transmission of higher harmonics: ~-15 dB). 
Temperature measurements are performed with 7 -point constantan-manganin 
thermocouple probes (ELLA-CS, Czech Republic). Fast data acquisition (all 196 
channels read within 320 ms) is feasible with a high resolution (0.005°C) 
thermometry system (De Leeuw et al., 1993). 
A UNIX-workstation provides the connection between thermometry, power 
supply and operator. Features of the treatment control software are: pre-
treatment functionality check of applicators and thermometry, automatic or 
manual temperature control per electrode, clear display and automatic storage 
of treatment data and a user-friendly graphical user interface. 
Furthermore, the workstation is used for treatment planning. Three-
dimensional models are available for calculation of the distributions of power 
absorption and temperature for heterogeneous tissues. 
A more extensive description of the MECS-system has been given by 
Lagendijk et al. (1995). 
Both single-electrode applicators and multi-electrode applicators of various 
lengths can be used. In Figure 2a a diagram of a dual-electrode applicator is 
shown. An applicator consists of the applicator catheter, one or more elec-
trodes and a mUlti-point thermometer. An electrode comprises a tubular 
cbhdu6ting··segment Which·is conhecled···!o a lhih·feeder w;r". Th,,··segm""(s 
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of the standard applicators are constructed from a layer of silver paint 
(Electrodag 1415, Acheson Industries), For thermometry a multi-point 
thermocouple probe is inserted into the applicator catheter. 
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Figure 1. a) Diagram of the 27 MHz MECS-IHT system. b) Schematic of a switch module. The 
channel power can be adjusted by changing the duty time of the corresponding switch. 
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Figure 2. Diagram of a dual-electrode applicator. a) cross section parallel with applicator. b) cross 
section perpendicular to the applicator, 
2.2. Applicator impedance 
The appticator impedance (Z,) is the etectrical equivalent of one applicator 
electrode inserted in an a/terloading catheter surrounded by tissue. For a single 
electrode applicator Z, can be divided into three serial components, the elec-
trode impedance (Z,), the afterloading-catheter impedance (Z,) and the tissue 
impedance (ZI)' 
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2.2. 1. The electrode impedance 
The electrode consists of a cylindrical feeder wire which is connected to a 
conducting tubular segment. The resistance of a tubular or cylindrical (d, = 0 
m) conductor is 
R, 41 [0] (1 ) 
an(d~-di2) 
With I [m] the length, d, [m] the inner diameter, do [m] the outer diameter and 
a [5 m" ] the electrical conductivity. Using this equation the electrode 
impedance can be computed. The. resistance of a 20 cm long (typical 
applicator length), 50 jJm thick copper feeder wire (a= 0.6x1 0' 5 m") is about 
1.7 O. The resistance of an applicator segment, constructed from a thin (5 
jJm) layer of moderately conducting (a=0.04x10' 5 m") silver paint 
(Electrodag 1415, Acheson Industries) on a catheter (d, = 1.3 mm) is only 0.12 
O/cm. The feeder wire resistance is thus relatively large, compared with the 
segment resistance. 
2.2.2. The afterioading-catheter impedance 
The aiterloading-catheter impedance (Z,) includes both the capacitive coupling 
between the segment and the surrounding tissue, and the coupling between 
feeder wire and tissue. 
The coupling is predominantly capacitive. Nevertheless, the dielectric losses 
in the catheter materials have to be taken into account. These can be 
described by defining the complex dielectric constant: 
(2) 
The impedance between two, in one dimension infinitely long, conductors, 
separated by a dielectricum, is given by: 
z [Om] (3) 
with Eo the permittivity of free space (8.85x10,12 F m") and E, the dielectric 
constant of the dielectricum between the conductors. Fgis the geometry factor 
which is, for two concentric cylinders: 
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Fg = _1_ln.<1: (4) 
2" dl 
with do and d; the diameters of the outer and the inner cylinder, respectively. 
Usually, dielectric materials are characterized by the dielectric constant (f,) 
and the dielectric loss factor 
f/l 
tanto) =....'... 
f' ,
Using this expression, equation (3) becomes 
Z = tan(ol-j F C'C',..-,=-;'--',c;-;;" g Wfof,(1 +tan'(o)) 
(5) 
[Om] (6) 
Because the electrode segment and feeder wire lengths are relatively large, 
compared with the diameter of the afterloading catheter, Z, can be approxi-
mated using equation (61. As an example a typical single-electrode applicator 
is chosen with a 2 cm long electrode segment (d = 1.4 mm). The applicator 
catheter (do = 1.27 mm, d; = 0.861 is made of polythene (PE: f, = 2.4, tanto) = 0-
.0002). Inserted 12 cm deep in a standard polyoxymetylene (POM: f, = 3.7, 
tanto) =0.0051 afterloading catheter (do = 2 mm, d; = 1 .5 mm), the afterloading 
catheter impedance is about 1.4-625j O. The wire-tissue coupling (Cw.! =0.18 
pF cm'!) is small compared with the coupling between the electrode segment 
and tissue (C = 3.82 pF cm-". Consequently, heating along the leads will be 
insignificant. 
2.2.3. The tissue impedance 
The tissue impedance depends on the electrical conductivity and the dielectric 
constant of the tissue. Measurements of these properties on some mammalian 
tissues have been summarized by Gabriel et al. (1996). The complex dielectric 
constant of biological tissues is often written as: 
- I· a tE, = £,-J-
foW 
(7) 
with a the electrical conductivity and €, the dielectric constant of the tissue. 
The tissue impedance can be computed with: 
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z, [Om] (8) 
F 9 is a geometry factor, which depends on the geometry of applicators and 
ground plane. For two parallel cylindrical conductors with diameter d and 
spacing D the geometry factor is: 
.! In 2D-d (9) 
" d 
To calculate the tissue impedance in the situation of two parallel electrode 
segments with opposite phase, i.e. the impedance between one of the seg-
ments and the virtual ground plane in between, Fg has to be divided by a factor 
2. 
In Table 1 this impedance (0 cm) is given for the situation: d = 2 mm and 
D = 15 mm in fat, muscle and agar, respectively. This is an approximation of 
Z, of 1 cm long electrodes which are separated 1.5 cm from each other. It 
should be noticed that the electrode length is not small compared with the 
spacing and therefore, the actual Z, is somewhat smaller. The tissue impe-
dance has a significant capacitive part, especially in case of fatty tissue, but 
it is small compared with the imaginary component of the catheter impedance. 
Table 1. Tissue impedance between a conducting cylinder (diameter: 2 mm) and a 7.5 mm distant 
parallel conducting plane, calculated for several tissues. 
Z, 
Tissue a E, 
[S m"] [ ] Real [0 cm] Imaginary [0 cm] 
Fat 0.2 20 206 -31 
Muscle 0.7 50 60 -7 
Agar 0.6 80 68 -14 
2.2.4. Parasitic pathways to the system ground 
Besides the coupling between feeder wire and tissue (Cw.,), already mentioned 
in section 2.2.2., other unwanted routes for the 27 MHz current to flow to the 
system ground may be present. An overview of possible pathways in case of 
a dual-electrode applicator is shown in Figure 3. The coupling between an 
electrode and the thermocouple probe (Cw." and C,.,,) causes two extra 
pathways to the systemground ... One through thBt.issuB (C",,).vvhichmight 
induce, like Cw.I' extra unwanted tissue heating along the applicator, and one 
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through the thermocouple wires which might result in a decrease of the 
effective power and causes extra disturbance of the thermometry system. The 
direct coupling, not through tissue, between the electrodes of a multi-electrode 
applicator (Cw.wand Cw,,) could lead to energy absorption in the isolation 
material in between, and cause heating away from the electrode segments. 
Therefore, only applicator catheters with negligible dielectric loss factors 
should be used. 
The parasitic impedances between electrode(s}, thermocouple probe and 
tissue, computed with equation 6 and the geometry factors (4) and (9), are in 
good agreement with measurements. Typical measured values for the different 
types of parasitic coupling are given in Table 2. An overall parasitic capacitive 
coupling between the electrodes of an applicator as shown in Figure 2 of 
several pico-Farads is inevitable. This is of the same order as the coupling 
between the electrode segments through the tissue. Therefore, it is important 
to construct the applicator from low loss materials to minimize self-heating of 
the applicator. 
I 
-
tissue 
electr ode 1 CW,IJ{O.45} et(3.B) 
w,w (0.3) cw,le] (0.35) Cle,sI(0.55) H -·1 thermocouple probe CW,s (0.45) 7 ? CW,le] (O.25) Cle,sl{o.55) 
I 
Ctc,t (O.45 
cw,{ (O.65) ode 2 cl{3.B) 
1-
c 
-I~' 
electr 
r 
Figure 3. Schematic drawing of a dual-electrode applicator with the various capacitive pathways 
between the electrodes, the thermocouple probe and the tissue. The value between brackets gives 
the magnitUde of the coupling in pF em-'. 
Table 2. Parasitic capacitive coupling fpF em-'] between the components of a dual-electrode 
applicator and the tissue (measured). 
0.45' 
0.65' 
Cw,w 
0.30 0.35' 
1 : feeder wire inside the applicator catheter 
2: feeder wire outside the applicator catheter 
Cw,s 
0.45 0.55 
0.25' 
0.45 
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2.3. Impedance matching 
To minimize power reflection, the applicator impedance must be matched with 
the output impedance of the generator (500). The procedure is as follows. As 
was demonstrated in section 2.2., the impedance of an applicator in a tumour 
is mainly capacitive. Using a coaxial cable, about 3.5 meter long, to connect 
the electrode(s) to the power system, the applicator impedance is transformed 
to a real impedance of about 800 O. For four parallel channels, the impedance 
becomes 2000, which is transformed into 50 0 using a 4: 1 transmission line 
impedance transformer (Figure 1 b). The higher harmonics filter is a 50 0 
device. 
Transformation of a given load impedance (Z,,,) through a coaxial cable to 
an input impedance (Z'o) can be calculated using the transmission line formula: 
[0] (10) 
with Q ~ (a+ jB)I, in which a [nepers m-I ] is the cable attenuation, 
B (~2TT/), ~ w' PoIl,EoE,) y,) [m-I ] the wave number and I [m] the cable length. 
Furthermore, Zo is the cable impedance and Pof/, and EoE, the permeability and 
permittivity of the cable, respectively 
(po~ 1.3x10-6 H m-I). 
The procedure used to transform the applicator impedance (Z,) to 800 0 (Z'o) 
has been visualized in Figure 4a. The transmission line between switch and 
applicator includes 0.03 m stripline on the switch module (E, ~ 2.2, a~ 0.011), 
0.38 m coaxial cable in the 19-inch-cabinet (cabinet cable, E,~ 2.03, 
a~0.017), 2.5 m low loss coaxial cable from cabinet to patient (translation 
cable, E, ~ 1. 79, a~ 0.007) and the coaxial cable with a length meeting the 
matching conditions (matching cable, E, ~ 2.03, a~O.017). The relative 
permeability (p,) is 1 for all cables. If Z, is on the dashed matching-cable-curve, 
it is transformed to exactly 800 0, using a transmission line only and the 
appropriate length of the matching cable can be calculated using equation 
(10). If not, fine tuning, i.e. modification of Z, by addition of either a serial 
inductance (Zl) or a capacitor parallel to the applicator (Zcl is needed. 
For example, to match the impedance of a 2 cm electrode inserted in a 
polyoxymethylene (POM) afterloading catheter in muscle tissue (Z,~30-j630 
0), an inductance of 2.1 pH (Zl~5+j360 0) and a matching cable length of 
about 0.90 m are required. 
Normally, each electrode is connected to one channel of the power system. 
However, two to four channels can be combined if a high power is needed, 
e.g. in situations with large blood flow or with long applicators. Figure 4b 
shows the impedances which transform, without fine tuning, to 800 0, if Zoot 
is connected to one or more power channels. In general, a longer matching 
cable and a larger modification of Z, are needed for impedance matching, if an 
applicator is connected to Ill()reth'ln oneparalieltranslllission Ii"e Tri'';:'2;3()r 
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4). This means that part of the extra power gained is lost again in the extra ZL' 
For a small applicator impedance, e.g. in case of a long applicator, it might be 
more advantageous to take only the permanent parts of the transmission lines 
(striplines, cabinet cables and translation cables) parallel and connect them to 
one matching cable (n ~ 2,3,4). It should be noticed that the loss in this single 
matching cable increases due to the higher current (see section 2.4.2., Figure 
6). 
a) 
b) 
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Figure 4. Impedance matching. al If an applicator impedance (Za) cannot be transformed to 800 
0, using a transmission line only, a small inductance (ZL) or capacitor (not shown) is added. b) The 
cable-only matching curves for an applicator segment connected to one, two, three or four power 
channels with a single matching cable (n = 1,2,3 or 41 and with parallel matching cables (n' = 2,3 
or" 4J ~ "Only. ,the", ll1aJC".!bJIlR "c:~,~I,e" pa,r~ gJ Jtl~,J[~fll3rl}Ls,fligXL,lin!3" i\3, s,hC)wnLJhJ~, t:EflJ(ln9,~JH~JW!3J3Jl 
subsequent square symbols on the un = 1" curve is 10 em. 
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2.4, Effective power 
The effective power is defined as the power which contributes to the heating 
of the tissue, in the neighbourhood of the conducting segment, Using this 
definition means that absorption of electromagnetic energy in the afterloading-
catheter wall, followed by heat conduction into the tissue, is included, How-
ever, heating along the leads is excluded by this definition, 
The effective power per electrode depends on the input power of the 
channel(s) to which it is connected and furthermore on different kinds of 
energy loss between the duty cycle switches and the tissue, such as 
transmission line loss, dissipation in the matching inductance, self-heating of 
the applicator along the leads and energy leakage into the thermocouple probe, 
Figure 5 is a schematic drawing of an electrode connected to one channel of 
a switch module, The power effectively dissipated in the tissue around an 
electrode, i.e, dissipated in R, is: 
" Peff = lJa L (1](1,/ PinJ [Wl 111 ) 
i_1 
P'o" is the input power of channel i and n is the number of channels to which 
the electrode is connected, Furthermore, flfI" is the efficiency of the trans-
mission line i and fI, is the applicator efficiency, 
Pin i Pout,i L Rs :';~7'fWdE- ~~---~f-_---: -{OO)~l I c 
- Zl'n I' Zout,I' P QJJ' 
---------lBl- ' 
-----> _ Rp I R 
Zswitch _ 
. 
switch module transmission line applicator 
Figure 5. Schematic drawing of an electrode connected to one channel of a switch module. 
2.4, I, Channel input power 
In case of a perfect impedance matching IZ,o" = 800 n for i = 1 ,2,3,4) and 
neglecting the losses on the switch module, each of the four channels receives 
y., Pg", However, this channel input power IP,o", i = 1 ,2,3,4) alters if one or 
more channels are mismatched, First, since the input impedance of the switch 
module is not 50 n, Pg" is partially reflected IP,II) and secondly, the remaining 
forward power IP'Wd) does not necessarily split into four equal portions if the 
channel irnpedances IZ,o) are not the same, 
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The power dissipated beyond a higher harmonics filter is: 
with p the complex reflection coefficient, defined as: 
p 50 -Zswitch 
50 +Zswitch 
[WJ (12) 
(13) 
and Z,w;"h the equivalent impedance of four parallel channels transformed, with 
the 1:4 impedance transformer 
[OJ (14) 
The fraction of P
,Wd which goes into channel i is: 
f;= Re {4Z'WU,h} (15) 
Re (Z;,J 
Now the input power flowing into channel can be calculated, using the 
equations (12) and (15): 
[WJ (16) 
with 1], the efficiency of the switch module, representing the losses in the 
impedance transformer and in the switches. 
2.4.2. Efficiencv of the transmission line 
The efficiency of a transmission line i is defined as 
Pout,! 
ntl,; = --
Pin,; 
The power dissipated in an impedance Z is 
(17) 
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(18) 
with U the electrical potential over Z. The complex conjugated is denoted with 
an asterisk. 
Knowing that Z'o.' can be written as a function of Zoot." Zo and 0 (eq. 10), 
and, furthermore, using the relationship between the electrical potentials at 
both sides of the transmission line 
Zo sinhlQ) +Zoutcosh(Q) 
Zout 
119) 
the ratio between P,o.1 and Pout., can be computed as a function of Zout" and the 
properties of the transmission line (Zo, 0), 
The efficiency of the transmission line, as a function of the length of the 
matching cable, is shown in Figure 6, The efficiencies were calculated for a 
situation of perfect matching, Le, for each length of the matching cable a Zoot 
was taken which transforms to Z'o ~ 800 Q, If parallel transmission lines are 
used, generally longer matching cables and/or a larger "dissipating" matching 
inductance are needed. Therefore, the effective power is not fully proportional 
to the number of channels, Especially in case of parallel channels plus a single 
matching cable In ~ 2,3,4) the efficiency might be disappointing because of the 
larger current and thus an increased loss in the matching cable, 
transmission line efficiency 
0,7,-------------, 
0,4 
0,3 
0,2 
0,1 n=4 
°o~------
20 40 60 
n~1 
n=3 
80 100 
matching cable length [cm) 
120 
Figure 6. The efficiency of the transmission line as function of the length of the matching cable 
which is needed for matching Zout with 800 n. For an applicator segment connected to one, two, 
three or four power channels with a single matching cable (n = 1,2,3,4) and with parallel matching 
cables (n' ~ 2,3,4). 
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2.4.3. Applicator efficiency 
Not all output power of the transmission line is effective power. In Figure 5 the 
electrical equivalent of an applicator plus matching inductance is drawn. The 
effective part of Po",., is the power which is absorbed in R (P'If)' As mentioned 
above, extra ways to the system ground (Cp) might result in energy loss, 
indicated by Rp. Also dissipation in the matching inductance (L) and in the 
feeder wire do not contribute to tissue heating near the electrode segment. 
These losses are represented by R,. The applicator efficiency (I),) is defined as 
the ratio of the power dissipated in R and the sum of the output powers of the 
channels to which the applicator electrode is connected: 
I), (20) 
The loss in R, depends on the ratio between R, and R, as can be seen in Figure 
7a in which Rp = O. Further decrease of I), due to dissipation in R, will occur if 
the ratio between Cp and C increases. This is also demonstrated in Figure 7a. 
In Figure 7b, I),is shown as a function of Rp/R, if R,=O. As long as the impe-
dances associated with Cp and C are large compared with Rp and R, respect-
ively, I),is mainly dependent on the ratios between Cp/C, Rp/R and R,IR and not 
on the actual values of Cp, C, Rp and R, (in these calculations C = 10 pF, R = 40 
n, L= 1 pH). Furthermore, losses in R,or Rpare independent of L. However, the 
part of R, which is due to dissipation in the inductance is proportional to L. 
The overall efficiency (1)"'0)' which is defined as the ratio between P,1f and 
"P,,,, can be obtained by substitution of equation (16) by equation (11). In 
case of an appropriate impedance matching 1)"'0 is the product of I)" I)" and I),. 
In practice, a power loss of 30-40% in the applicator is not extreme. Typical 
transmission line efficiencies are in the range 35-45%. Hence, assuming 
negligible switch losses, the overall efficiency is about 20-30%. This means 
that if an electrode is connected to one power channel (5 W), the effective 
power is about 1-1.5 W. 
2.4.4. Mismatching of the applicator impedance 
In theory, an applicator impedance can always be transformed to exactly 800 
n. In practice, however, mismatching to some extent is unavoidable. The most 
important reason for this is that, for practical reasons, the impedance matching 
is performed in an agar-phantom at room temperature. As the electrical prop-
erties and/or the applicator geometry in the clinical situation are not exactly 
the same as in the matching set-up, the applicator impedance will differ, too. 
Eveoif fjpplicqtors "fe m.f1tched inflPatientjust bef.ore.trea.lrn.ent, mismatchir19 
will occur as Z, changes during treatment due to the temperature rise, changes 
40 Chapter 3 
in blood flow or because of a change in the impedance of the afterloading 
catheter due to water absorption in the catheter wall. Other practical reasons 
for a, generally small, mismatch are that the matching inductances are only 
available at distinct values and that the transmission line used, often does not 
have exactly the right length. 
a) 
b) 
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Figure 7. The applicator efficiency, al as function of RJR (Ap =OL b) as function of RplR (Rs=O). 
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The problems that may arise if applicator impedances are not matched 
accurately (Z,,"'8000) are insufficient effective power and, if Z" varies per 
channel, a cross-coupling between the four channels of one switch-module. 
In case of mismatching, part of the generator power is reflected, which 
decreases P,,,. In the worst case situation, i.e. if more than 20% of the power 
is reflected, the generators are switched off automatically to protect both 
patient and heating system. Mismatching does not always result in a lower 
efficiency. The transmission line efficiency can be lower as well as higher than 
under perfect matching conditions. Furthermore, if Z" is different per channel, 
some channels will get more and some will get less than y., of the generator 
power. This latter effect makes the power control of one channel dependent 
of another. Using the theory described above, the heating efficiency can be 
predicted for a certain Zoo, and transmission line length (see Figure 8). 
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Figure 8. Computed channel~efficiency as a function of 20U1 ' Applicator losses are omitted. a) 
Same lout for all four channels of the switch module. bJ 20 'Jl of only one channel is varied, Zin for 
the other channels is kept at 800 n. The length of the matching cables is 85.5 em. The triangle 
indicates the 'perfect match point and 'the"dots 'correspond wlth'thEdive experiments of Table"3. 
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2.5. Power requirements 
To estimate the power absorption density, required to reach a certain minimum 
tumour temperature rise in the steady state, a simple spherical homogeneous 
tumour model was used. An effective heat conductivity was used to account 
for increased heat transport due to blood flow. The tumour and the implant 
volume are two concentric spheres. If the implant consists of "n" electrodes 
each with a length "I" !including the longitudinal spacing) and they are inserted 
in parallel afterloading catheters with a spacing "d", then the radius of the 
implant volume can be defined as r
,mpl", = (%nld'/rr)Y'. The effective power of 
electrodes is assumed to be homogeneously spread over the implant volume, 
resulting in a power absorption rate: 
(21 ) 
with Polf the power deposited in the tissue by each electrode and D, (ld')" 
the electrode density [m,3]. 
The stationary radial temperature distribution can be obtained by solving the 
heat equation for a sphere'symmetric medium: 
..!.~ [k r' a T(r) 1 = -P(r) 
r' ar ar 
(22) 
with T(r) the temperature [DC], k the effective heat conductivity [W 
m" DC"] and P(r) the power absorption rate [W m'3]. The solution of equation 
22 is: 
T(r) T~ + Pr'!mPfant Pr' 2k 6k 
[DC] (23) 
and 
3 
T(r) T~ + Primp/ant 1 3k -r 
[DC] (24) 
for r<rimPlant and r~rimplantl respectively. To> [OC] is the temperature at large 
distance from the implant centre. The minimum tumour temperature (T ml,,) is 
found at the edge of the tumour, i.e. at r=rtumour' With r=rtumourand T=Tminin 
equations 23 and 24, expressions for the required power absorption rate are 
obtained: 
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p = 2k(Tm!o-37) 
2 1 2 
fimPlant-3"tumoUf 
and 
p =: 3rtumou,k(Tmin-37) 
3 
(implant 
[Wl 
[Wl 
for rtumour < fimplant and for rtumour ~ rimplantl respectively f with Too = 37°C. 
2.6. Experimental verification 
(25) 
(26) 
The aim of the experiments was to test the effective power theory of section 
2.4. First, a series of calorimetric effective power measurements were 
performed, using load impedances (Zoo,), consisting of a resistor (R) and a 
capacitor (C) only. The resistors were placed in a known quantity of 
demineralized water and the temperature rise was measured after a certain 
time of heating, using a thermocouple probe. From these data and the specific 
heat coefficient of water (41BO J kg"! 0C-') the effective power per load was 
computed. 
Because most of P ,"I is dissipated in the resistors, the loads can be seen as 
perfect applicators, i.e. with f}, '" 1. 
The experiments were performed with four equal loads, connected to the 
four channels of one switch module. The magnitudes of both Rand C were 
varied to study the effect of mismatching on Pelf' Equal Z'o and different Z'o 
mismatching were investigated with all four channels switched on or only one 
channel switched on, respectively. 
Furthermore, P'" was measured for two types of clinically used applicators 
to study the applicator losses. A thermally isolated box (5x5.5xBcm3 ) was 
filled with 200 ml saline solution with a muscle-equivalent NaCI concentration 
of 3.B gil (at 20 oC: f, = 79, 
0=0.6 (r'm"'). Four parallel POM catheters (d,=1.5 mm, d,=2 mm) were 
positioned in a square geometry, with 1.5 cm spacing. In each catheter either 
a dual-electrode applicator (electrode-segment length: 2 cm, longitudinal 
spacing: 1 cm) was inserted or it was loaded with two single-electrode appli-
cators (electrode-segment length: 2 cm), inserted from opposite sides and also 
with a longitudinal spacing of 1 cm. In each catheter, one electrode was 
connected to a OO-channel and one to a 1 BOo-channel of the power system. 
All OO-electrodes were at one side of the central plane perpendicular to the 
catheters and the 1 BOo-electrodes were at the other side. The measurements 
.'foJere.perforrnedwith .. or.'foJithout ... a7-po.i.nt .thermocouple prope ..... Eac.h .. Pe,,-ya.l.u..6. 
is the average of five measurements. 
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The applicators were matched in the saline solution at environmental 
temperature. First, the applicator impedance Z, was established. The 
impedance between the two electrodes, of one dual-electrode applicator or of 
two single-electrode applicators, in one afterloading catheter (2Z,) was 
measured using a network-analyzer (HP8751 A). A balanced-to-unbalanced 1: 1 
impedance transformer was inserted between applicators and network-analyzer 
to assure that the measurement was symmetric around the system ground. 
Subsequently, the inductance (L) and the length of the matching cable (lm",h)' 
needed for a perfect matching, were computed. 
The components of Zow i.e. the applicator impedance plus the impedance of 
the matching inductance (Zl) (Figure 5), were obtained to compute the applica-
tor efficiency (fI,). First, the electrode impedance (R" about 1.7 0) and the 
impedance of the matching coil (Zl) were measured. From these measurements 
R" which is the sum of R, and the real part of Zl' was obtained. In order to 
estimate Cp and Rp the impedance between two electrodes was measured in 
air instead of the saline solution and R, was subtracted. The measurements in 
air and in the NaCI-solution together give C and R. 
Simultaneously with all P,"-measurements P'Wd and P,,, were measured 
between filter and switch module, using a Bird-power-meter. 
3. Results 
3.1. Experiments with Rand C components 
The aim was to investigate the effect of impedance matching on P'ff. The 
experiments with the simulated applicators, described in section 2.6., were 
performed with a matching cable of 85.5 cm. P,II has been measured for five 
load impedances, one giving a negligible power reflection (Zoot = 27-295j 0) and 
four values around this optimum. Furthermore, the measurements were 
compared with the theory. The results are summarized in Table 3. The gener-
ator power, with all channels switched off, i.e. switched to 800 O-Ioads, was 
20.4 W. The overall efficiency (flm",) which is defined as the ratio between P,II 
and y.,P,,, was found to be rather dependent on Zoot. More power was 
absorbed in the water for increasing C and for increasing R. This is in 
qualitative agreement with efficiency calculations. Figure 8 shows the 
computed efficiency as a function of Zoot for the situation in which fI, = fI, = 1 . 
The triangle denotes the load impedance which transforms to exactly 800 0 
if Im'''h is 85.5 cm. The circles mark the five loads used in the experiments. 
Looking at Table 3, load no. 2 seems to give the best impedance matching, 
i.e. the lowest reflected power, while the theory predicts the best match for 
load no. 5. 
On the other hand, in case of mismatching the sum of P'"d and P,,, is 
expected to remain equal to P,,,. This is only seen with load no. 5. Apparently, 
the 1·/8···power·· splitting· (Figure ····1i1jaoesno(··· fLinctronperfecOY foc···la,g er 
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mismatching, resulting in a lower P,,, with load no. 2 than with load no. 5. 
A more quantitative comparison of the efficiencies obtained from the 
measurements and the calculated efficiencies (Table 3) shows a difference 
which cannot be explained in terms of measurement errors. The ratio between 
fl meo, and fI",o is a measure for losses which were not included in the calcula-
tions. These were found to be in the range of 36 to 64%. The losses in Zoo, 
and in the switch module are the ones that were omitted in the computations. 
However, since R is the main dissipating component of Zoot and energy leakage 
out of the water can be neglected, P 00' can be calculated from the temperature 
rise of the water and fI, is expected to be close to 1. Furthermore, no sig-
nificant temperature rise was observed in the switch module when all four 
channels were switched on. Therefore, it is unlikely that the fI, multiplied by 
fI, could have been so low that this could explain the differences between flmeo, 
and "calc' 
Table 3. Effective power measurements with ZO,-,t consisting of a resistor and a capacitor. 
(i) Four channels switched on. 
Zout 
No Peff Pfwd Prfl 'lmeas 
[0] [0] [Wl [Wl [Wl [] 
1 10 -295j 0.29 (0.02) 21.5 0.8 0.06 
2 27 -295j 0.87 (0.04) 22.0 0.3 0.17 
3 119 -295j 1.56 (0.06) 20.5 1.8 0.31 
4 27 -405j 0.33 (0.01) 21.7 3.5 0.06 
5 27 -220j 1.14 (0.04) 17.6 2.1 0.22 
(ii) One channel switched on, 
Zout 
No Peft Ptwd Prfl I]meas 
[0] [0] [Wl [Wl [Wl [] 
1 10 -295j 0.17 (0.04) 20.7 0.3 0.03 
2 27 -295j 0.75 (0.03) 21.3 0.3 0.15 
3 119 -295j 1.91 (0.12) 20.0 0.3 0.37 
4 27 -405j 0.24 (0.02) 20.6 0.3 0.05 
5 27 -220j 1.25 (0.03) 19.7 0.7 0.25 
vatU£!$ betwB1m brackets"aUl the, standard ,deviations"aJterJiIlB"meaSUrements" 
1 With I]s = 'Ia = 1 
I]calc 
, 
[] 
0.10 
0.24 
0.48 
0.13 
0040 
f}calc 
, 
[] 
0.08 
0.25 
0.79 
0.13 
0.41 
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The exact cause for this missing power is still unknown at the moment. 
Probably, the load impedances also act as antennas, as a result of which part 
of the energy is not dissipated in the resistances and therefore not absorbed 
in the water. 
3.2. Experiments with real applicators 
If real applicators are used, applicator losses are unavoidable. We will show 
how the applicator design can affect the composition of Zoo, and thus fI,. The 
components of Zoo, were measured for both a single-electrode and a dual-
electrode applicator, with or without thermo-couple probe. From the measure-
ments of Z, in the saline solution the appropriate Imoteh and L were chosen. For 
the single-electrode and the dual-electrode applicators the lengths of the 
matching cables were 85.5 cm and 72.5 cm, respectively. To transform Zoo, 
roughly to Zoot.id", corresponding with these lengths, i.e. 26-227j nand 
13-150j n, respectively, a matching inductance was added. For the dual-elec-
trode applicators, with or without thermometer inside, 1.6 pH was taken. 
Because the single-electrode impedance is rather dependent on whether or not 
a thermometer is inserted, two different matching inductances were used, i.e. 
2.6 pH with and 1.3 pH without thermocouple probe. The actual impedance 
of ZL was measured separately. The components of Zoot and the resulting 
applicator efficiency are shown in Table 4. Because the matching cable is 
shorter when the dual-electrodes are used, the transmission line efficiency is 
somewhat larger than for the single-electrode applicators, i.e. 0.41 versus 
0.38 (Figure 6). 
The measured and calculated effective powers are given in Table 5. As with 
the RC-Ioads the measured heating efficiency is somewhat lower than 
predicted, but the qualitative agreement between measurements and 
computations is good. If no thermocouple probe is inserted, the single-
electrode applicator is, as expected, more effective than the dual-electrode 
applicator, in which extra losses are induced by the cross-coupling between 
the leads. However, if a thermometer is added, the single-electrode applicator 
efficiency decreases considerably, while Po" of the dual-electrode applicator is 
only slightly lower with than without thermocouple probe. The reason for this 
difference is that in the latter case the thermocouple probe is inside the 
applicator at about zero potential and therefore energy leakage through the 
thermocouple leads towards the thermometry system can be neglected. A 
thermometer in a single-electrode applicator enlarges the antenna behaviour 
of the applicator which causes a high-resistive parasitic pathway to the system 
ground. 
Although the impedance matching was performed with a set of two 
electrodes, the matching with eight electrodes remained good, except for the 
eight single-electrode applicators with thermometer. In this situation, the 
thermocouple leads are radiating antennas. Therefore, the applicator 
impedance strongly depends on the experimental set-up; For example, ·Z;with 
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eight applicators in the phantom is different from Z, with two applicators. 
Another example is that Z, changes if the thermometers are disconnected from 
the thermometry system. These effects are not seen if dual-electrode 
applicators are used. To obtain a good matching, using the single-electrode 
applicators with thermometer, these measurements of P,"have been performed 
in the matching situation, i.e. using two applicators. 
Table 4. Components of lQut and the calculated applicator efficiency. 
Single-electrode applicator Dual-electrode applicator 
(- ) (+) (- ) (+) 
Zout [0] 34-228j 36-228j 19-202j 16-155j 
C [pFJ 6.2 6.0 6.3 6.3 
R [0] 49.7 55.4 49.6 50.1 
Cp [pFJ 2.5 6.9 6.2 7.6 
Rp [0] 34.2 68.7 6.7 4.7 
L [tJHJ 2.6 1.3 1.6 1.6 
R, [OJ 6.2 4.3 4.7 4.7 
fJa,catc [] 0.74 0.33 0.67 0.63 
(-): Without thermocouple probe inside the applicator. 
( +): With thermocouple probe connected to thermometry system. 
Table 5. Peff' computed and measured values. 
Single-electrode applicator Dual-electrode applicator 
P elf,calc (W] 
P elf,Oleas [W] 
(-) 
1.41 
1.25 (0.03) 
(+) 
0.63 
0.59 (0.02) 
(-) (+ ) 
1.37 1.29 
1.04 (0.04) 0.92 (0.04) 
Values between brackets is the standard deviation after five measurements. 
(-): Without thermocouple probe inside the applicator. 
(+): With thermocouple probe connected to thermometry system. 
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4. Discussion 
In the previous section it was found that, using typically clinical applicators 
with well matched electrodes, P,,, is about 1 W. To investigate under which 
conditions this value is high enough, the model described in section 2.5. can 
be used. With a P,,, of about 0.5 W some unwanted power loss due to 
mismatching is taken into account. As an example a well perfused tumour is 
taken which can be described with an effective heat conductivity of k = 3 Wm-
'DC-' (Crezee et al., 1991), which is about five times the intrinsic value of 
muscle tissue. Furthermore, a target temperature at the edge of the tumour of 
43 D C and an electrode density of about 0.2x106 electrodes per m3 were 
chosen. The latter, for example, corresponds with electrodes with an effective 
length (I), i.e. including the longitudinal spacing between the electrodes, of 2.5 
cm and a distance between the afterloading catheters (d) of 1.5 cm. Here, D, 
was defined as (ld')-'. The power absorption rate follows from either equation 
25 or equation 26 and P,,, can be computed using equation 21. In Figure 9 P,,, 
is shown as a function of the tumour radius. The radius of the implanted 
volume was varied. It can be seen that small tumours can be heated 
sufficiently with a P,,, of 0.5 W, but only if the implanted volume exceeds the 
tumour volume. For larger tumours lower P,,, is sufficient. It is obvious that 
with increasing tumour size more electrodes are needed to cover the whole 
tumour. Therefore, there is an upper limit for the tumour radius which depends 
on the available number of electrodes (nmaJ. If ftumour = fimplant' this radius 
follows from the equations 21 and 26: 
nmaxPeff 
r -~~~~~IT IIJmO!lf,maX 4rrk(T
min 
37) [m] (27) 
The maximum number of electrodes that can be used is 64. If k=3 Wm-' DC-1, 
Tmin = 43°C and Pelf = 0.5 WI ftumour,max = 7 em. The electrode density 
(3n/4I7r') in this situation is 0.04x10'm-', e.g. 5.5 cm long electrodes and 2 
cm catheter spacing. 
It should be noticed that, in contrast with the model assumption that the 
power absorption is homogeneous in the implant volume, in reality it is rather 
inhomogeneous. It is an intrinsic property of interstitial hyperthermia that the 
highest absorption rate is found near the applicators. If the distance between 
the electrodes would be too large, T mio may no longer be located at the edge 
of the tumour, but somewhere in between the electrodes. In these situations 
T mio is often limited by pain caused by high temperatures near the electrodes 
and not by the available P,,,. Therefore, large catheter spacing should be 
avoided, especially in sensible regions as the head and neck. With the 27 MHz 
current source IHT-system a reasonably homogeneous temperature distribution 
can be reached through heat conduction, as long as the distances between the 
afterloading catheters do not exceed 1.5 cm, which is also an upper limit in 
brachytherapy. -
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Furthermore, in order to minimize inhomogeneous heating due to larger blood 
vessels or spatial variation of electrical and thermal tissue properties, one 
should always choose the shortest possible electrodes. Sometimes a 
compromise has to be found between I and d. For example, if D, = 0.04xl0' 
m-' and the tissue is quite homogeneous, it might be better to take I longer and 
d smaller than the above- mentioned 1= 5.5 em and d = 2 cm. 
In practice, a high-density implant with 1 em distance between the 
afterloading catheters and electrodes with an effective length of 1.5 cm (D, = 
O. 7xl 0' electrodes per m') is feasible. This decreases the required effective 
power with a factor of almost 4 in comparison with the example shown in 
Figure 9. 
There may be situations in which sufficient power is not available, for 
example, in case of a small, highly perfused tumour. Especially if it is preferred 
to keep the afterloading catheters within the tumour volume, e.g. because of 
the risk of normal tissue damage in brain tumours. To achieve more effective 
power in these situations, there are several possibilities. First, it is possible to 
connect each electrode to two, three or four channels. This reduces the 
number of electrodes which can be used and thus limits the maximum 
treatable tumour size. However, shortage of effective power mainly occurs for 
smaller tumours. 
Secondly, one could deliberately allow some mismatching to improve I)". In 
Figure 8 it can be seen that if Zoot is less capacitive or more resistive than 
Zout,ldeal for a certain 'match I the overall efficiency increases. Furthermore, one can 
search for ways to optimize I),. This applicator efficiency depends on R,/R, 
Rp/R and C,IC (Figure 7) and can be improved by decreasing one or more of 
these ratios. Applicator design, size and material of afterloading catheter, and 
the losses in the matching inductances are the main factors to be improved. 
To reach an optimal coupling with the tissue the electrode segments must 
fit tightly in the afterloading catheters. This requires either straight catheters 
or flexible segments and the catheters must not be narrowed by e.g. buttons, 
screws or sharp curves. 
The applicator efficiency also depends on the afterloading catheter. C,IC can 
be lowered by decreasing the ratio between the outer and inner diameter or by 
increasing the dielectric constant of the catheter material. A higher dielectric 
loss factor would increase R and thus decrease R,/R and RplR. However, this 
would make the applicators acting like hot sources which results in a less 
homogeneous temperature distribution. 
The losses represented by R, are mainly due to dissipation in the serial 
matching inductance. Impedance matching with a parallel low loss capacitor 
instead of L might lower R,. In case of a dual-electrode applicator this can be 
achieved by a design with a larger coupling between the electrodes. 
Factors which do have effect on I), but cannot be manipulated are the 
electrical properties of the tissue. Hot spots are often seen in high- resistive 
fatty tissue. Although a and f, cannot be changed, some manipulation of R is 
possible by choosing a more or a less resistive phase configuration of the 
electrodes. 
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In the present design of the heating system the maximum P,1f is limited by 
the choice to transform the applicator impedance to 800 0. Therefore, the 
maximum efficiency will be in the range 0.35-0.45, which is the efficiency of 
the transmission line (Figure 6). Together with an additional loss factor of 
about 0.5 this means that maximally about 1 W of the 5 W channel input 
power will be dissipated effectively in the tissue if the electrode is properly 
matched. Using the theory of section 2.4.2., it can be easily shown that 
transforming the impedance to a lower value results in a higher transmission 
line efficiency. For example, with ZiO = 200 0 instead of 800 017" will be more 
than 0.8. For the moment, the above mentioned solutions of more channels 
per electrode or deliberate mismatching are adequate in situations in which 
sufficient power is not available. 
Uncontrolled mismatching should be avoided. If for some reason the 
impedance is not matched correctly, three problems may occur. First, a system 
error makes it impossible to continue the treatment. Secondly, power steering 
problems may arise due to cross coupling between electrodes connected to 
the same switch module. This means that P'lfof each electrode depends on the 
duty cycle of the other three electrodes. Last, but probably most important, 
adequate heating is not possible due to a decreased P'If' 
A system error due to mismatching is in most cases induced by too much 
reflected power. It arises when an applicator is defective, connected to the 
wrong channel or when the electrode segments are shifted out of the tissue. 
In practice, the solution to this problem can be found in checking each 
applicator separately and replacing them if necessary. 
Mismatching occurs when the tissue impedance is different from the match 
phantom and does affect P,If' If different electrodes are surrounded by 
different tissues, P'1f may vary per electrode. These variations have proved to 
be small in clinical applications and can be controlled by the automatic tem-
perature control algorithm of the system. However, if four electrodes 
connected to the same switching module are mismatched, their power cannot 
be controlled independently. In Table 3 it can be seen that P'1f changes if three 
out of four channels are switched off. To avoid toxicity in the patient, abrupt 
large changes of duty cycles, such as 100% to 0%, should be carried out in 
several steps. Safety procedures have been incorporated in the temperature 
control algorithm to avoid overheating. 
If P'1f decreases due to mismatching, the target temperature may not be 
reached. This happens mostly when R in vivo is lower than in the agar phan-
tom used for impedance matching. Because a muscle-equivalent phantom is 
used, patient tissue resistance is in most cases equal or higher. Furthermore, 
the phase configuration used in the patient could be less resistive than in the 
phantom. For example, in section 3.2. it was shown that P'1f of the dual-
electrode applicators with thermometer was 0.92 W. Changing the phases of 
the electrodes in two of the four catheters reduces R with about 10 0. P'If.m", 
in this situation decreases to 0.55 W. A third reason for a lower R during treat-
ment is the higher temperature. In Figure 10 the ratio between the tissue 
impedancesata certain temperature T and at 24°C is shown as functional 
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the temperature. The ratio was calculated using equation 8 and a and E, were 
computed with the equations of Stogryn (1971) for a saline solution with 3.8 
g NaGI per litre and a frequency of 27 MHz. If e.g. the matching took place at 
24°G with Zt = 60-7j 0, the tissue impedance is 42-3j 0 at 44°G. This 
certainly results in a lower P,1f but is on the other hand a protection mechanism 
at higher temperatures. 
In general, pre-matching in a muscle-equivalent phantom in a one- dual-
electrode applicator configuration gives clinically applicable applicators. 
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5. Conclusions 
The effective power per electrode which is matched correctly is about 1 W. 
Mismatching can affect POIf considerably. However. because the matching 
theory is well understood, mismatching is not a serious problem in clinical 
practice and can even be used to increase Polf if necessary. Impedance match-
ing of applicators in a muscle-equivalent phantom is feasible. No serious 
mismatching is expected during treatment. The main conclusion is that with 
the MECS-IHT system sufficient power can be deposited in the tissue to obtain 
an adequate heating treatment of well perfused tumours. 
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Abstract 
The multi-electrode current source (MECS) interstitial hyperthermia (IHT) 
system uses thermocouple thermometry. To obtain inhomogeneous tempera-
ture distribution and to limit the number of traumas due to implanted 
catheters, most catheters are use for both heating and thermometry. Implica-
tions of temperature measurement inside applicators are discussed. Particular-
ly, the impact of selfheating of both the applicator and the afterloading 
catheter were investigated. 
A one-dimensional cylindrical model was used to compute the difference 
between the temperature inside the applicators (LIT,,) and the tissue just 
outside the afterloading catheter (LIT,",) as a function of power absorption in 
the afterloading catheter, selfheating of the applicator and the effective 
thermal conductivity of the surrounding tissue. Furthermore, the relative 
artefact (ERR), i.e. (lIT,,-lIT,", )llIT", was measured in a muscle equivalent 
agar phantom at different positions in a dual-electrode applicator and for 
different catheter materials. A method to estimate the tissue temperature by 
power-off temperature decay measurement inside the applicator was 
investigated. 
Using clinical dual-electrode applicators in standard brachytherapy catheters 
ina muscle:equivaJentphantQm,LlTinisJypicallytwice .. ashighas .. 1ITou,·.·The 
main reason for this difference is selfheating of the thin feeder wires in the 
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centre of the applicator. The measurement error caused by energy absorption 
in the afterloading catheter is small, i.e. even for materials with a high 
dielectric loss factor less than 5%. About 5 s after power has been switched 
off, Tio in the electrodes represents the maximum tissue temperature just 
before power-off. This delay time Itd".y) and ERR are independent of Tio • 
However, they do depend on the thermal properties of the tissue. Therefore, 
ERR and td"oy and their stability in perfused tissues have to be investigated to 
enable a reliable estimation of the tissue temperatures around electrodes in 
clinical practice. 
1. Introduction 
In hyperthermia, accurate measurement of tissue temperatures is essential. 
During a treatment, temperature information is needed as an input for power 
steering in order to optimize the temperature distribution. Furthermore, the 
temperature as a function of location and time is crucial in the discussion 
about the relation between thermal dose and clinical outcome, i.e. tumour 
response and normal tissue toxicity. 
A temperature measurement error can be defined as the difference between 
the temperature reading and the tissue temperature at the position of interest 
which is not necessarily the sensor position. 
The 27 MHz multi electrode current source IMECS) interstitial hyperthermia 
IIHT) system IVisser et al 1989, Lagendijk et al 1995) uses manganin-
constantan thermocouple thermometry. Clinical useof thermocouples has been 
discussed thoroughly by Carnochan et al 11986). Using thermocouples in 
combination with 27 MHz IHT, the two important potential sources of 
measurement errors are: firstly, the presence of large temperature gradients 
and secondly, the applied 27 MHz electromagnetic field. 
Temperature gradients of 1-2°C mm-1 at the edge of the tumour and near 
the applicators during the heating-up period are typical for interstitial 
hyperthermia. Measurement errors, due to thermal conduction along the 
thermocouple leads IDickinson 1985) or along the applicator plus thermometer 
IRyan et al 1989), or due to a temperature gradient across the junctions of 
multi-point thermocouple probes IBach Anderson et a/1984, Dickinson 1985, 
Lagendijk and De Leeuw 1993), can be reduced considerably if manganin-
constantan instead of copper-constantan thermocouples are used. 
In practice, measurement errors with manganin-constantan thermocouples 
due to high longitudinal temperature gradients are equivalent to a shift of the 
thermocouple probe of less than 1 mm. This is considered to be acceptable, 
particularly because the uncertainty about the exact sensor position relative 
to the target volume is generally more than 1 mm. 
With respect to the measurement errors related to the 27 MHz heating 
method, it should be noticed that, due to the high operating frequency and the 
fact that, generally, thermocouple probes are inserted in the applicators, the 
ca pacitive c()upfirig between tnermocou pie pi6bearid neaiingiipplicatofis hot 
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negligible (1-5 pF) compared with the electrode-tissue coupling (5-10 pF). This 
coupling may induce a so-called common mode current if the impedance 
towards the thermometry instrumentation is low, resulting in disturbance of 
the thermocouple-voltage reading and in selfheating of the thermocouple leads 
and/or the cold junction connector. This problem has been discussed in detail 
by Crezee et a/(1997). In addition, the surrounding tissue may be heated due 
to either capacitive or inductive coupling between tissue and leads. Further-
more, a difference between the electrical resistances of the thermocouple 
metals may give rise to a junction current, increasing the junction temperature 
(Chakraborty and Brezovich 1982). This can be minimized by choosing 
balanced thermocouples made of, for example, manganin-constantan instead 
of copper-constantan. In general, the so-called pick-up errors due to the 27 
MHz electromagnetic field can be reduced by low-pass filtering of the 
thermocouple signals. 
The most important measurement error in interstitial hyperthermia is caused 
by the fact that sensors are often placed inside the heating applicator and are 
not in direct contact with the tissue. Although the distance between the 
sensor and the actual position of interest in the tissue, just outside the 
afterloading catheter, is small (about 1 mm). a radial temperature gradient may 
occur. The temperature measured in the applicator will be higher than the 
tissue temperature if electromagnetic energy is absorbed in between tissue and 
thermometer, e.g. in the catheter wall due to dielectric losses or because of 
selfheating in the applicator and/or the thermocouple probes. 
The difference between the temperature in the applicator and the tissue 
temperature distribution just outside the afterloading catheter, as a function 
of thermal properties of the tissue and of selfheating in the applicator and the 
afterloading catheter, was examined through model calculations and phantom 
measurements. Furthermore, a method was explored to minimize this artifact, 
by applying a certain delay time between power switch-off and temperature 
measurement. 
2. Materials and methods 
2.1. The MECS-IHT system 
The 27 MHz MECS-IHT system has been developed in a collaboration between 
the University Hospital Utrecht and the Daniel den Hoed Cancer Center 
Rotterdam (Lagendijk et a/ 1995). Three units can be distinguished, i.e. a 
power supply system, a thermometry system and a UNIX workstation to 
provide the connection between the first two units and the operator. The 
power unit consists of has two groups of 32 coherent channels each. The two 
groups are 180 0 out of phase. 
Multi-electrode applicators can be inserted in standard brachytherapy 
afterloading catheters. The current source heating method has been described 
earlier(Marchill ,,(aI1989; Visser"t al1989;Deurloo "taI1991). 
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Temperature measurements are performed with 7-point constantan-manganin 
thermocouple probes (ELLA-CS, Czech Republic). Fast data acquisition (all 196 
channels within 320 ms) is feasible with a high resolution thermometry system 
(De Leeuw et a/1993). 
Undisturbed temperature measurement is possible with 7-channel RF-filters, 
specially designed for the 7-point thermocouple probes. They consist of a 
ferrite toroid (14 x 9 x 5 mm, p = 100, ferroxcube 4C6, Philips) and eight 
ceramic capacitors (220 nF). All eight thermocouple wires were wound 10 
times around half a single toroid and were connected to the shielding, via a 
capacitor. The coil impedance at 27 MHz is about 870 + 131 OJ Q (7.7 pH). 
Measurements using a network analyzer (HP8751A) show that an attenuation 
of more than 90 dB can be achieved. A diagram is shown in Figure 1. 
<-- hot junction cold junction ---> 
L 
c 
Figure 1. Design for one of the leads of a 7-channel RF-filter. 
2.2. Model calculations 
A simple steady state model was used to estimate the difference between the 
temperature in the centre of the applicator and the tissue temperature at the 
outside of the afterloading catheter. The applicator, afterloading catheter and 
tissue were approximated by infinitely long cylinders. A cross section is shown 
in Figure 2. The effective heat conductivity model was used to take blood flow 
into account. For a homogeneous, cylinder-symmetric medium, the heat equa-
tion is 
2. ~rk (r) D T(r) +P(r) = 0 
r Dr ,f( Dr 
(1 ) 
With k'ff (r) the effective heat conductivity (Wm" C-' ) of the medium and P(r) 
the cylinder symmetric-volumetric heat production (Wm-3 ). 
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Figure 2. Cross section of the model for the applicator (f srI ), the afterloading catheter (f, < r s r 2) 
and the part of surrounding tissue in which a temperature gradient exists (r 2 < r S (:3)' The applicator 
is divided in an absorbing part (rsfo) and a non-absorbing part (ro <rs(1). Typical values for f Of 
fl' (2 and'3 are 0.1, 0.75,1 and 10 mm, respectively, 
The selfheating in the electrodes and in the thermocouple probe was modelled 
using a power-absorption-per-meter factor Q (Wm-' ). Q is assumed to be 
absorbed homogeneously within a cylinder with radius ro' The heat absorption 
density in this cylinder is 
Q Po(r) = -
TTr'o 
(2) 
The remaining part of the applicator (a low-loss polythene catheter) and the 
afterloading catheter lumen, i.e. between ro and r" is assumed to be without 
loss. If the afterloading catheter material and the tissue are assumed to be 
homogeneous, the absorption density is proportional to 1/r'. The densities of 
electromagnetic energy absorption in the afterloading catheter wall (between 
r, and r, ) and in the surrounding tissue (between r, and r 3) are 
and 
P,(r) = [_I ]' a 
2TT (WEoE,,,l'+(a)' r' 
1 a, 
r' 
(3) 
(4) 
respectively, with I the current flowing from the applicator (A m-' ), Eo the 
permittivity of free space and W the radial frequency of the heating system. 
Furthermore, tanto) and Er., are the dielectric loss factor and the relative 
permittivity of the catheter material, respectively; a and Er., are the electric 
conductivity and the relative permittivity of the tissue. The metabolic heat 
production in the tissue was neglected. a, and a, are constants. 
ThefoliowingboundarycohtlitiOfiS wer,,-usedtos6IveeqUa1tdn-1for-1l8ch 
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of the media. Firstly, the heat flow through a certain cylinder surface is equal 
to the heat absorbed within that cylinder, which means that the applicator is 
thermally isolated at r = O. Secondly, the temperature distribution is continuous 
at the transition of two media and is assumed to be 37 DC at r = r 3 • The 
resulting temperature distributions in the tissue ITt)' the afterloading catheter 
wall IT,), the non-absorbing part of the applicator and catheter IT,)' and the 
central absorbing part of the applicator ITo) are given by the equations 5, 6, 
7 and 8, respectively 
T,lr) = 37+ [_~_ a'in r,+ a'lnr,]ln-.C+.s..(lInr')'-lInr)') 
2rrk, k, r3 k, r3 2k, 
[OCI 15) 
[OCI 16) 
T.(r) [OCI 17) 
Tolr) = T'lro)+~[1-[-.C]'l 4rrko ro [OCI 18) 
The radial temperature artefact is defined as the difference between the 
temperature rise inside the applicator at r = 0 It. T;o) and just outside the 
afterloading catheter at r = r, It. Toot). Because this artefact is proportional to 
the absolute temperature rise, the artefact was divided by It. T;o ) to obtain a 
dimensionless relative artefact 
ERR 6. ~rI -ll Tout 
6. lin 
19) 
2.3. Measurements 
The difference between the temperature inside the applicator (T;o) and outside 
the afterloading catheter IT,",) has been studied in situations similar to clinical 
practice, with respect to the afterloading catheter, the applicator and the 
thermocouple probe. A dual-electrode applicator louter diameter = 1.4 mm) 
was inserted in a standard brachytherapy catheter linner diameter = 1 .5 mm, 
outer diameter = 2.0 mm), in a muscle-equivalent agar phantom IIshida and 
Kato 1980). Both T,o and T,", were measured with a 7-point manganin-
constantan thermocouple probe louter diameter=0.5 mm). One probe was 
inserted inside the applicator, the other was placed outside the afterloading 
catheter. 
Two parameters wereusedto evaluate the relative measurementeHor(ERR), 
as was defined in equation 9, and the so-called delay time It""y). The latter 
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is the time after power has been switched off, at which T,o has become equal 
to Toot at the moment of switching power off. If t"", is known, it can be used 
to approximate Toot by measuring T,o ' 
ERR was determined for four different brachytherapy afterloading catheters. 
One catheter was made of high-loss PA 11-nylon (NY1, tan(o) ~0.04) and one 
of polyoxymethylene (POM) with a ten-fold lower dielectric loss factor 
(tan(o) ~0.005). The other two were made of PA6-nylon (NY2 (brown), NY3 
(white)) catheters with lower dielectric losses than NY1 but comparable with 
POM. In the experiments a dual-electrode applicator with 20 mm long 
electrodes at 10 mm separation was used and T,o and Toot were measured 
with two 7-point manganin-constantan thermocouple probes with a distance 
of 10 mm between the points (Figure 3a). 
a) 
> 20mm 
afterloadmg catheter ~O 
applicator catheter \ ~ 
,~"''"'" d 
'=- :5J&Q 3 
"e"· D'" ........ ··01 
feeder wire 
thermometry catheter 
7-point thermocouple probe 
b) 
'''''oa,'ioo 110 mm l aT catheter 5 mm 
aoolicato",ath,eter ~ 
wire 
7·point thermocouple 
Figure 3, Diagrams of the two applicator-thermometer geometries used for the Tin -Tou1 
measurements. The applicators consist of two tubular electrodes, constructed from layers of silver 
paint on an applicator (0:0.9/1 ,3 mm)and connected to thin feeder wires(0:0.05 mm).lnside the 
applicator and outside the afterloading catheter (0:1.5/2,0 mml 7-point thermocouple probes 
(0:0.5 mm) are placed. 
Nowadays, IHT treatments of brain tumours are performed using dual-
electrode applicators with 10 mm long electrodes, inserted in low-loss (€, 
= 3.6, tan(o) ~0.005) afterloading catheters (NY3). For this combination ERR 
and t",., were studied. Firstly, during and after a short 60 s power pulse, 
using.an. RF-fil ter and secondly , .. for" longer period ,d uring which the electrode 
temperatures were controlled automatically (Kaatee et al 1997), thereby 
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mimicking clinical practice. Both T,o and To"t were measured with a 7-point 
manganin-constantan thermocouple probe with a distance of 7.5 mm between 
the points. A diagram is shown in Figure 3b. During an IHT-treatment the 
temperatures measured inside in each electrode are controlled automatically. 
The power of each electrode can be adjusted independently with steps of 5%, 
whereby 100% corresponds with an effective power of about 1 W. A control 
cycle consists of a power-on period and a power-off period for temperature 
measurement. The power-off period is divided into a "recovery period", to 
allow the electronic disturbance of the data acquisition equipment to 
disappear, and the actual" measuring period", during which temperatures are 
measured with a frequency of one measurement per second and starting from 
about 0.5 s after the beginning of the measuring period. The length of these 
periods can be chosen freely. Temperature rises inside and outside the two 
electrodes were measured with power-on, recovery and measuring times of 
20, 2 and 8 s, respectively. The relative measurement error as a function of 
time was examined. Furthermore, T,o was compared with TO"t at the moment 
the power was actually switched off IToot.m,,)' The latter was obtained by 
linear extrapolation using the first two To"t -measurements of each control 
cycle. This T out,max can be seen as the maximum tissue temperature and 
therefore the value which should be controlled. 
3. Results 
3.1. Model calculations 
If not explicitly stated otherwise, the following parameters were used: 1=5 
Aim, tano=0.04, E, =3.6, ra =0.1 mm, r, =0.75 mm, r, =1 mm and r3 =10 
mm. Furthermore, the effective heat conductivities for the dissipating and the 
non-absorbing parts of the applicator, the afterloading catheter and the tissue 
were taken 390, 0.1, 0.3 and 0.6 W m-' DC-' , respectively. 
In Figure 4a the dependency of the relative artefact on the electrical properties 
of the afterloading catheter material, i.e. the dielectric loss factor ItanI6)) and 
the electrical permittivity iE,)' is shown. Selfheating of the applicator was 
omitted in this case, i.e. 0 was taken 0 W/m. The ranges over which tanlo) 
and E, were varied comprise the properties of most afterloading catheter 
materials. It can be seen that the contribution of power dissipation in the 
afterloading catheter to the artefact is relatively small. Even for high-loss nylon 
the difference between T,o and To"' is only about 6% of the temperature rise 
inside the applicator. 
A more serious effect can be expected from absorption in the applicator 
itself. This is demonstrated in Figure 4b. The relative artefact is shown as a 
function of the relative absorption in the applicator 10,,1.)' i.e. the ratio 
between 0 and the total power absorption per meter. Tan(o) was set at 0, so 
there was no absorption in the afterloading catheter. If only 5% of the 
'" "Ctro mag netic '"nerg y' is absorbed i riTheapplicator 'and TtTs' assu med 'that 
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power absorption is limited to a small cylinder in the centre of the applicator, 
e.g. the thermocouple probe and/or the feeder wires (ro =0.1 mm), then the 
difference between T" and T,", is about 40% of the temperature rise inside 
the applicator. 
Finally, the radial heat flow was varied by varying k,,,. A dissipating catheter 
material (tano=0.04, €, =3.6) was used and Q was kept constant at 0.23 
W/m, which is 1 % of the total absorbed power if k,,, =0.6 W m" °C' and r3 
= 10 mm. Figure 4c shows that the difference between Ti, and T '"' increases 
considerably with increasing heat flow in the tissue. 
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Figure 4. The relative artefact, i.e . .6. Tin -.6, TouJl\ Tin, as a function of a) the dielectric properties of 
the afterloading catheter Han6, c() without selfheating of the applicator; b) selfheating of the 
applicator (Oret,' fo J without absorption in the afterloading catheter; c) effective heat conductivity 
oIut,h~ ti,ss~e ,(~,3} with absorption in both afterloadin,g catheter Han,o = O.()4, 1:, = 3,.6) a,n~,~ppl,ica,t,CJ:r 
(0 = 0.23 W/m). . . 
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3.2. Measurements 
Figure 5a shows the temperature rise after 60 s of heating along a dual 
electrode applicator with 2 em long electrodes (Figure 3a), for various catheter 
materials. As expected, the highest temperatures were measured using the 
strongly absorbing nylon (NY1). However, no higher relative error was seen 
(Figure 5b). The mean values of ERR in the electrodes for the different catheter 
materials were 0.31 (± 0.05). 0.30 (±0.03). 0.34 (± 0.1 0) and 0.36 (±0.04) 
for POM, NY1, NY2 an NY3 respectively. The values between brackets are the 
standard deviations. Furthermore, note that ERR is higher at those positions 
where the agar is not heated directly by the electrodes. 
a) temperature rise ('e) 
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15 
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Figure 5. a) b.T,,, and lI.T,,,"\ after a power pulse of 60 s and b) the corresponding relative error 
(ERR) along a dual-electrode applicator (see Figure 3a) in four afterloading catheters of different 
mate'ifats. 
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In Figure 6a, the temperature rises inside (b. T;o) and outside (b. T 0",) both 
electrodes of a dual-electrode applicator (Figure 3b) are shown as a function 
of time, using an RF-filter. The temperature rise in electrode 1 (tip) is higher 
than in electrode 2, which is due to a higher efficiency of the tip-electrode in 
this applicator design. The corresponding ERRs, according to equation 1 are 
displayed in Figure 6b. After about 10 s, ERR has reached its maximum and 
decreases slowly until the power is switched off, after which a steep decay 
is observed. 
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Figure 6. a) b. Tin and .6. Tout for both electrodes of a dual-electrode applicator (see Figure 3b), 
during and after a 60 s power pulse, b) the corresponding relative errors (ERR). 
The results of the automatic temperature control measurements are shown 
in Figure 7. A control cycle of 20 s power on and 10 s power off (Figure 7a) 
appears ideal to control the maximum agar temperature (b.T"'.m,,j, i.e. the last 
niea§ll(edb.T;~is tlie 'sanieasfhe estinialed "allle OIb.T;;,· jus!" nertli" 
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electrodes have been switched off. In Figure 7b it can be seen that ERR rapidly 
decreases during each power-off period. However, ERR at a certain time in the 
control cycle stabilizes after a number of cycles. 
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Figure 7. a) .6.. Tin (thin lines) and .6.. Toul,rna, (thick lines) and b) ERR for both electrodes of a dual-
electrode applicator (see Figure 3b)' during a period of automatic temperature control using a 
control cycle: 20 s power on, 2 s recovery time and 8 s temperature measurements. 6. T Oul,max is 
the estimated maximum tissue temperature at the time of switching off the power, which was 
obtained by extrapolation of the temperatures measured outside the afterloading catheter. 
4. DisclIssion 
In clinicallHT, the number of catheters, which can be implanted, is limited by 
patient tolerance. In general , most catheters should be used for heating to 
reach a reasonable homogeneous temperature distribution. Therefore, 
temperature information is mainly obtained from measurements inside 
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applicator (T,,). However, it is important to know and control the temperature 
just outside the afterloading catheter (T,",), which, in general, is lower than T" 
. Firstly, to avoid overestimation of the tissue temperatures, resulting in 
insufficient thermal dose. Secondly, to avoid hot spots, which are usually 
found near the electrodes and which can cause pain. If those hot spots are not 
detected they will limit the tolerated power levels for all electrodes and lead 
to cold regions in other parts of the treatment target volume. 
As stated before, the radial measurement error is induced by dissipation of 
electromagnetic energy between the measuring position and the site of 
interest, in combination with a thermal resistance in between. For the 
electrodes of a dual-electrode applicator (as was shown in Figure 3b) inserted 
in an agar phantom, ERR and td"" are typically 0.5 and 5 s, respectively. This 
means that with power switched on, the temperature rise just outside the 
afterloading catheter is only 50% of the temperature rise measured inside the 
electrodes and that T", measured 5 s after power is switched off, gives a 
good estimation of the maximum Tool' It was found that ERR and tde", were 
the same, with or without an RF-filter (data not shown). Furthermore, by 
varying the electrode power, it was confirmed that both ERR and tdel" are 
independent of the absolute temperature rise (data not shown). On the other 
hand, ERR and t"", do depend on the applicator design and are not constant 
along an applicator. In general, both ERR and tde,ey are higher at those regions 
where the tissue is not heated directly by an electrode. This means that the 
above-mentioned values for ERR and tde", are appropriate to predict the 
maximum Tool near switched on electrodes, which makes it possible to control 
the maximum tissue temperature. However, this method is less suitable to 
obtain more detailed information about the temperature distribution along the 
afterloading catheter, e.g. to study dose-response relationships. 
Selfheating of the applicator, i.e. particularly of the thin (50 f/m) leads to the 
tip-electrodes in the centre of the applicator, is probably a more important 
cause for the difference between T" and Tool than the dielectric losses in the 
afterloading catheter. This was demonstrated in the model calculations 
(Figures 4a and 4b) and by the experiments with the different catheter 
materials, in which no significant difference was found between the measure-
ments of ERR for high-loss nylon and the other catheter materials with a lower 
dielectric loss factor (Figure 5b). However, this does not mean there is no need 
to avoid using afterloading catheter material with a high dielectric loss factor. 
The effect on ERR may be limited but high-loss catheters still considerably 
increase the inhomogeneity of the temperature distribution in the surrounding 
tissue (Kaatee et a/1995) because less electromagnetic energy is absorbed 
directly in the tissue. 
ERR and tde", are not only a function of applicator design and afterloading 
catheter properties but also of the time-dependent temperature distribution in 
the tissue. In the Figures 6b and 7b it can be seen that the relative error 
decreases until a steady state is reached. The actual steady state temperature 
distribution and thus ERR will depend on the thermal properties of the tissue 
(Flgure4c) ,but·· also onthep(}WeYaosorptiondlstrlbutiorlahd thusoht1ie 
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presence of neighbouring electrodes and on the electrical tissue properties. 
The simplified cylindrical steady state model seems not appropriate to predict 
ERR accurately. The main reason for this is that the concentric cylinder 
geometry in the model is not suitable to describe a real applicator with feeder 
wires and a thermocouple probe each at different distances from the central 
axis, which may vary along the applicator. Furthermore, the model cannot be 
used to calculate td",y . It may be questioned, wether more sophisticated 
models, such as the time-dependent high-resolution model used by Van der 
Koijk et al. (1998), can produce the values needed in the complex clinical 
situation in which tissue properties are generally unknown. In vivo measure-
ments of ERR and td",y in various perfused tissues would give a better insight 
in this matter. 
A more practical solution would be to use special afterloading catheters 
dedicated to IHT with one or more thermocouple probes at the outside of the 
catheter. With these thermometers tissue temperatures can be measured more 
directly. Additionally, it may even be possible to use the thermocouple probes 
to measure tissue properties and their variations during treatment. This would 
be valuable because acquisition of input parameters for power absorption and 
thermal computer models is considered an important problem. The temperature 
decay during the power-off periods gives information about the thermal 
properties of the tissue near the catheter. Furthermore, two or more 
thermocouple probes together might serve as an electrical impedance probe. 
Although RF-filters are not strictly required if temperatures are measured 
after switching off the electrodes, they are useful. The risk of measurement 
errors due to local selfheating of the cold-junction connectors, particularly with 
single electrode applicators, is eliminated. Additionally, the thermometry 
system does not have to recover from RF-disturbance, so that the first 2 s of 
the temperature decay (2 s is the minimum required RF recovery time if no 
filter is used) can be measured as well. Furthermore, by using filters tempera-
ture measurements can be performed during heating. This gives the possibility 
to detect unexpected quick temperature rises, e.g. due to sudden perfusion 
changes, if power is switched on. 
5. Conclusions 
In a muscle-equivalent agar phantom the electrode temperatures overestimate 
the temperature rise of the surrounding tissue roughly by a factor two. 
However, ERR is not homogeneous along the applicator and it can be expected 
that ERR will be higher in perfused tissues. If the electrode power is switched 
off periodically, the electrode temperature about 5 s after power-off represents 
the maximum agar temperature quite well. Power-off temperature measure-
ments are useful to avoid overestimation of tissue temperatures during clinical 
IHT. Nevertheless, the values and the stability of td",y in perfused tissues have 
to be invesligaledfirsClrileg ration afthermo melrY in!o thealteflaad irig 
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catheters may be another solution to overcome the present radial temperature 
artefact. 
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Chapter 5 
Implications of using thermocouple thermometry in 
27 MHz capacitively coupled interstitial 
hyperthermia; interference between thermometry 
and heating system 
This chapter was published as: 
Crazee J, Van der Koijk JF, Kaatee RSJP and lagendijk JJW, 1997, Implications of using 
thermocouple thermometry in 27 MHz multi-electrode capacitively coupled interstitial 
hyperthermia, Physics in Medicine and Biology 42: 637-650. 
Abstract 
The 27 MHz Multi Electrode Current Source (MECS) interstitial hyperthermia 
system uses segmented electrodes, 10-20 mm long, to steer the 3D power 
deposition. This power control at a scale of 1-2 cm requires detailed and 
accurate temperature feedback data, to this end seven point thermocouples 
are integrated into the probes. 
The aim of this work was to evaluate the feasibility and reliability of 
integrated thermometry in the 27 MHz MECS system, with special attention 
for interference between electrode and thermometry and its effect on system 
performance. We investigated the impact of a seven sensor thermocouple 
probe (Outer Diameter 150 ,um) on the apparent impedance and power output 
of a 20 mm dual electrode (O.D. 1.5 mm) in a polyethylene catheter in a 
muscle equivalent medium (at ~ 0.6 Sm-t ). 
The cross coupling between electrode and thermocouple was found to be 
small (1-2 pF) and to cause no problems in the dual electrode mode, and only 
minimal problems in the single electrode mode. Power loss into the 
thermometry system can be prevented using simple filters. The temperature 
readings are reliableandrepresentativeoftheactualtissue temperature around 
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the electrode. Selfheating effects, occurring in some catheter materials, are 
eliminated by sampling the temperature after a short power off interval. 
We conclude that integrated thermocouple thermometry is compatible with 
27 MHz capacitively coupled interstitial hyperthermia. The performance of the 
system is not affected and the temperatures measured are a reliable indication 
of the maximum tissue temperatures. 
1. Introduction 
The Multi Electrode Current Source (MECS) interstitial hyperthermia system 
developed at the Departments of Radiotherapy and Biomedical Engineering of 
the University Hospital Utrecht and the Department of Clinical Physics of the 
Daniel Den Hoed Cancer Center in Rotterdam (Lagendijk 1990, et al. 1995, 
Kaatee et al. 1995) is based on the capacitively coupled 27 MHz rf heating 
technique for brachytherapy implant catheters (Visser et al. 1989, Marchal et 
al. 1989, Deurloo et al. 1991). The three dimensional power steering of the 
MECS system is an important feature, as power control on a centimetre scale 
or better greatly improves temperature uniformity (Crezee and Lagendijk 
1992). Few techniques comply with this requirement: scanned focused 
ultrasound (SF US) (Lagendijk et al. 1994) and interstitial heating techniques 
with three dimensional power control, like the ultrasound applicators 
developed by Diederich (1996) and the MECS system where each probe 
consists of multiple independently controllable electrodes to provide longitudi-
nal temperature control along the catheter (van der Koijk et al. 1996, Kaatee 
et al. 1997). A disadvantage of SFUS techniques is the need for extensive 
invasive thermometry to provide feedback data for power control. 
1 .1. Thermometry 
Three dimensional temperature control requires feedback of detailed 
thermometry data for power control, with a resolution matching the degrees 
of freedom available to power deposition (Hand 1993). Non-invasive 
thermometry techniques based on radiometry and ultrasound are promising but 
not yet sufficiently reliable, especially due to their sensitivity to blood flow 
changes (Hand 1993). Instead invasive thermometry is used, either integrated 
into the heating probes or in separate, non-heated catheters. 
Thermometry in the electrode catheters is likely to give an impression of the 
maximum temperatures in the implant and to be suitable for power control of 
individual electrodes. The array of seven or fourteen point thermocouple 
strings in each catheter yields a detailed three dimensional temperature 
distribution without additional trauma to the patient. Disadvantages are that 
minimum tissue temperatures cannot be measured directly, and the proximity 
of the electrodes may cause temperature artifacts (Astrahan et al. 1988) and 
iriferfere with lheoperlltiono! tlie electrodes .. 
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Thermometry in separate non-heated catheters is likely to give an impression 
of the minimum tissue temperature, without selfheating effects. Disadvantage 
is the extra trauma inflicted on the patient, Emami et al. (1991) recommend 
minimum numbers of extra catheters ranging between two (for 3-8 heat 
sources) and six (for 33 or more heat sources). The 3D control provided by the 
segmented electrodes of the MECS system requires matching 3D 
thermometry, or equal numbers of heating and thermometry catheters. That 
is unacceptable: it would be more logical to improve temperature uniformity 
by using extra catheters for extra electrodes, not for thermometry. 
The thermometry of the MECS system is therefore integrated into the 
electrode probes, each containing a seven point thermocouple string providing 
an average of two contacts per electrode. The system can handle 64 
electrodes and 196 thermocouples. The objective of this paper is to evaluate 
the feasibility of integrated thermometry, and especially the effect of 
interference between thermometry and electrodes on the performance of the 
MECS system, and the reliability of integrated thermometry. Our thermometry 
system suppresses all electronic interference immediately after switching off 
the power, but during power on interference may induce currents in the 
thermocouple, heating the leads or the cold junction and causing temperature 
artifacts lasting the first seconds after power off (De Leeuw et al. 1993). 
2. Theory 
2.1. Principle of the MECS system 
Shown in Figure 1 is a dual electrode, consisting of two electrodes with 
opposite phase in a single catheter. In this balanced dual electrode mode 
current flows from one electrode into the tissue around the electrode, then 
through the tissue to the other electrode, the plane between the electrodes 
perpendicular to the catheter is effectively at zero potential. The impedance 
of an electrode is the sum of the catheter and tissue impedance 
1 
Zel = Zcalh + Zt ::::;c '2 fe + Rt 
I IT cath 
(1 ) 
with f = 27 MHz and assuming Re Z'oth = 0 and 1m Z, = O. The catheter with 
radius r,oth acts as a capacitor C"'h between the electrode and the tissue 
Cca1h 
2rr€O€cath1el 
In(rcath Ire,) 
F (2) 
with fo = 8.85x10-12 Fm-' the free space permittivity, f,,'h the relative 
permittivity of the catheter, I" the length and r" the radius of the electrode 
(Visser et al. 1989). A2 cm long electrode in a polyethylene (pe)cilthet"rvtlith 
f,,'h = 2, r" = 0.8 and r,,'h = 1.0 mm, yields Cee'h = 10 pF or IZ,othl = 600 
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O. Re Z"'h '" 0 because dielectric losses are negligible in pe (tg " = 0.0004), 
therefore all heat production is generated by the resistance in the tissue, which 
for a cylindrical geometry can be estimated to be 
(3) 
with 0', the conductivity of tissue and a cylindrical ground at r,w"d' Equation 
3 yields R, '" 30 0 for the 2 cm long electrode in muscle with 0', = 0.6 Sm" 
and assuming r,toocd '" 1 Or'''h' This agrees well with R, = 29.9 0 found in 
accurate 3-D numerical simulations in which the ground plane was correctly 
modelled between the electrodes (De Bree et al. 1996). The electrode acts like 
a current source since R, <{ IZ'''hl (Deurloo et al. 1991). The presence of an 
external ground plane allows imbalance between the plus and minus electrode, 
necessary for power control: Maximum power is about 1.5 W, lower levels are 
obtained by duty cycle modulation of the power. 
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Figure 1. Schematic view of dual electrode 
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Figure 2, Route of secondary current through thermocouple to ground for dual electrode (2a) and 
single electrode (2b). Dotted: Two filtering methods discussed in section 2.3, 
2.2. Interaction between electrode and thermocouple 
A seven point thermocouple is located inside the dual electrode (Figure 1). The 
leads of each electrode (Outer Diameter 50 /1m) and the thermocouple (one 
manganin and seven constantan wires, total 0.0. 150 /1m) run parallel for 
some distance. The resulting capacitive coupling is small but not negligible, 
about 1-2 pF (Appendix 1). Thus the leads of the thermocouple and other 
electrode provide alternative routes for the current, the apparent electrode 
admittance is 
(4) 
with Y" and ~, the admittance of the parallel routes into the thermocouple and 
the opposite lead, respectively. We are concerned with the impact of Y" on 
sysfem pei!()rmance, this depsrll:!sonil1econjjgLJration of the electrodes: 
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In the dual electrode mode a small capacitively coupled current flows from 
one lead and electrode to the thermocouple, and from the thermocouple to the 
lead and electrode of opposite phase. In this balanced situation the 
thermocouple is effectively at zero potential, there will be no current from the 
thermocouple to the thermometry system or the external ground plane (Figure 
2a). Current directly from lead to thermocouple will cause no heat production 
provided low loss catheter materials are used. Indirect currents through the 
tissue are not favoured due to the comparatively high tissue-thermocouple 
impedance IZH,I (Appendix 1). 
Duty cycle power control implies during part of the cycle one electrode may 
be on while the other is off. In this unbalanced single electrode mode the 
thermocouple probe is not at zero potential and the current from the lead into 
the probe will flow to ground along different routes: The first across the 
catheter wall into the tissue to the external ground plane, causing tissue 
heating along the length of the thermocouple probe. The second and most 
important into the thermometry system, possibly causing cold junction heating 
and other temperature artifacts (Figure 2b). Measurement of the impedance 
of a 4 m seven sensor probe connected to the thermometry system yielded Re 
ZP<Ob' z 500 n, 1m ZpWb, z O. Therefore in the single electrode mode 
Z =Z +Z z 1 
tc I-Ie probe i2rrfC 
" 
(5) 
with RIO = Re Z" z Re ZP<Ob" and C" the capacitive coupling between lead and 
thermocouple (z 1-2 pF). 
2.3. Simulation of apparent impedance and power loss in the single electrode 
mode 
Analytical expressions for the effect of the presence of a thermocouple on the 
apparent impedance of the electrode Z"p and power loss in the single electrode 
mode are derived in Appendix 2. These were used to simulate the effect of 
insertion of a thermocouple into an electrode (RI = 40 n, Coa'h = 11.7 pF) by 
a gradual rise of C" from 0 to 3 pF, shown in Figure 3a. A range of possible 
thermocouple resistances Rio between 10-' and 10' n is tested to get an 
impression of the critical range. For Rio < 10 n the effect on Z,pp is a reduction 
of 11m Z,pp I, dissipation in the secondary circuit PI' remains zero. For RIO > 10 
n the reduction of 11m Z,pp I is accompanied by an increase in Re Z,pp (20 n for 
Rio = 1 kn) and P" becomes significant (equals Pol for Rio = 1 kn). When Rio 
approaches 1 Mn the impact of the secondary circuit becomes negligible. This 
behaviour is similar but more pronounced for an electrode with very low R, = 
10 nand C"," = 5.8 pF (Figure 3b). The maximum increase in Re Z"p is now 
90 n, combined with a P" ten times the primary dissipation P". The simulation 
in Figure 4 shows the Rio dependence of P" for C" = 1.5 pF, showing a peak 
at about 5 kn when Re ZI' = 11m Z" I (equation A2). The amplitude of the 
peak (equati()riA3fVariesf()rdiffeiehf cOiribinatiorisOrC';'h --and -- R;,if is 
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minimal when the capacitive coupling and tissue resistance in the primary 
circuit are maximal (C,"h = 11.7 pF, R, = 400). 
The results in Figure 4 are based on the ratio between average power 
dissipation in the secondary and the primary circuit derived in Appendix 2 
(equation A 1): 
(6) 
and suggest two methods for minimising Pte. The first is a low pass filter in the 
thermocouple leads, achieving I Z" I = 00, with the advantage that measure-
ment of the temperature during power on is possible. Note that the filter does 
not block currents from the thermocouple via the tissue to the external ground, 
therefore the maximal achievable IZ"I = IZ"'HI"""dl < 00 (see Figure 2b). 
A second method is to reduce R" to zero; then only the imaginary compo-
nent of the apparent impedance 1m Zoo, is affected by thermometry, with 
minimal heat loss due to the secondary current. A low resistance connection 
between the thermocouple leads and ground yields R" z 0 and blocks all other 
secondary routes. A capacitor C".,"""d is suitable as it does not affect the dc 
temperature signal of the thermocouple (Figure 2b). 
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R, '" 10, C." '" 5.6 
Figure 4. Relative power loss PIC/(Pl~ + PI) simulated as a function of RIc for Gtc = 1.5 pF, RI = 10 
or 40 n and 1m Zcath = -500 or -1000 0, 
3. Experiment 
3.1. Materials and methods 
A dual electrode consisting of two 20 mm long electrodes (copper foil, 0.0. 
1.5 mm) mounted on a 15 cm long pe tube (0.0. 1.2 mm) with a separation 
of 10 mm, connected with 50 pm thick leads, was inserted in a pe catheter 
(1.0. 1.6, 0.0. 2.0 mm) in a muscle equivalent phantom: A 12x12x12 cm 
perspex container filled with a solution of 0.3% NaCI in Agar (a, = 0.6 Sm"). 
The apparent impedance Z'op was measured with respect to a flat copper 
electrode placed at the approximate location of the virtual ground plane in the 
balanced dual electrode mode (see Figure 1) using a vector impedance meter 
(HP 4193A). Unless otherwise stated the thermocouple probe was a seven 
sensor constantan·manganin probe contained in a 0.5 mm diameter teflon 
tube, with eight 50 pm leads and a length of 4 m (Ella CS). Resolution of the 
196 channel thermometry system is 0.005°C (De Leeuw et al. 1993). The 
capacitive short cut to ground was achieved using the capacitive coupling 
between the thermocouple leads and the thermocouple shielding, and 
connecting the latter to ground (C".,,,",, = 200 pF). 
The effective electrode power P" was obtained by measuring the tempera· 
ture rise brought about by an implant of 2x2 dual electrodes (spacing 16 mm) 
in a well conducting tissue phantom containing V = 700 ml 0.45% NaCI 
solution yielding R, = 10 Q; P" = '18 Vpcd Tldt. To facilitate measurement of the 
secondary dissipation P,c the thermometry system and most of the 4 m 
thermocouple leads were replaced by an equivalent 500 Q resistor placed in 
70 ml of aql.ladesCP" was then determined by measuring the temperatl.lrerise 
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of the water. A capacitor provided the parallel short cut to ground. 
3.2. Results 
3.2.1. Interaction between lead and thermocouple 
The presence of capacitive coupling between thermocouple and electrode is 
shown by monitoring the apparent impedance of the electrode Zoo, while a 20 
cm long, grounded thermocouple probe (RIO ~ 0) is gradually inserted into the 
electrode, placed in a pe catheter in the muscle phantom (Figure 5). The result 
is the development of a second route to ground, parallel to the primary route 
from the electrode. As Re Z" ~ 0 the increase in the apparent capacity C," 
directly reflects the increasing capacity in the parasitary route (equation A4): 
C," ~ COO'h + C'c with C"'h ~ 11 pF and C" ~ 1-1.5 pF, as predicted in 
Appendix 1. 
C.pp (pF) electrode 
13E~~== 
t.G. 
12.5 
RIGHT 
11~----L-----L-~--·L-----~----~----~--~ 
o 2 4 6 8 10 12 
Inserllon depth thermocouple (cm) 
Figure 5. Apparent capacitive coupling Capp between electrode (lei = 20, r~1 = 0.75 mm) in pe 
catheter (J.D. 1.6, O.D. 2.0 mm) and tissue as a function of insertion depth of a seven sensor 
thermocouple probe with RIc:;'=; O. 
The effect of a single sensor thermocouple probe on a poorly coupled single 
electrode (COO'h ~ 6.5 pF) in a muscle equivalent medium (R, ~ 30 0) is a 
reduction of 11m Z,,, I and an increase of Re Z,,, (Figure 6), similar to the 
curves in Figure 3 which were predicted to be associated with a significant 
dissipation in the thermometry system P". A connection to ground C".9WOOd 
reduces the effect on Re Z,,,, a reduction predicted to eliminate the power loss 
P,,, This predicted restoration of system performance wasdemonstrated by 
measurement of Po, and P" in a well conducting medium (Table 1): For a single 
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electrode the heat loss was 38% without Ctc..groundl with Ctc.grOUnd the loss was 
nil. The losses computed with equation 6 were 43% and 0%, respectively, 
with Rio = 500 fl, C" = 1.5 pF and C'''h = 11.7 pF. The tissue resistance R, 
= 10 fl was chosen very low to enhance the effect of the secondary circuit 
on system efficiency. Note that even under these unfavourable conditions 
losses are minimal for a dual electrode, as predicted in section 2.2. 
Table 1. Relative power dissipation Ptc/(Ptc + PI) in thermometry circuit (RIc = 500 0, Gtc = 1.5 pF) 
for a 20 mm electrode (CCath = 11.7 pF) in a tissue phantom (Rt = 10 0): Measured and 
(computed) value. 
electrode mode 
dual 
single 
without Gtc-grOund 
0.10(0) 
0.38 (0.43) 
with C"',,,"cd = O.01fJF 
0(0) 
0(0) 
C,,, (pF) 1m Z.pp (Ohm) 
-600,--------------------------, 
-650 
-700 
-750 
-800 
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-900 
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shielding connected to earth 
I 
\ 
~ 
~ 
~ 
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Figure 6. Apparent impedance Zapp of an electrode (lei = 20, r~1 = 0.75 mm) in a pe catheter (1.0, 
1.6, 0.0. 2.0 mm) in muscle equivalent tissue as a function of insertion depth of a single sensor 
thermocouple probe, with and without short circuit to ground. 
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3.2.2. Reliability thermometry 
A further test is whether the temperatures measured inside the probe reflect 
the actual tissue temperature, and without electronic artifacts. We found the 
temperature measured inside a 2 cm long electrode in a pe catheter is nearly 
equal to the temperature outside the catheter. The temperature decay after 
one minute of power on was determined both inside and outside the catheter, 
the difference is not significant (Figure 7). The absence of electronic artifacts 
was verified in a similar experiment by determining the temperature decay 
after one minute of power on, both with the integrated thermometry present 
and with a thermocouple introduced into the electrode after switching off the 
power. Again no significant difference was found (data not shown). 
T ("C) 
25,-----------------------------------, 
24 
23 
120 180 240 300 
t (sec) 
III power 
-.- Inside 
+ outside 
Figure 7. Comparison between the temperature decay measured inside and outside a two em long 
electrode (0,0. 1.5 mm) in a pe catheter (J.D. 1.6,0.0. 2.0 mm) in muscle equivalent tissue after 
one minute of heating. 
4. Discussion 
Capacitive coupling between thermocouple and electrode can only cause 
problems for a dual electrode operating in the single electrode mode, but even 
that is unacceptable as it reduces our spatial power steering capacity. 
Equation A2 shows loss is maximal when the thermocouple resistance Rtc ~ 
11m Ztc I, the capacitive coupling between the lead and the thermocouple. For 
instance, for Ctc = 1.5 pF this is equivalent to Rtc = 5 kO. Fortunately Rtc is 
rmJChJoYl'er in __ .9_lJf sYstem, RIc =5QOo,Jmdti1esimulaliOnsin fi9_IJI.B_ 4_ 
(backed by equation A3) also show power loss strongly depends on COO" and 
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Rt; losses are acceptable in normal tissue (R t > 30 0) with a normal capacitive 
coupling between electrode and tissue: C"th > 1 0 pF as shown in Figure 5. To 
demonstrate the effect of filters on heat loss (Table 1) we used a special 
phantom with Rt ~ 10 n, below the normal range: 30 < Rt < 180 n for 10 
< I" < 20 mm and 0.2 < at < 0.6 Sm·t (fat-muscle). Furthermore, the 
combination of Rt ~ 10 nand C'''h ~ 11.7 pF is impossible, Rt = 10 n is 
equivalent to an electrode at least 6 cm long (depending on the medium), 
yielding C"th > 30 pF. 
Thus no special measures are necessary for maintaining system efficiency, 
but low pass filters (currently developed at the Daniel den Hoed Cancer 
Center) have the advantage of allowing undisturbed measurement of the 
temperature during power on. The second type of filter is a capacitor between 
the thermocouple and ground, and suppresses secondary currents causing 
heating along the length of the thermocouple in the patient. 
Reliable temperature feedback for each electrode is essential for achieving 
3D power control: Temperature data acquired from within an electrode were 
found to give a reliable indication of the maximum tissue temperature. This is 
a significant advantage over techniques where power levels are controlled by 
thermometry in extra catheters yielding minimum rather than maximum tumour 
temperatures: That may lead to severe hot spots near the electrodes. The 
temperature inside reflects the temperature outside because no heat is 
generated in polyethylene, the temperature rise inside is achieved solely by 
conduction. Heat production does occur in high loss materials and causes a 
shift of the temperature maximum from the tissue to the interior of the probe; 
thermometry inside the probe overestimates the tissue temperature. A short 
power off interval allows the extra temperature rise in the very small volume 
of the probe to diffuse into the surrounding tissue, the registered temperature 
drops to the true tissue temperature. Another consequence of heat generation 
in the catheter wall is a reduction of the effective penetration depth of the 
system. In the worst case all power is dissipated in the probe, equivalent to 
the zero penetration depth or conductive heating. 
Direct measurement of minimum tumour temperature is not possible using 
thermometry in the electrode catheters. We are currently investigating an 
indirect method for obtaining an impression of the minimum temperature in the 
implant without using extra thermometry catheters: After stationary tempera-
tures have been reached we sequentially interrupt the power of each electrode 
for about one minute to allow the local temperature maximum around the 
electrode to diffuse away. 
5. Conclusion 
Thermocouple thermometry inside the catheters is compatible with 27 MHz 
capacitively coupled interstitial hyperthermia. The performance of the system 
is not affected and the temperatures measured are a reliable indication of the 
ma){'j'rliiJ"m"'tTss"ue"tfim'Pe'rafu'iiis","" 
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Appendix 1. capacitive coupling between electrode and 
thermocouple 
The direct capacitive coupling C,." between the leads of the electrode and the 
thermocouple is (8 }:> f1ead,tc) 
[FJ 
with footh = 2 the relative permittivity of the polyethylene catheter wall, I the 
length of the parallel leads, a = 0.6 mm the distance between lead and 
thermocouple, r'"d = 25 jJm and rIo = 75 jJm the radii of the thermocouple and 
the lead of the electrode, yielding a capacitive coupling of approximately 0.2 
pF/cm. There is also an indirect route possible, from lead via tissue C,.t to the 
thermocouple Ct.to . However, parallel to Ct." is a tissue route to ground, and 
this route dominates since Rt is much smaller than 1 Zt." 1 > 1 kQ. Experimental 
results confirmed that the indirect coupling C,.t." is negligible. 
In addition we consider the direct capacitive coupling between the 
thermocouple and the electrode, with radius rei = 0.6 mm 
yielding about 0.5 pF/cm. Overall the total secondary coupling Ctc = C
'
.tc + Cel. 
"between lead/electrode and thermocouple = 1-2 pF, depending of the length 
of the lead and the electrode. 
Appendix 2. 
The impact of the presence of a thermocouple with capacitive coupling C" and 
resistance Re Z" on the apparent impedance Z,pp of an electrode with Re Zel 
Rt and 1m Zel = Zcalh = ~i/2"fCcath: 
Zapp = (Z;,l + Z/c1)-1 = 
ReZe,(lm' Z" +Re' Z,,) +Re Z,,(lm' Ze,+Re'Ze,) 
--~~~~~~~--~~--~~~~~+ (ReZe,+ReZ,y + (lmZe,+lmZ,,)' 
The corresponding time averaged power dissipation ratio is 
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(A1) 
In Figure 4 this ratio is plotted as a function of Re Z" and reaches a maximum 
when 
= ° 
which holds for 
The maximal power ratio then becomes 
p"J IZ"I' Im'Z" 
Pel Re2,,~I'mZ,,1 = 2 ReZtc ReZel ::::: 2RrcRt 
(A2) 
(A3) 
since Re Z" <1i 1m Z". Note the strong dependence on both Co,," and R,. 
When Re Z" = 0, for instance when the thermocouple is connected to ground 
with a large capacitor, Z,pp simplifies to 
ReZ,/m' Z" +j[imZ,,(/m' Z,,+Re'Z,,) +lmZ,/m' Z"l 
Re'Z" + (/mZ,,+lmZ,,)' 
We divide numerator and denominator by Im2Z" and get 
I Z (1 Re' Z") 1m' Z" m (c +-- +--
1m' Z,' ImZ" ImZ,pp - _=-'= __ -"--;-=----'-_ 
Re'Z" + (1 + ImZ,,), 
Im2Ze/ ImZe/ 
Then because the tissue resistance R, 
catheter wall, 
Re Z" <1i 1m Z", the impedance of the 
ImZ"lmZ" 
ImZi~' +' -ln1Zel 
C app ::::: Gea/I} + G tc (A4) 
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The change in C,pp caused by insertion of a thermocouple into the probe is a 
direct measure for the secondary coupling between the lead and the 
thermocouple when Re Z" = O. 
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Chapter 6 
Spatial temperature control with a 27 MHz current 
source interstitial hyperthermia system 
This chapter was published as: 
Kaatee RSJP, Crezee J, Kanis APt Lagendijk JJW, Levendag PC and Visser AG, 1997, Spatial 
temperature control with a 27 MHz current source interstitial hyperthermia system. 
International Journal of Radiation Oncology,Biology,Physics 37: 189~ 197. 
Abstract 
This paper gives an overview of the properties of a 27 MHz current source 
(CS) interstitial hyperthermia (lHT) system, affecting temperature uniformity. 
Applicators can be inserted in standard flexible afterloading catheters. 
Maximum temperatures are measured with seven point constantan-manganin 
thermocouple probes inside each applicator. Temperature can be controlled 
automatically using a simple control algorithm. Three dimensional power 
absorption and thermal models for inhomogeneous tissues are available to 
optimize applicator geometry and phase configuration. Properties of the 
interstitial heating system have been verified both in phantom experiments and 
in in vivo treatments of rhabdomyosarcomas implanted in the flank of a rat. 
An experiment with four electrodes in one catheter proves that longitudinal 
control of the specific absorption rate (SAR) is feasible. Local cooling applied 
by cold water circulation through a catheter perpendicular to the afterloading 
catheter could be compensated by independent control of electrode power. 
Furthermore, comparison of two different phase configurations using four dual 
electrode applicators shows that the SAR distribution can be manipulated 
significantly, utilizing the phase of the electrodes. Finally, the temperature can 
be controlled safely and model calculations are in fair agreement with the 
measurements. 
Using the features of the 27 MHz CS-IHT system, spatial temperature control 
is possible arapproxlmately1 .5 em. 
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1. Introduction 
The goal of hyperthermia is to achieve a certain elevated temperature over the 
whole tumor volume, without overheating surrounding normal tissue. 
The actual value of the required minimum tumour temperature is still a point 
of discussion. Traditionally, clinicians aimed at temperatures equal to or higher 
than 42-43 DC for relatively short treatment times of about 1 h, both in treat-
ments with external heating (Kapp et al., 1990) and with interstitial heating 
(Seegenschmiedt et al., 1992). 
More recently, the effectiveness of concurrent, long duration (45-72 h), 
mild (41 DC) hyperthermia (HT), and radiotherapy (RT) has been investigated 
experimentally (Armour et al., 1994a; Armour et al., 1994b) and clinically 
(Garcia et al., 1992; Marchosky et al., 1992). 
At present, the minimum tumour temperature realized in practice is often 
lower than was aimed for in the treatment protocol. Sometimes this is due to 
limitations in applicator power, but a more fundamental reason is that large 
vessels (Crezee et al., 1992) and spatial variations in thermal and electrical 
tissue properties cause inhomogeneous heating, which cannot be compensated 
because of insufficient spatial control of power deposition. In this case, further 
increasing of applicator power would lead to excessive normal tissue tempera-
tures or hot spots in the tumour, resulting in pain and lor unacceptable toxicity. 
Therefore, to avoid under dosed regions in the tumour, three dimensional 
control of the specific absorption rate (SAR), on the same scale as the tissue 
heterogeneity, is needed. 
However, 3D SAR steering alone is not enough. Firstly, it must be known 
where the cold spots are. Modeling calculations could be used to predict the 
temperature distribution. However, as long as tissue properties and their time 
dependence cannot be determined exactly, and thus reliable calculation of the 
temperature distribution is not possible, measurements are indispensable. 
In clinical hyperthermia treatment of recurrent breast cancer, it was found 
that the treatment series average of the maximum temperature measured at 
the coldest spot in the tumour is related inversely to the number of invasive 
tumour measurement points (Van der Zee et al., 1992). Therefore, tempera-
ture measurements should be done preferably at the same spatial scale as the 
tumour heterogeneity. Depending on the reliability of modelling calculations, 
the number of measurement points might be reduced. 
Experiments in artificially perfused bovine tongues (Crezee et al., 1991) and 
modelling calculations of the temperature distribution in heterogeneous brain 
tissue with realistic vessel trees (Lagendijk et al., 1994b) showed that power 
deposition and temperature measurement with a spatial resolution of about 
1 em in three directions are needed to obtain a homogeneous temperature 
distribution. One way to accomplish this is through interstitial hyperthermia, 
provided that independent longitudinal control per afterloading catheter is 
feasible. The high density of applicators and thermometers enables compen-
sation for spatialvariationsinbloodflow and tissue properties. In.addition, 
overheating of normal tissue can be avoided. However, a drawback 01 most 
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IHT systems is that the exchange of energy between applicator and tissue is 
limited to a small area around the catheter (electromagnetic systems) or, even 
worse, to the catheter surface (hot source systems), which might result in an 
inhomogeneous temperature distribution if not enough applicators are used. 
This paper describes the features of the 27 MHz current source (CS) 
interstitial hyperthermia (IHT) system, focusing on the possibilities to improve 
the homogeneity of the temperature distribution. 
2. Methods and Materials 
2.1. The 27 MHz current source hyperthermia system 
The 27 MHz CS IHT system has been developed in a collaboration between 
the University Hospital Utrecht and the Dr. Daniel den Hoed Cancer Center 
Rotterdam (DDHCC) (Lagendijk et al., 1994c). Three units can be distin-
guished, i.e., a heating system, a thermometry system, and a control unit. 
The heating system, based on the 27 MHz current source heating method 
(Marchal et al., 1989; Visser et al., 1989; Deurloo et al., 1991), has two 
coherent groups of 32 channels, which are 180° out of phase. To maintain 
the strict phase relation between the channels, duty cycle power steering is 
used (5 W per channel adjustable with steps of 0.25 WI. 
Multielectrode applicators can be inserted in standard brachytherapy 
afterloading catheters (inner diameter (10): 1.5 mm, outer diameter (00): 
2.0 mm). 
A schematic design of a dual-electrode applicator with two segments of 
conducting paint (Electrodag 1415, Acheson Industries) on a polythene 
catheter is shown in Figure 1. A thin (50 ,um) copper feeder wire is connected 
to each segment. 
Temperature measurements are performed with seven point constantan-
manganin thermocouple probes (probe diameter: 0.5 mm, ELLA-CS Czech 
Republic). Fast data-acquisition (all 196 channels within 320 ms) is feasible 
with a high resolution (0.005°C) thermometry system (De Leeuw et al., 
1993). 
The third unit, a UNIX workstation (Silicon Graphics Iris Indigo R3000), 
provides the connection between power supply, thermometry, and operator. 
The main features of the treatment software (C + +) are pretreatment quality 
check of applicators and thermometry, automatic or manual temperature 
control per electrode, clear display, and automatic storage of treatment data 
and a user friendly graphical user interface. 
The phantom experiments were performed in muscle-equivalent agar 
phantoms (1 I H20, 30 g agar, 3.2 g NaCI, 37 ml formaldehyde) (Ishida et al., 
1980), with low loss (tgo = 0.005), polyoxymethylene (POM) afterloading 
catheters (1.5 mm 10, 2.0 mm 00, supplied by Nucletron Corporation, The 
Netherlands) . 
88 
applicator catheter 
~ 
200mm 
20mm 
tOmm 
Chapter 6 
........ C& .• ,,@ .. 'Il ... -@- ., .. ,@J 
 elect~es~g~e~~J '] 
seven point thermocouple probe 
Figure 1. Schematic design of the dual electrode applicator. 
2.2. Modelling calculations 
The software, used for the calculations, has been developed by the 
hyperthermia group in Utrecht (De Bree et al., 1994; Kolle et al., 1994). 
Using a quasi-static approximation of the Maxwell equations, the electric 
potential distribution and the power absorption distribution can be computed 
for a certain volume if the electrical properties (electrical conductivity (0), 
relative permittivity (E,)) and the position of current andlor voltage sources are 
known (SAR model). Subsequently, the temperature distribution can be 
calculated at any time (thermal model) from the SAR distribution, the density 
(p), and the thermal properties (specific heat capacity (c p), thermal conductiv-
ity (k), perfusion). Both models are three dimensional, at a resolution of 1 mm 
and for heterogeneous tissues. The tissue properties used for the computa-
tions are shown in Table 1. 
Table 1. Tissue properties used for the modelling calculations 
tissue p 0 E, cp k 
[kg m'3] [O"m"] [] [J kg" K"] [W m"K"] 
agar 1000 0.6 80 3590 0.6 
muscle 1020 0.6 113 3500 0.6 
fat 900 0.43 20 2300 0.2 
3. Results: System features affecting temperature uniformity 
3.1. Current source applicators 
The inipedance assocTatedwith the capacitivecouplingbelweenthe electrodes 
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and the surrounding tissue, through the wall of the afterloading catheter, is 
high compared to the tissue resistance. A typical impedance for a 20 mm elec-
trode (00 ~ 1.5 mm) inside a polyoxymethylene (POM) catheter 
(00 ~ 2 mm) in muscular tissue is about 500-600j O. Therefore, the 
electrodes behave like current sources (Visser et al., 1989) with a uniform 
current density along the afterloading catheter, which is relatively independent 
on applicator geometry. Even electrodes with opposite phase can be inserted 
in the same catheter (Oeurloo et al., 1991; Lagendijk, 1991). Furthermore, 
because coupling between the feeder wire and the tissue appears to be 
negligible, the heated region is limited to the physical size of the electrodes 
and thus can be chosen freely by choosing length and position of the 
electrodes. The effectively absorbed power per electrode, which has been 
obtained from calorimetric measurements, is typically in the range 1-1.5 W. 
A disadvantage of electromagnetic hyperthermia systems in general is that 
energy absorption is strongly dependent on the permittivity and the electrical 
conductivity of the tissue. If a current source electrode is surrounded by 
different tissue types, inhomogeneous heating may occur. This is clearly 
demonstrated in Figure 2. One of the electrodes of a dual electrode applicator 
is placed partly in fat and partly in muscle. This results in a hotspot on the fat 
side and stresses the importance of both treatment planning and longitudinal 
temperature control. 
T [0C] 
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Figure 2. The calculated temperature distribution, after 5 min of heating, along a dual electrode 
applicator, with one of the electrodes partly in fat and partly in muscle (properties in Table 1). A 
h()t"sp(}t 9c,~urs in the fatW tissu,e._ 
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3.2. longitudinal SAR control 
Because blood vessel structure and heterogeneity of the tissue properties are 
three dimensional, 3D SAR control is needed as well. This can be obtained 
with segmented applicators, but requires a relatively large number of heating 
channels. With the current source IHT system the power of 64 electrodes can 
be controlled independently. Figure 3 demonstrates the ability of the system 
of longitudinal SAR control with four electrodes of 20 mm and a longitudinal 
spacing of 10 mm (Figure 3a). The experimental setup involved two dual 
electrode applicators inserted in a POM afterloading catheter from opposite 
sites. Temperatures were measured with a seven point thermocouple probe in 
each applicator. In Figure 3b two power configurations are compared. Firstly, 
with equal power per electrode and secondly, with decreasing power from a 
duty cycle of 100% for the left electrode to 25% for the right electrode. The 
temperature change distribution along the catheter, after 1 min of heating, 
was calculated (solid lines) and measured (circles and triangles). It can be seen 
that the temperature rise is fairly proportional to the electrode power. 
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Figure 3. Longitudinal SAR control. (a) Schematic design of the experimental set-up. (b) The 
temperature change distribution, after 1 min of heating, calculated (solid lines) and measured in 
the applicators (symbols) for two different electrode power configurations (A: duty cycles of 100% 
for all electrodes and B: duty cycles of 100%, 75%, 50%, and 25%). Local cooling, through 
circulation of water with a temperature of 2°C was applied in (c) and (d). Control temperature and 
electrode power as a function of time are shown in (c). All control temperatures were easily main-
tained at the targettemperature (28°C). To keep the figure clear, only the curves of the electrodes 
2.1 and 2.2 are shown. The temperature distribution along the electrodes before and just after the 
vyat~rcircul(l!IQOJ~I1:U;hQVYftt!1J:f). AH,h9u9,h,th,e control temperatun3§ vyer~, k~pt ,at tb~ t!3r9~t, \lalue, 
a cold spot arises near the cooling catheter. 
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An example of compensating local cooling utilizing longitudinal SAR control 
is shown in Figure 3 (a-b). To realize cooling at one position along the 
afterloading catheter, cold (2°C) water was circulated through an extra 
afterloading catheter perpendicular to the applicators. In each electrode one 
control thermometer was chosen. The target temperature for these sensors 
was set at 28°C. When the target temperature was reached, at t~ 10 min, 
water circulation was started. All control temperatures were maintained at the 
target value until the water circulation was stopped at t ~ 26 min (Figure 3c). 
During the period of water circulation, only the control sensor closest to the 
cold water tube has been cooled, which can be seen in the power-time 
diagram, in the lower panel of Figure 3c. To keep this figure clear, the 
temperature and power curves of the electrodes 1.1 and 1.2, which were 
almost identical to those of electrode 2.2, have been excluded. This confirms 
that independent temperature control per electrode is possible. Figure 3d 
shows the temperature distribution measured along the electrodes, before and 
just after the water circulation. Although the control sensors have been kept 
at the target temperature, the temperature in the centre has dropped, due to 
the applied cooling. This demonstrates the importance of temperature 
measurements outside the electrodes to detect these cold spots. Because 
thermometry is seldom sufficiently extensive, temperature measurements 
should be combined with reliable temperature computations. Furthermore, 
sufficient electrode power and electrode lengths which match the tissue 
inhomogeneity are essential for good longitudinal control. 
3.3. Phase configuration SAR control 
The SAR distribution does not only depend on electrode geometry and power 
amplitude, but also on the power phase. The effect of the phase configuration 
on the temperature distribution is clearly shown in Figure 4. Four dual 
electrode applicators are inserted in four parallel catheters, implanted in a 
square (15 x 15 mm') geometry (Figure 4a). The temperature distribution 
along the central axis, parallel to the applicators, was calculated (solid lines) 
and measured (circles and triangles) after 1 min of heating for two different 
phase configurations (Figure 4b). If all tip electrodes have the same phase 
(Situation A), then maximum energy absorption is found in the centre of the 
implant. This is due to constructive interference of the electric fields of the 
applicators. The maximum turns into a minimum if the electrode connections 
are inverted for two of the applicators (Situation B). 
4.4. Automatic temperature control 
For a large number of electrodes, manual power steering is not convenient and 
it could even be dangerous. Automatic temperature control is to be preferred. 
The· 2 7 MHz eSc) HTcsysten1usesastraightfo rwardcontrolalg orithmto 
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calculate the power duty cycle as a function of the temperature measured 
inside the electrode. In case more than one temperature sensor per electrode 
is used, the sensor with the highest temperature is chosen to be the control 
sensor. First, the target temperature (T"",,) and the control cycle time (to,o',) 
are chosen. The latter must be sufficiently short to be alert to sudden changes 
in perfusion and to minimize temperature fluctuations if the optimal power is 
between two adjustable levels. Cycle times in the range of 30-60 s appear to 
be safe if low loss afterloading catheters, e.g., POM (tg6=0.005) are used. 
However, 15 s are needed for absorbing material such as nylon (tg6=0.04). 
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Figure 4. Phase configuration SAR control. a) Four dual electrode applicators have been inserted 
in four parallel POM catheters in an agar phantom, The dark and the light electrodes are 180 0 out 
of phase. Two phase configurations have been compared (A and Bl, b) The temperature change 
distribution, after 1 min of heating, was calculated (solid Jines) and measured (symbols) along the 
central axis paraifel with the applicators. For configuration A the maximum temperature rise was 
f9vmtJo ~ th~"GJmtLe",~Ve, -to" G,pnsJ(u,Qt1y~, jnt!;:lrJerenQ~ J:JJ, tlw ,!;,~t!1'!'~t~"The" lflmp~ralYr~ (;tt~lr!pJ.'tion 
for configuration B has a minimum in the centre, 
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The temperature is measured during every toy"~"~ and the temperature 
expected for the next measurement (T"tim"'d) is linearly extrapolated from the 
previous temperature (T''''ioo,) and the present temperature (T,,,,,,,). Then the 
duty cycle change is taken to be proportional with the difference between 
Tta/gat and Testimated: 
I1de =a( Ttarget - restimaled) (1 ) 
with a the control factor. The control method is visualized in Figure 5a. 
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Fig. 5. The automatic control algorithm. (a) Visualization of the algorithm. At t=O the target 
temperature was set at 40°C and the control factor was taken 25 (see text). (b) Temperature-time 
di,Cl9ram, for three (Jjtferent co,nt(ol f;.'!CJQH;t IQ'"=J",,J O"oc lOQ,,,Tw,g~! ,7, +3,~,CL 
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The first requirement for automatic temperature control is obviously that it 
must be safe. The following considerations are relevant in this respect. First, 
maximum energy absorption will be close to the electrodes. Therefore, with 
temperature sensors inside all electrodes, the maximum tumour temperatures 
are always detected. Furthermore, continuous readout of the thermocouple 
voltages, during a control cycle, is possible using RF filtering. Power will be 
turned off independently of the control algorithm if the measured temperature 
is higher than a chosen maximum, or if it is unrealistically low, e.g., due to a 
defect RF filter or a shifted sensor or applicator. 
Besides being safe, the algorithm must work properly, which means that 
once T"'9" has been set, it must be reached quickly and maintained stable. 
Before the treatment starts, a power pulse is given for each electrode to check 
the functionality and the set-up definition of applicators and thermometry. 
T""" is reached more rapidly if the control factor a is increased, but a 
temperature overshoot might occur (Figure 5b). In clinical practice, a is in the 
range of 5-10 and can be kept the same for all applicators during the whole 
treatment. 
In Figure 6 an example is given of an automatically controlled (a= 6, 
toy"~, = 1 Os) IHT treatment of a rhabdomyosarcoma in the flank of a female 
WagRij rat. Four POM afterloading catheters were implanted with 10 mm 
spacing. Two single electrode applicators (2 cm long) with equal phase and 
two with opposite phase were inserted. The temperature was measured in the 
electrodes and, via an extra thermometry catheter, in the tumour centre. 
First, the target temperature for the electrodes was set at 43°C which is 
about 18°C above the low (due to anesthesia) starting temperature of 25°C. 
The differences in heating up rate are due to spatial variations in blood flow 
and/or tissue properties, because power-temperature characteristics in an agar 
phantom were the same for all applicators. After about 16 min, the target 
temperature was increased to 47°C to improve the central temperature. 
Halfway the treatment power was turned off for 150 s. The slow decrease in 
the centre demonstrates that the temperature is more or less homogeneous 
between the electrodes. The relatively rapid temperature fall in the electrodes 
just after power was turned off shows that only a small region around the 
electrodes has a high (47°C) temperature. The core temperature, which was 
measured in the rectum, was stable during the treatment. 
4. Discussion 
The SAR and thermal models used to calculate the SAR distributions and the 
temperature distributions have been found to be useful tools for the 
optimization and evaluation of the treatment. The calculations predict the 
positions of hot and cold spots accurately. In general, quantitative prediction 
of clinical temperature distributions is difficult, for two reasons. Firstly, the 
models need further refinement. Applicator description and modelling of 
perfusion a", the main challengesinihisrespect. 
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Fig. 6. Automatic temperature control during a treatment of a rhabdomyosarcoma growing in the 
flank of a female WagRij rat. The tumour was implanted with a 10 mm square implant in which 
four 20 mm long single electrode applicators were inserted. The temperature was measured in 
each applicator (control sensors) and in the centre of the tumour. First, the target temperature of 
the automatic temperature control was set at 43°C. Later, at t = 16 min, it was increased to 
47°C. Halfway through the treatment power was turned off for 150 s, The temperature-time (a) 
and power-time (h) diagrams are shown. The control factor during the treatment was 7. 
Secondly, accurate input parameters, i.e., tissue properties and blood flow, 
cannot always be obtained with the current imaging techniques (CT, MRI, 
MRA). Therefore, extensive invasive temperature measurements remain 
necessary. However, the qualitative temperature distributions calculated with 
the 3D models, which are available for the 27 MHz current source IHT system, 
are very useful for optimization of the treatment quality. After implantation of 
the afterloading catheters, pretreatment computations can be used to find the 
optimal applicator geometry, e.g., electrode position relative to tissue 
tHiris1ti6ris (FlgOfe·2), ana to hiiixihiliellie advalitagesofphaseCilrifiguratloli 
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SAR control. Extra thermometry can be placed at locations where cold spots 
are expected. Furthermore, the modelling calculations can serve as a measure 
for the treatment quality. In combination with the measured temperatures, a 
good estimation of the thermal dose is possible, which is essential for the 
evaluation of clinical trials. 
The current source behaviour of the applicators may have advantages over 
other interstitial heating techniques for some applications. 
Compared to local current field (LCF) radio frequency (RF) heating, the 
current source heating method is more suitable for irregular implants, i.e., 
implants with varying separations between neighbouring catheters or with 
curved catheters. In case of LCF-RF IHT, nonparallel implanted galvanically 
coupled applicators (voltage sources) can lead to severe hot spots (Strohbehn 
et al., 1986). 
Furthermore, the current injection is homogeneous along the electrodes and 
independent from length and position of the electrodes. This is an advantage 
over microwave antennas, where the temperature distribution strongly 
depends on insertion depth and a cold tip is often seen (Ryan, 1991). The 
latter is an important drawback, if an increased implantation depth beyond the 
distant tumour edge is not possible. In addition, using the current source 
system, better normal tissue sparing is achieved in case of deep-seated 
tumours, because there is no heating along the feed line. It is important to 
realize that a homogeneous temperature distribution along the electrodes is 
achieved only if the tissue around the electrodes is homogeneous (see 
Figure 2). Therefore, short electrodes should be used and electrode placement 
over tissue boundaries should be avoided. 
Direct energy absorption in tissue at a distance from the afterloading 
catheter, is a pro compared to heating via thermal conduction alone, because 
a higher heat penetration depth can be expected, resulting in a more 
homogeneous temperature distribution, for a certain applicator density. 
Effective heating depths, defined as the radial distance from the applicator 
at which the temperature rise is 50% of the maximum temperature rise, have 
been calculated for single cylindrical hot source, RF-LCF, and ultrasound 
applicators with an outside diameter of 2 mm (Diedrich et al., 1993). The one 
dimensional steady state solution of the bioheat transfer equation in a medium 
with perfusion of 2.0 kg m'3 s" was calculated, using a finite difference tech-
nique. The effective heating radius of a RF-LCF electrode (7.3 mm) was 
significantly higher than with thermal conduction only (2.7 mm). As in RF-LCF 
heating, the power absorption around a CS applicator is proportional to 1/r', 
which gives a heating radius of 7.3 mm. It should be mentioned that dielectric 
losses in some afterloading catheter materials such as nylon, could decrease 
this value. The highest effective heating depths were achieved with ultrasound 
applicators (10 mm at 9 MHz, 11.5 mm at 5 MHz, and 15.4 mm at 1 MHz). 
An estimation of the effective heating depth of a single microwave antenna 
operating at 915 MHz can be obtained from the in vivo measurements in 
muscle tissue (Satoh et al., 1988). The heating depth, measured at the 
positiOhal the antenna gap ;wasaboutl1" mmfora dipole antenna and about 
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9 mm for a helical coil antenna. Both antennas had a 3.5 cm long tip and were 
inserted to a depth of 7 cm. 
With arrays of coherent electromagnetic sources it might be possible to 
improve the power absorption at depth, through constructive interference of 
the absorption distributions of individual applicators. The experiment reported 
in section 3.3 demonstrated that manipulation of the specific absorption rate 
at depth is possible. 
The degree of spatial temperature control strongly depends on the electrode 
density. In brachytherapy, the distance chosen between afterloading catheters 
is usually in the range of 1-1.5 cm. The minimum electrode length needed for 
sufficient coupling between electrode and tissue is about 1.5 cm. At present, 
dual electrode applicators are used, but applicators with three electrodes are 
being tested. So, if an afterloading catheter is accessible from both sides, 
maximum longitudinal control, i.e., on a 1.5 cm scale, can be obtained over 
a length of 7.5 cm, including the longitudinal spacing (0.5 cm) between the 
electrodes. The maximum tumour volume which can be treated is dependent 
on the available number of heating channels. 
With the 64 channels of the clinical heating system, maximum spatial 
control can be achieved within one heating session, in a volume of 4.5 x 4.5 
x7.5cm'. 
To handle this relatively large number of applicators, safe automatic 
temperature control is a necessity in interstitial hyperthermia. 
The only external hyperthermia method which has the ability of even sub-
centimetre spatial SAR control, is scanned focused ultrasound (SFUS) (Hunt, 
1990). In theory, very homogeneous thermal dose distributions are possible 
(Lagendijk et al., 1994a). Disadvantages are high absorption in bone and 
reflection at tissue-air interfaces. As mentioned above, thermometry catheters 
will be needed for SAR control but can be thinner than standard afterloading 
catheters. In contrast with most IHT techniques, hot spots are not always 
detected, which could make SFUS treatments less safe. 
Inadequate heating technology and thermal dosimetry are considered a 
probable cause of failure of trials comparing thermoradiotherapy with 
radiotherapy alone (Moros et al., 1994). 
To improve this situation, three dimensional temperature control is 
essential. 
The 27 MHz current source IHT system has several features, enabling it to 
attain a fairly homogeneous temperature distribution. Further development of 
treatment planning techniques is needed to exploit the possibilities of improved 
spatial temperature control. 
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Abstract 
In interstitial hyperthermia temperature measurements are mainly performed 
inside heating applicators and therefore, give the maximum temperatures in a 
rather heterogeneous temperature distribution. The problem of how to 
estimate lesion temperatures using the multi-electrode current-source (MECS) 
interstitial hyperthermia (IHT) system in the brain is studied, for two implants 
at either extreme of the volume range encountered in clinical practice. 
A small (diameter:1 cm) and a large (diameter:4 cm) target volume were 
heated with 2 and 18 electrodes (length: 1 cm), respectively. Temperatures 
were measured with thermocouple probes in the electrodes and' in an extra 
afterloading catheter at the edge of the target volume. The edge temperature 
was used to set the target temperature for the electrodes which were 
controlled automatically. Each control cycle was divided in a power-on and a 
power-off period. From the temperature decay during the latter period informa-
tion was obtained about the temperature between the electrodes. The 
significance of these data was examined through model calculations. 
···-rhiidesirednlil1imumtempe':aiLlre of40°(:;atih" edge of the target 
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volume could be reached and maintained easily. Although the hot spots near 
the electrodes were high (about 50°C), they were also very local. The 
temperature decay method shows that most of the tissue temperatures in the 
target volumes were in the range of 40°C to 44°C. 
In conclusion, it is feasible to heat the brain adequately using the MECS-IHT 
system. Furthermore the electrode temperatures read during heating are not 
suitable to assess the temperature distribution. For this purpose, extra sensors 
outside the electrodes andlor application of the decay-method are required. 
1. Introduction 
With respect to the use of thermometry for optimization and evaluation of the 
treatment quality, interstitial hyperthermia (lHT) differs from external heating 
techniques, due to its characteristic temperature distributions with hot spots 
around the electrodes (Levendag et ai, 1993). 
In fact, applicator temperatures are only useful to control the maximum tissue 
temperature. However, sensors inside the applicator often overestimate the 
tissue temperature, due to self-heating of the applicator andlor thermometer. 
Measurements in thermometry catheters, i.e. without a working applicator, 
give in general reliable tissue temperatures if sufficient precautions are taken. 
These sensors, if placed in the centre between the applicators and at the edge 
of the target volume, give information about the local minima in the tempera-
ture distribution. Knowledge about the minimum temperature in the target 
volume is important for good treatment control. Therefore, quality assurance 
demands for number and place of the sensors, as were defined in the RTOG 
QA-guidelines for IHT by Emami et al (1991) should be followed. In case of 
inhomogeneous perfusion andlor the presence of large blood vessels even 
more thermometers should be used. However, in practice the number of 
catheters which can be implanted is limited by patient tolerance. Furthermore 
the homogeneity of the temperature distribution strongly depends on the 
electrode density. Therefore a compromise has to be made between heating 
catheters and thermometry catheters which often leads to a shortage of 
information about the minimum temperatures. 
In some situations minimum temperature control is possible using the 
applicator temperatures only. DeFord et al. (1991) was able to estimate the 
minimum temperatures between conductive interstitial applicators in brain 
tissue, as a function of the ratio between the applicator power and the 
temperature rise in the applicator. Another way to judge the temperature 
distribution during the treatment using applicator temperatures, is to study the 
temperature decay after turning off the power. This should give information 
about the lower tissue temperatures at some distance of the applicator. In 
addition these power-off intervals reduce self-heating artifacts, if present. 
However, Newman et al. (1990) have demonstrated that calculation of thermal 
tissue properties, using clinical thermal washout data requires correct 
modelling of theheati rig geometry, tfit' acWaltherma I boundary '. conditions, 
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and the initial temperature distribution. Using the applicator-temperature decay 
to estimate the temperatures elsewhere wil be even more difficult. 
Evaluation of the treatment in terms of the commonly used treatment quality 
parameters, as were summarized by Erb and Seegenschmiedt (1995), using 
the available measured temperatures without extra information, is even more 
difficult than to control the minimum temperature. Because of the relatively 
high temperature gradients (typically 1°C/mm) associated with interstitial 
heating, the sensor density, needed to calculate the delivered thermal dose 
with parameters such as T 90 and T moo"' should be much higher than for 
external heating techniques, probably too high to be feasible. 
Model calculations could be a solution to this problem. Tissue properties can 
be varied until the calculated temperature distribution corresponds well with 
the temperature data obtained during the treatment. Subsequently, thermal 
dose parameters can be computed. 
The use of thermometry in applicator catheters and thermometry catheters in 
the clinical situation will be discussed for the 27 MHz multi-electrode current-
source (MECS) IHT system. This system has been developed in a collaboration 
between the university hospital Utrecht and the Daniel den Hoed Cancer 
Centre Rotterdam. Promising features of MECS-IHT regarding 3D spatial 
temperature control have already been confirmed in model calculations (Kaatee 
et al., 1997, Lagendijk et al., 1994, Van de Koijk et al. , 1996), in muscle-
equivalent phantom measurements (Deurloo et al., 1991, Kaatee et al., 1997, 
Visser et al., 1989) and in vivo, in rhabdomyosarcomas growing in the flank 
of a rat (Kaatee et al., 1995). Clinical application of the MECS-IHT system 
involves treatments of high grade (grade III/IV) gliomas. The experience in the 
Daniel den Hoed Cancer Centre with IHT of high grade gliomas, until August 
1997, is based on the treatments of 7 patients. In this paper methods of 
thermometry use are investigated for two of these treatments, i.e. the treat-
ment of a small (diameter: 1 cm, 2 electrodes) and of a large (diameter: 4 cm, 
18 electrodes) target volume. 
2. Materials and Methods 
2.1. The 27 MHZ multi-electrode current-source interstitial hyperthermia 
system 
The 27 MHz current source hyperthermia system can be split into three sec-
tions, i.e. a 27 MHz heating unit, a thermometry system, and a workstation 
for treatment planning and treatment control. The power system has 64 
coherent channels, divided into two groups with a phase difference of 180 0 • 
Duty cycle power steering (from 0 to 100% of a cycle time of 200 ms, in 
steps of 5%) is used to maintain the strict phase relation between the 
channels. The electromagnetic energy isdep()sited in the tissue by mulii-
104 Chapter 7 
electrode applicators, inserted in plastic afterloading catheters. 
Temperature measurements are performed with 7-points constantan-manganin 
thermocouple probes IELLA-CS, Czech Republic). Fast data-acquisition lall196 
channels read within 320 ms) is feasible using a high resolution 10.005°C) 
thermometry system IDe Leeuw et al., 1993) 
A UNIX-workstation provides the connection between thermometry, power 
supply and operator. Some features of the treatment control software are: 
automatic or manual temperature control per electrode, clear display and 
automatic storage of treatment data and a user-friendly graphical user 
interface. 
Furthermore the work station is used for treatment planning. Three-dimension-
al models are available for calculation of the distributions of power absorption 
and temperature, for heterogeneous tissues. 
A more extensive description of the MECS-system has been given by Lagendijk 
et al. /1994). 
2.2. Placement of afterloading catheters, applicators and thermometers 
In general target dimensions in the brain are in the range of 10 to 50 mm. 
Typically 1 to 10 afterloading catheters are implanted parallel at distances of 
about 5-10 mm. The catheters have blunt tips to minimize damage to the 
blood vessels and are made of a special type of nylon which has a low dielec-
tric loss Itano "'0.002) The latter is necessary to avoid large absorption of 
electromagnetic energy in the catheter wall. 
In figure 1 a top view of the small and the large implant, discussed in this 
paper, are shown. The catheters denoted by closed circles are used for 
thermometry only. In the other catheters dual-electrode applicators are inserted 
with 10 mm long electrodes at a longitudinal distance of 5 mm, with a 7 -point 
thermocouple probe 17.5 or 10 mm distance between the measure points) 
inside IKaatee et ai, 1997b). Two concentric circles denote that the 
afterloading catheter is inserted through a hollow titanium screw which is used 
for fixation of the implant template to the skull. Thermocouple-probe and 
applicators are fixed to the catheters using luer-Iock adapters ICook). All tip-
electrodes are connected with the same phase. The phase of the other 
electrodes are shifted 180°. Inside each applicator, the temperature is 
measured with 7-point manganin-constantan thermocouple probes. In most 
applicators the distance between the points is 7.5 mm and in the others 10 
mm. In the thermometry catheter the temperature was measured at 14 points 
with a 5 mm resolution. 
The electrodes were placed mostly inside the target volume to avoid hot spots 
in the surrounding normal tissue. Only in case of the small target volume the 
electrodes exceeded the target volume boundary by 5 mm at each side, to be 
able to deliver sufficient energy to compensate for heat flow due to blood flow 
and thermal conduction IKaatee et al. 1997b). 
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2.3. Treatment schedule and goal 
After surgery the patients received 33 fractions of 1.8 Gy external radiother-
apy (ERT) followed by a combination of IHT and pulsed dose rate (PDR) 
interstitial radiotherapy (lRT). The latter consisted of 4 fractions per day (8:00, 
11 :00, 14:00 and 17:00 hours) of 2 Gy per fraction and an overall dose of 24 
Gy. On the first whole day of the brachytherapy treatment three IHT-sessions 
of about two hours were administered between the PDR-fractions. The 
treatment goal was to achieve a minimum temperature of 40 DC in the 
treatment volume as long as possible. 
2.4. Treatment control 
In each electrode one temperature sensor was selected as control sensor. The 
temperature measured with this sensor is used to control the power of the 
corresponding electrode. A control cycle consists of a power-on period and a 
power-off period to measure temperatures. The power-off period is divided into 
a "recovery period", to allow the electronic disturbance of the data-acquisition 
equipment to disappear, and the actual "measurement period", during which 
temperatures are measured with a frequency of 1 measurement per second. 
Except from the recovery period which must be at least 1 s, the length of the 
various periods can be chosen freely. The choice of the control cycle 
parameters is somewhat arbitrary. In general, longer power-off time gives more 
temperature-decay information but requires a longer power-on period to main-
tain the effective power at a certain level which makes the automatic control 
procedure less alert. In case of the large implant the power-on, recovery and 
measurement times were 10, 2 and 3 s respectively. For the small implant 
these times were 55, 2 and 8 s. To heat a smaller target volume, a higher 
absorption density is required (Kaatee et al., 1997b). Therefore, the ratio 
between power-on and power-off time is higher for the small than for the large 
implant. 
During the power-off period the temperature decreases. The temperature 
which is controlled by the automatic temperature control algorithm is the last 
measured temperature during a measurement interval. If the power-off time is 
chosen correctly then the controlled temperature corresponds with the maxi-
mum tissue temperature just outside the afterloading catheter wall. Unfortu-
nately, the required power-off time is not only related with the type of 
applicator and afterloading catheter but depends also on the tissue properties 
and on the geometry of the implant. Therefore short term (0-15 s) decay of 
the applicator temperatures, after all electrodes were switched off simulta-
neously, was studied to determine the waiting time after which the electrode 
temperatures can be interpreted as maximum tissue temperatures. 
In practice, the actual value of the maximum tissue temperature was 
considered of less importance than the obtained minimum temperature in the 
target· volUme 
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The temperature measured with the sensor in the thermometry catheters close 
to the edge of the target volume was taken as a first estimation of the 
minimum temperature. The electrode target temperature was kept equal in all 
electrodes, and was adjusted until an edge temperature of 40°C was reached. 
In case of the large implant, occasionally the electrodes in one of the 
afterloading catheters were turned off for 1-2 minutes, to obtain information 
about local minimum tissue temperatures in a certain region of the target 
volume. 
2.5. Model calculations 
Model calculations were performed after the treatment of the large implant to 
determine the meaning of the applicator temperatures, 1-2 minutes after the 
power is switched off in relation with local minimum tissue temperatures. 
The models used for the computation of the power absorption density and the 
resulting temperature distribution, have been described by De Bree et al. 
(1996) 
and Kotte et al. (1996), respectively. 
The patient tissue geometry was obtained using CT-data and was divided into 
voxels with a resolution of 1 mm in three dimensions. Each voxel was 
classified as either brain tissue or air or bone depending on its Hounsfield 
value. No distinction could be made between grey and white matter. The 
tissue properties used for the calculation are given in table 1. The air was kept 
at a fixed temperature of 25°C. Heat transfer from skin to the air was taken 
into account using a heat transfer coefficient of 8.1 W m- 2 K- 1 • 
Because discrete vessel data were not available, blood flow was incorporated 
in the model using the heat sink theory (Pennes, 1948). Blood flow rates (wb 
) of 0.5 and 50 (initial value) ml/100g tissuelmin were chosen for bone and 
brain tissue respectively. The latter was varied to match the computational 
results with the clinical measurements. The specific heat capacity coefficient 
of blood (cb ) was set at 3825 Jkg-1 K- 1 • Each metal electrode and the 
afterloading catheter in which it is inserted are modelled together as a current 
source electrode. Because a voxel size of 1 mm is too large for accurate 
numerical modelling of the interaction between electrodes and the surrounding 
tissue, this was implemented analytically (De Bree et al. 1996, Van der Koijk 
et al. 1997b). This was possible because the electrodes are described as a 
geometrical objects, independent of the tissue grid resolution. 
The goal of the simulations was to reproduce the clinical temperature decay 
measurements for 1-2 minutes, by varying the blood flow rate of the brain 
tissue. In an iterative procedure, the electrode powers, i.e. the current 
injections, were modified and the resulting power absorption and temperature 
distributions were calculated, until all steady state electrode temperatures 
reached a certain target temperature. Subsequently, the electrodes in one 
catheter were tUrned Offandtne powe(absorpti6h Was calculated f6rthisnew 
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situation. Next, the temperature decrease was calculated and compared with 
the clinical decay measurements. The whole simulation was repeated, while 
the brain blood flow rate was varied, until a good agreement between 
computation and measurement was found. 
Table 1. Tissue properties used for the model calculations 1 
Medium a E, p c k 
[0-' m-'I [I [kgm-'I [Jkg-' K-'I [Wm-' K-'I 
air 0 1 1.3 0.001 0.004 
brain 0.39 150 1000 3600 0.53 
bone 0.04 9 1600 1400 0.65 
1 data obtained from the COMAC BME task group report of the European Society for Hyperthermic 
Oncology (1992): Treatment planning and modelling in hyperthermia 
small implant large implant 
°6 
@3 
°7 
°9 °4 $1 
°8 
@10 °2 
10mm 
°5 
Figure 1. Top view of two brain implants. a) small implant with 2 catheters. b) large implant with 
10 catheters. The closed circles denote catheters used for thermometry only and the double circles 
represent catheters inserted through a hollow titanium screw. 
3. Results 
Figure 2 displays the electrode temperatures as a function of the time after the 
power of all electrodes was switched off (t polf )' For the large implant (section 
b) the steepest and the most gradual decay are shown, which were found in 
the skull-side-electrode in catheter 3 and in the tip-electrode in catheter 8 
respectively. In addition, the edge temperatures measured in the thermometry 
.G.8_t_heJefsareshQ'!YI}.Jn@oerg!,.aj!J§teJ _temp_eratuf'l. d"crea$e w_a~. JO_UI}<:l .in 
the electrodes which were closest to the skull and in those at the edge of the 
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implant. Because the automatic control algorithm uses the last measured 
temperature of each control cycle, the maximum electrode temperatures, i.e. 
at tpoff ~ 0 s, obtained through extrapolation of the curves, vary per electrode 
and are higher in the skull-side and edge-side electrodes. In case of the small 
implant, the temperature measured in the electrodes at tPoff ~ 9.5 s, had to be 
44°C to reach the wanted 40°C at the edge of the target volume. For the 
large implant a target temperature of 45°C, in this case measured at tPoff 
~4.5 s, was needed. The electrode temperatures at tPoff ~O in the small 
implant were several degrees higher than in the large implant. Furthermore, it 
can be seen that the electrode temperatures decrease steeply during the first 
10 seconds while the temperatures measured in the thermometry catheter do 
not change at all during a short time of power-off. 
a) 
temperature ("C) 
55 
53 '. 
5t ". :. 
49 
'tiP 
47 
45 
43 skull 
4t 
edge 
390 2 4 6 8 10 12 14 
time after power off (5) 
b) 
temperature ('C) 
55 
53 
51 
49 .. 
::> :::""-~::::::::::-__ ~tiP!'J<'(C~at,,:,he~t~er:.!28) 
43 skull (C~-_____ _ 
41 edge 390~~2~==4==~6==~8===I~O==~1=2===1=4j 
time after power off (8) 
Figure 2. The electrode temperatures as a function of the time after switching off all electrodes. 
a) The temperatures in the electrodes of the small implant and the edge temperature measured in 
the thermometry catheter. b) The temperatures in two electrodes of the large implant, i.e. the tip-
electrode, in "catheter 8"and" the, , skull.side, electrode_ in,catheter,,3, and "the ,edge"temperature 
measured in the thermometry catheter. The curves are extrapolated to tpOfi = 0 s. 
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In figure 3 the temperature distributions along the catheters are shown. For 
the small implant, the distributions, 2.5 sand 9.5 s after switching off both 
electrodes, is displayed (fig.3a) and for the large implant tPoff was 14.5 s (fig. 
3b). Figure 3a shows that the temperature inhomogeneity along the applicator 
which is still present at tPoff = 2.5 s almost has disappeared at tPoff = 9.5 s. The 
temperature distribution along the thermometry catheter does not change at 
all during the first 9.5 s. The vertical stripes in figure 3 correspond with the 
positions where each catheter crosses the edges of the target volume. Looking 
at the temperatures at these positions it is clear that at tPoff = 14.5 s most 
parts of the large target volume have been at a temperature between 40 and 
45 ac. There are only two exceptions which are found in the catheters 3 and 
10 near the skull. These are the catheters inserted via the metal screws used 
for fixation of the implantation template. These screws provide a relatively 
hi9h thermal conduction along the catheter causing an underestimation of the 
temperatures near the screws at tPoff = 14.5 s. 
a) temperature ('C) 
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Figure 3. The temperature distributions along the catheters. a) The small implant, t poff = 2.5 s (solid 
lines) and t polf = 9.5 s {dotted linesl. bl The large implant, t poff = 14.5 g, The encircled points give 
the temperatures measured in the thermometry catheter at the edge of the target volume, the 
vertical marks indicate the edges of the target volume for each catheter, Furthermore the numbers 
coriesp'6nd with'thifci'atfiefei rlumtieis"iii-'figlfrff 1. 
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During the large-implant treatment occasionally an applicator, i.e. consisting 
of two electrodes, was turned off for a longer period of time to obtain more 
information about the temperature of a larger area around one of the applica-
tors. In figure 4 the temperature decrease during multiple control cycles is 
shown for two situations. In section a) the applicator in the central catheter 
8 was turned of and in section b) this was done for the applicator in catheter 
9 which is located at the edge opposite to the edge of the thermometry 
catheter 1. To keep the figures clear only the temperatures measured in the 
electrodes close to the skull in the catheters 8 and 9 and at the edge in the 
thermometry catheter are given and only the last measured temperature per 
control cycle is shown. The electrode temperatures at tPoff =0 are different in 
both sections, because the target temperature for the electrodes were not the 
same i.e, 45°C and 44°C in the figures 4a and 4b respectively. Figure 4 
demonstrates that the central region of the target volume has been at least 
44°C. Furthermore it can be seen that the temperature in catheter 9 remains 
fairly stable after about 60 s and still above 41°C. 
a) temperature ('C) 
46 
skull (catheter 9) 
45 
--------
44 skull (catheter 8) 
43 
42 
41 
40 edge 
39
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time after power off (s) 
b) 
temperature (~C) 
46 
45 
44 skull (catheter 8) 
43 ~ 42 - skull (catheter 9) 
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Ume after power off (5) 
Figure 4. Temperature decrease in the electrodes ctose to the skull in the catheters 8 and 9 and 
atth~ ,ed,g~t inJbe the:rrnomeJry",c,atheJeI J ,,,aHs.Lone ,(JppHcatoJ was,JumliutoJt fOJ J-2 ,minutEH1" 
a) the applicator in catheter 8 was turned off b) The applicator in catheter 9 was turned off. 
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The measurements presented in figure 4 could be reproduced through model 
calculations using a blood flow 23.5 mll100g tissue/min. This is illustrated in 
figure 5b which corresponds with the results in figure 4b. Figure 5a shows the 
steady state temperature distribution in a plane through the skull-side elec-
trodes, perpendicular to the afterloading catheters. The electrode target tem-
perature was 44°C. Local cold spots between the catheters are not below 
40°C. Furthermore, it can be seen that at all edges of the target volume, i.e. 
convex hull around and at 5 mm distance of the electrodes, the temperature 
has been above 40°C. 
46,-------,-------,-------,--------
45 
skull (catheter 8) 
44~----------------------~----~ 
skull (catheter 9) 
41 
40 edge 
390L------~3~0------~60--------g~0--------120 
time after power off (s) 
Figure 5. al calculated steady-state temperature distribution in a plane across the skull-side 
electrodes perpendicular to the afterloading catheters. b) Calculated temperature decay in the 
skull-side electrode in afterloading catheter 9, after the electrodes in this catheter were switched 
off. 
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4. Discussion 
It is clear that temperature measurements in interstitial hyperthermia require 
a critical interpretation. This is mainly due to the characteristic temperature 
distribution with hot spots around the applicators. Therefore, knowledge about 
temperatures inside applicators during heating is not sufficient to decide 
whether the treatment quality is good. Applicator temperatures are a poor 
measure for minimum temperature in the target volume (T mio), and in case of 
the MECS·system the maximum tissue temperature just outside the afterloa· 
ding catheters (T m,') is overestimated, due to energy absorption in the 
applicator and in the afterloading catheter (Van der Koijk et al. 1997a). 
Regarding treatment safety, it is an advantage that the tissue temperature is 
never higher than the temperature in the electrodes (T"",,,,,). By measuring the 
temperature after switching off power, no RF filtering of the thermocouple 
signals is needed and a better estimation of the maximum tissue temperature 
can be achieved. The interval between power·off and measurement must be 
at least 1-2 seconds to allow the electromagnetic disturbance of the 
thermometry system to disappear, and just long enough to let the T",,,,,,, 
decrease to the value of T mox at the moment power was switched off. The 
interval depends on the applicator type and on the afterloading catheter 
properties and dimensions. A rough estimate can be obtained using the 
diffusion time of heat conduction obtained from the one·dimensional 
differential heat equation: 
T per' 
4k 
(1 ) 
For a distance between thermometer and tissue: r = 1 0.3 m and for a medium 
in between with a density: p = 1500 kg m·3 , an effective heat conductivity: 
k = 0.25 W m" °C" and a specific heat coefficient: c = 1500 J Kg" °C" , this 
diffusion time is about 2 s. Furthermore the presence of air layers between 
thermometer and tissue, power absorption in the afterloading catheter and 
thermal conduction along the applicator will affect T. 
If the required power-off interval is measured in an agar muscle-equivalent 
phantom, using the applicator and afterloading catheter which are also used 
for IHT in the brain, it takes 5-6 s before T"",,,,, is equal to T mox at the 
moment the power was switched off (data not shown). 
However, in clinical practice the actual waiting time needed also depends on 
the temperature gradient in the tissue near the electrode and thus on factors 
like the presence of neighbouring electrodes, the electrode spacing and the 
thermal properties of the tissue. Because of these remaining uncertainties and 
regarding the steep gradients in figure 2 (typically 1 °C/s) electrode tempera-
tures measured 5 s after power-off are only a rough estimate of T me< 
It could be questioned if the knowledge of the actual hot spot temperatures 
isieally imp()rtant fbr the qualify of the treatment. Themairi (l()alo! 
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hyperthermia is to reach a certain minimum temperature elevation in the whole 
target volume. Therefore, a practical approach for treatment control is to 
choose a somewhat arbitrary power-off time and adjust the last measured 
electrode temperatures until the wanted T m;o is reached, without looking at the 
actual electrode temperatures. However, this requires information about the 
minimum tissue temperature. Measurement of temperatures in extra 
thermometry catheters can provide this information but due to patient 
tolerance and the risks associated with implanting additional catheters such 
measurements are generally very limited. Under certain restrictions it might be 
sufficient to measure only the temperature at, or just outside the edge of the 
tumour, at one position, and use this value to set the temperature for all 
electrodes. This is only allowed if the measured edge temperature can be 
assumed to be the minimum temperature in the target volume. Therefore the 
tissue must be reasonably homogeneous regarding the perfusion and electrical 
properties and the electrodes must lay within the target volume. Furthermore, 
the distance between the edge sensor and the nearest electrode must be at 
least half of the largest distance between neighbouring electrodes to ensure 
that the local minima between the applicators are not lower than the measured 
edge temperature. Even if these conditions are met it is recommended to stop 
periodically the heating in one of the afterloading catheters to investigate the 
local minimum tissue temperature in other parts of the target volume. The 
power-off time required to obtain reliable information about T m;o depends on 
the spacing between the catheters and the blood perfusion. At present, 
estimation of the required waiting time by model calculations during the 
treatment is too time-consuming. A practical method to estimate T mlo is to wait 
until the measured temperature decay curves (figure 4) are largely levelled off. 
This method appears to be reliable in a homogeneous medium as is demon-
strated in figure 5. It is obvious that for the small implant T m;o can not be 
determined this way. In this case either an extra thermometry catheter or 
sufficient data of previous treatments from which electrode temperature decay 
information could be derived are needed. 
Model calculation results, which use the electrode temperatures as input 
data, should be examined with care. Accurate modelling of self-heating of the 
applicators and the afterloading catheters is difficult. The power absorption 
inside the electrodes was omitted completely in the presented model 
calculations and therefore the calculated temperature inside the electrodes was 
underestimated. For the estimation of the average blood perfusion rate, the 
temperatures in the central electrode-voxel and its direct neighbour voxels 
were averaged. The target for this mean electrode temperature was set at the 
same value as the clinical electrode target temperature 4.5 s after power-off. 
Despite the uncertainties about the temperatures close to the electrodes, the 
calculated and measured long term (60-120 s) temperature decays can be 
brought in close agreement with each other by varying only the blood 
perfusion rate in the thermal model (see figures 4b and 5b). 
Although the computations give a good idea about the temperature of 
electrode spacing related ·cold· spots,colderregions induced by larger vessels 
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remain invisible. The effects of discrete vasculature on the temperature 
distribution can be studied with the present thermal models (Kotte et ai, 1996) 
but it is not easy to obtain the required vessel data, e.g. by phase contrast 
magnetic resonance angiography. More information about spatial variations of 
blood flow can be obtained if the long term decay method is used to estimate 
blood perfusion rates per electrode region. Although modelling calculation has 
its limitations it gives additional information which can improve both treatment 
control and treatment evaluation methods. 
Regarding the performance of the MECS-IHT system, it can be said that it 
is feasible to reach a minimum temperature of 40 DC in both small and large 
target volumes. In the centre of the large implant the temperature was about 
44 DC (figure 4) except of small local hot spots near the electrodes of less than 
50 DC (figure 2b). To reach the desired minimum temperature of 40 DC in the 
small implant the electrode temperatures had to be several degrees higher 
(figure 2a). In figure 3a was shown that at tPoff = 9.5 s the applicator 
temperature was decreased to about 43 DC while the temperature at 5mm 
distance had not changed at all. According to equation 1 and table 1, a time 
of 9.5 s corresponds with a radial diffusion of about 2 mm. This demonstrates 
that the high temperatures are limited to a small area near the electrodes. 
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Summary and general discussion 
1. Introduction 
Hyperthermia is a cancer therapy, which is normally applied in combination 
with other treatment modalities such as radiotherapy or chemotherapy. The 
aim of hyperthermia is to increase tumour temperatures to 40-45 DC. The 
rationale for hyperthermia is that it improves the effectiveness of the combined 
therapy, without increasing the toxicity. A number of randomised trials have 
demonstrated the effectiveness of hyperthermia, especially in combination 
with radiotherapy. 
A heating technique which has been developed to be combined with interstitial 
radiotherapy (IRT) is interstitial hyperthermia (lHT). In IHT, the heating 
applicators are placed inside the target volume. The development of the 27 
MHz current-source interstitial heating method started in the middle eighties. 
In a collaboration between the University Hospital Utrecht and the Daniel den 
Hoed Cancer Center in Rotterdam, the multi-electrode current-source (MECS) 
IHT system has been developed. Basically, this system consists of three units. 
Firstly, the actual heating system, including a 27 MHz electromagnetic power 
unit and multi-electrode applicators Secondly, a 196-channel thermometry 
system with 7-point manganin-constantan thermocouple thermometers. 
Thirdly, a computer plus treatment control software which provides the 
connection between the first two units and the operator. The applicators, 
consisting of one or more electrodes. can be inserted in the same plastic 
catheters which are implanted in the target volume, for afterloading IRT. 
Because the impedance of the catheter wall compared with the tissue 
impedance is relatively high, the electrodes behave like current' sources. The 
power unit has 2 groups of 32 channels with opposite phase. The power can 
be controlled separately for each channel. Current flows from the electrodes 
with· onephase;totheelectlddes· with a phase shift bfT 80 0 "hdi" dissipated 
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in the tissue. The actual temperature rise is measured with thermocouple 
probes inside applicators or inside extra non-heating catheters. The main 
advantage of interstitial treatment is that locally a high dose can be delivered 
while the surrounding normal tissue is spared. For adequate heating of the 
target volume a sufficiently high power absorption density in the tissue and 
good spatial temperature control are the major requirements. 
In this study, which was supported by the Dutch Cancer Society, the perform-
ance of the MECS-IHT system was examined, focusing on the efficiency of the 
power deposition in tissue and on the homogeneity of the temperature 
distribution. Furthermore the system was introduced in the clinic and a current-
source IHT system for small animals has been developed. 
2. An interstitial hyperthermia system for small animals 
To study the effectiveness of interstitial hyperthermia in combination with 
interstitial radiotherapy in tumours growing in the flank of a rat, a 4 channel 
version of a current-source IHT-system has been developed. The heating 
system consists of four single-electrode applicators each with independent 
impedance tuning and connected to four 27 MHz generators. Current flows 
from the electrodes to an external ground plane underneath the rat. 
Temperatures are measured with single-point thermocouple probes inside each 
electrode and with an extra 7-point thermocouple thermometer perpendicular 
to the electrodes. RF-filters, constructed with ferrite toroids, enable continuous 
temperature measurement, which is not disturbed by the 27 MHz electromag-
netic field. 
This system has been used to treat various solid tumours with volumes in the 
range 1500-2000 mm3 • Temperatures up to 46 DC at the edges of the 
tumour, which can be seen as the minimum temperatures are easily reached 
within 4-10 minutes. The clear display of the temperatures and the limited 
number of electrodes make it feasible to control the minimum temperature 
within ±0.5 D C during a treatment period up to 2 hours, by manual power 
steering. 
3. Efficiency of the power deposition in the tissue 
An important requirement for reaching a certain temperature elevation is that 
the power, actually delivered to the tissue, is sufficiently high. To check this 
for the MECS system, firstly, the required power absorption density for 
different situations was approximated through model calculations and 
secondly, the efficiency of the energy transport from generator to tissue was 
investigated. 
Using a simple spherical tumour model, an estimation of the power absorption 
densitV,J1eededl<lIe!,ci] a certain minimurn ternperature,can be calculated as 
a function of the tumour size, the electrode density and the effective heat 
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conductivity coefficient (k,,,) of the tissue. Electrodes with a length of 2 cm, 
inserted in afterloading catheters, with a spacing of 1.5 cm, are representative 
for clinical practice. In this situation, the effective power per electrode (P,,,)' 
needed to reach a temperature of 43°C at the edge of a well perfused tumour 
(k,,, =3 Wm-' oC-' ) with a diameter of 4 cm is about 0.5 W. Because the 
generator power is 5 W per heating channel, the efficiency of the energy 
transport in this situation must be at least 10%, if each electrode is connected 
to one heating channel. 
The heating efficiency is mainly determined by the method used to match the 
electrode impedance with the impedance of the generator. This impedance 
matching is necessary to minimise power reflection. In the MECS-IHT system 
the impedance of the applicator placed in the tissue is transformed to 800 0 
by adjusting the length of the transmission line between applicator and 
generator. For fine tuning, a small inductance or capacitor can be added to the 
applicator. The maximum efficiency, utilising this matching procedure, is in the 
range 35-45%, depending on the exact applicator impedance. The remaining 
generator power is absorbed in the transmission line. In practice, the effective 
power is reduced further due to applicator losses. Depending on applicator 
design and electrical properties of the tissue the applicator efficiency is 60-
70% . This gives an overall efficiency of 20-30% . Measurements in saline 
phantoms with properly-matched 2cm-electrodes show that the effective 
power per electrode is typically 1 W, corresponding with an efficiency of 20%, 
which is in agreement with the model predictions. For most practical situations 
this is sufficient. 
4. System features affecting the temperature homogeneity 
An important advantage of IHT is the possibility of three dimensional spatial 
control of the power deposition on a cm-scale, due to the high density of 
applicators and thermometers inside the target volume. This enables sparing 
of normal tissue and compensation for spatial variation in tissue cooling, 
caused by the heterogeneity of blood perfusion and the thermal properties of 
the tissue. On the other hand, the power absorption distribution on a mm-scale 
is heterogeneous: Most of the energy is absorbed near the applicators and this 
fact may result in large differences between maximum and minimum tempera-
tures in the target volume. Therefore, in case of IHT, treatment planning and 
treatment control are even more important than they are for external heating 
methods. 
First of all, the quality of the temperature distribution depends on the 
geometry of the afterloading catheters. If the distance between the catheters 
increases, the temperature heterogeneity also rapidly increases. For the current 
source heating method a spacing of maximally 15 mm appears to be accept-
able. In general, this maximum is considered sufficiently large, especially 
because catheter distances exceeding 15 mm, are also in interstitial radiother-
apyin many cases regarded as inadequate. 
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An advantage of the capacitive coupling between the electrodes and the tissue 
is that the electrodes act as current sources. Because the catheter wall impe-
dance is high compared to the tissue impedance, the current injection is 
homogeneous along the electrode independently of the electrode length and 
the electrode placement relatively to the other electrodes. This makes the 
current source heating method suitable for irregular implants, i.e. nonparallel 
andlor curved catheters. Furthermore, length and position of the heated area 
along a afterloading catheter can be chosen freely. However, it should be 
noticed that homogeneous heating along an electrode is only possible if the 
properties of the surrounding tissue are homogeneous too. 
Short electrodes should be used for a optimal spatial control of the power 
deposition and to avoid electrode placement over tissue boundaries. Further-
more, because the variations in blood perfusion are three-dimensional, 
longitudinal power control. i.e. using several electrodes in one catheter, is 
required. At the moment dual-electrode applicators, with 10 mm long 
electrodes separated by 5 mm, are frequently used in clinical practice. A high 
electrode density implies a large number of electrodes of which the power has 
to be controlled independently. Manual control, is inconvenient and could even 
be dangerous. Therefore a simple but adequate control algorithm has been 
developed to control the temperatures measured inside the electrodes 
automatically. 
The power absorption distribution depends not only on the magnitude of the 
electrode powers but on the power phase configuration as well. The 
absorption pattern in the tissue can be changed considerably, if the phase of 
some of the electrodes is altered. To exploit the features of the MECS-IHT 
maximally in order to improve the homogeneity of the temperature distribution, 
treatment planning is essential. For this purpose, software is available to 
calculate the power absorption and the resulting temperature distribution for 
a certain electrode configuration, if the electrical and thermal tissue properties 
are known. 
5. Thermometry 
An IHT temperature distribution depends on the position, power and phase of 
the electrodes and the thermal properties of the tissue. In general, the 
temperatures measured inside the electrodes are considered to be maximum 
tissue temperatures while the minimum temperatures are expected to be 
located in between the afterloading catheters and at the edge of the implanted 
volume. Information about the latter can be obtained either through implanting 
extra catheters for thermometry only or from decay characteristics of the 
applicator temperatures after switching off the power. 
Regarding the accuracy of thermocouple thermometry in MECS-IHT, there are 
two main reasons for measurements errors (i.e. the difference between the 
temperature reading and the tissue temperature at the position of interest): 1) 
thepresellce oTthe2TMHzSfeClf6magnetic field andZ) thefactlhatthe 
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thermometers are not in direct contact with the tissue. 
The high capacitive coupling between thermocouple probes and heating 
applicator (1-5 pF) induces 27 MHz current in the thermocouple leads, 
resulting in disturbance of the thermocouple-voltage reading and causing 
measurement errors due to self heating of the thermometer. Undisturbed 
measurement is possible with specially designed 7-channel RF-filters or by 
interrupting the RF-power for at least 2 s. 
Furthermore, the thermal resistance between a thermocouple probe and the 
tissue, caused by layers of plastic and air in between, can induce measure-
ment errors if there is a temperature gradient along the afterloading catheter. 
In IHT, high temperature gradients of 1-2 °C/mm are not exceptional. 
Measurement errors made with manganin-constantan thermocouple probes in 
standard afterloading catheters are comparable with those induced by a 0.5 
mm shift of the probe. This is considered to be acceptable, especially because 
the uncertainty about the exact sensor position relative to the target volume 
is generally larger (;" 1 mm). 
The differences between the temperatures measured inside an applicator (T,o) 
and the tissue temperature just outside the afterloading catheter (To",) are 
considerably larger, due to energy dissipation in the applicator and the catheter 
wall. Using clinical dual-electrode applicators in standard brachytherapy cathe-
ters, LI T,o is typically twice as high as LIT,", . A one-dimensional cylindrical 
model was used to compute this artefact as a function of the dielectric 
properties of the afterloading catheter material, the power fraction absorbed 
in the applicator and the thermal properties of the surrounding tissue. The 
model gives a good qualitative understanding of the measurement error, 
regarding applicator temperatures. However, extension of the model to three 
dimensions is required, for an accurate calculation of the artefact in clinical 
situations. A method to estimate the maximum tissue temperature is to study 
the temperature decay inside the applicator, after switching off the power. In 
an agar muscle equivalent phantom, about 5 s after the power is switched off, 
T,o in the electrodes represents the maximum tissue temperature just before 
the power was switched off. 
6. Clinical thermometry, during MECS-IHT in brain tumours 
In the Daniel den Hoed Cancer Center 7 patients with high grade (III/IV) 
gliomas have been treated with IHT as adjuvant to pulsed-dose-rate interstitial 
radiotherapy (PDR). Three heat fractions of about 2 hours were given between 
the four PDR-fractions on the first full day of irradiation. The target volumes 
(diameter: 1-4 cm) were heated with 1 up to 9 dual-electrode applicators 
(electrode length: 1 cm) inserted in low-loss nylon afterloading catheters. The 
distance between the catheters was about 1 cm. The power was interrupted 
to measure temperatures. 7-point manganin-constantan thermocouple probes 
were inserted inside each applioatorand, .. if present,.inanextraafterloading. 
catheter. The temperatures measured inside the electrodes were controlled 
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automatically at a certain target value. This electrode target temperature was 
increased until the required minimum tissue temperature of 40°C was 
reached. Two methods were used to estimate the minimum tissue tempera-
ture. Firstly through direct measurement with a sensor in an thermometry 
catheter close to the edge of the target volume. Secondly, by switching off 
the electrodes of one of the applicators. About 1 minute after switching off 
the power the temperatures measured inside the applicator give an impression 
of the local minimum temperature of the surrounding tissue. The heating 
efficiency of the applicators was sufficient to reach the required minimum 
temperature of 40°C. The homogeneity of the temperature distributions in 
the tissue was acceptable. The temperature of most of the target volume was 
in the range 40-43 °C. Hot spots with temperatures up to 46°C Were found 
in a small area around the electrodes. 
7. Future developments and discussion 
Using the MECS-IHT system, with distances between afterloading catheters 
of about 1 cm, brain tissue can be heated sufficiently, i.e. the required 
minimum temperature of 40°C can be reached. However, there are situations 
thinkable, in which adequate heating becomes more difficult, such as a higher 
target value for the minimum temperature, a decreased power absorption 
density or a larger heat transport in the tissue. For example, the power 
absorption density decreases if the afterloading catheters are implanted with 
.Iarger spacing. Distances of 1.5 cm or even more are not exceptional for 
implants in the base of the tongue. Another factor which may lead to a 
shortage of power deposition in some parts of the target volume is heat 
induced pain. This problem can not be solved through a higher generator 
power or a larger heating efficiency. The only way to prevent pain is to keep 
the maximum tissue temperature sufficiently low. For example, in the tongue 
region, temperatures up to 45°C appear to be tolerable. This means that for 
higher minimum temperatures, the temperature distribution has to be more 
homogeneous. With respect to this requirement the MECS-IHT system is quite 
competitive with other IHT-systems. The energy deposition directly in the 
tissue at some distance of the afterloading catheter is an advantage over so 
called hot source systems (ferromagnetic seeds, hot water, electrical resistive 
applicators). Furthermore the heated region along the afterloading catheter is 
less dependant on factors as applicator size, insertion depth and catheter 
geometry and therefore can be chosen more freely than in case of IHT using 
microwave applicators or galvanically coupled RF-electrodes. 
Nevertheless the homogeneity obtained with the MECS-system can be 
improved further. This can be achieved by increasing the electrode density 
either through smaller distances between the afterloading catheters or by 
decreasing the length of the electrodes. At present dual-electrode applicators 
w.ith 0.5 crn .longH.lectrodesand applicators with four electrodesare being 
tested. Furthermore, the power absorption and thus the temperature 
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distribution becomes less heterogeneous if less absorbing afterloading catheter 
materials, such as teflon or polythene are used and/or if the electrodes are 
connected in a such a way that, as much as possible, the power phase of 
neighbouring electrodes is different. The latter improves the homogeneity of 
the current density distribution. In addition it might be considered to increase 
the catheter diameter (power absorption is proportional to 1 /r' ) or to cool the 
applicators with water or air in order to reduce the hot spots near the 
electrodes. Most methods to improve the homogeneity have the disadvantage 
of decreasing the effective power absorption density. Increasing the number 
of afterloading catheters is the only way to improve both the magnitude and 
the spatial distribution of the power absorption density, but it is often 
considered less desirable, regarding patient tolerance. 
The effective power per electrode can be enlarged by increasing either the 
input power or the heating efficiency. The first option can be achieved through 
connecting each electrode to more than one heating channel. It is obvious that 
this reduces the number of electrodes that can be used and thus reduces the 
maximum target volume that can be treated and/or the homogeneity of the 
temperature distribution. Furthermore, modification of applicator and fine-
tuning elements can improve the heating efficiency but this gain is expected 
to be marginal. A more significant improvement of the heating efficiency may 
be achieved if a different impedance match technique is used. For example if 
the applicator impedance is transformed to 200 instead of 800 ohm the 
efficiency would increase with about a factor 2. However, it should be added 
that an impedance transformation to 200 ohm will be more sensitive for 
variations in the impedance of the applicator and the tissue. Furthermore the 
inductance, added to the applicator for fine tuning, will be larger and therefore 
more energy absorbing. 
Although in some situations a power deficiency may occur using the present 
MECS-system, there are no fundamental limitations on the number of heating 
channels and the input power per channel. Therefore, from a technical point 
of view, there are no restrictions on the target volume and the power density 
in the tissue. 
The research described in this thesis focused on the quality of the temperature 
distribution. Future studies may concentrate more on dose-effect relations. 
Generally, hyperthermia is more effective if it is given simultaneously with 
radiotherapy. In this respect, it would be interesting to integrate the MECS-
applicators and the afterloading catheters, leaving a lumen for the radioactive 
sources. In addition the measurements of the maximum tissue temperatures 
can be improved if thermocouple probes are placed at the outer wall of these 
MECS-catheters. 
At this moment, the quality of MECS-IHT can be improved furthermore through 
a number of technical and procedural changes. On the other hand, these 
modifications are in many situations not strictly required for adequate heating. 
Therefore, it can only be justified to put more efforts in further development, 
if there are sufficient clinical indications for IHT and will be in the future. 
Ihgeneral,lHT isconsideied a treatment optiohinlhefirstplaceif IRT is part 
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of the standard treatment and secondly, if the effect of the standard treatment 
is expected to be insufficient (e.g. less than 60-70% local control of disease). 
Implantation of catheters only for IHT or addition of IHT to reduce the IRT 
dose in order to minimize radiation side-effects are possible treatment 
modalities but these options are not yet widely accepted as long as IHT is an 
experimental treatment. The only way to determine whether or not IHT in 
combination with radiotherapy is effective, is through a randomized trial. 
Therefore the third requirement for IHT should be that it can be evaluated in 
a randomized study. The main problem in this respect is that the incidence of 
cases obeying the first two requirements is often too low to obtain a 
meaningful answer in a reasonable time. Depending on the actual benefit of 
IHT, the number of patients needed for a statistically significant result varies 
from several tens to several hundreds. In the Daniel den Hoed Cancer Center, 
the incidence of possible indications such as high grade (1II/IV) gliomas, (0% 
local control) and large (T3/T 4) tumours in the base of the tongue (about 30% 
local control) are 0-5 and 5-10 patients per year respectively. However, this 
is not a unique problem in oncology and is generally approached, through a 
multi-centre study. 
At present, the good results of recent randomized hyperthermia trials and the 
good heating performance of the MECS-IHT system in brain applications 
should encourage new randomized IHT-trials and further improvement of the 
MECS-IHT treatments. 
Samenvatting en discussie 
1. Inleiding 
Hyperthermie is een van de behandelingsmethodes van kanker. Hierbij wordt 
gestreefd naar een verhoging van de temperatuur in de tumor tot 40-45 0 C. In 
het algemeen wordt hyperthermie toegepast in combinatie met een of meer 
andere therapie;;n zoals radiotherapie of chemotherapie. Hyperthermie op zich 
is weinig effectief maar het kan het resultaat van een therapie waar het mee 
gecombineerd wordt verbeteren zonder toename van de bijwerkingen. Voor 
een aantal situaties, zoals hyperthermie gecombineerd met radiotherapie bij 
baarmoederhalskanker, is de effectiviteit van de combinatietherapie aange-
toond in studies waarbij d.m.v. loting werd bepaald (randomisatie) of een 
pati;;nt radiotherapie met of zonder hyperthermie kreeg. 
Interstiti;;le (van binnen uit) hyperthermie (lHT) is een verwarmingsmethode die 
speciaal is ontwikkeld voor de combinatie met interstiti;;le radiotherapie (IRT). 
Esn van de interstiti;;le verwarmingstechnieken is de 27 MHz stroom-bron 
methode. De ontwikkeling hiervan startte in het midden van de jaren 80. In 
een samenwerking tussen het Academisch Ziekenhuis Utrecht en de Daniel 
den hoed Kliniek in Rotterdam werd het zgn. MECS-IHT systeem ontwikkeld. 
MECS staat voor "multi-elektrode current-source". Het systeem bestaat 
grofweg uit drie onderdelen. Ten eerste, het eigenlijke verwarmingssysteem, 
dat 27 MHz vermogen produceert en via elektrodes op de plaats van 
bestemming brengt. Ten tweede een 196-kanaals thermometriesysteem en 
tenslotte nog een computer plus besturingsprogrammatuur die de verbinding 
vormt tussen de eerste twee onderdelen en de persoon die het MECS-systeem 
bedient. De elektrodes worden in, in het doelgebied ge'implanteerde kunststof 
slangetjes (katheters) geschoven, die ook gebruikt kunnen worden om IRT-
stralingsbronnen te positioneren. Een IHT-applicator kan bestaan uit een of 
meerdere elektrodes. Het verwarmingssysteem heeft twee groepen van elk 32 
kanalen waarvan de fase tegengesteldis.De 27 MHz"stroomtussen de "plus'" 
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en "min"-elektrodes wordt, ten gevolge van de weerstand die het ondervindt 
in het weefsel omgezet in warmte. Omdat de impedantie van een katheter-
wand relatief groot is vergeleken met de weerstand van het weefsel eromheen, 
gedragen de elektrodes zich als stroombronnen. De weefsel temperatuur wordt 
gemeten met behulp van thermokoppel-thermometers in de applicatoren en in 
niet voor verwarming gebruikte katheters. 
Het voordeel van een interstitiiile behandeling is dat er in een bepaald 
doelgebied een hoge dosis kan worden afgegeven terwijl het omringende 
gezonde weefsel lOveel mogelijk gespaard blijft. De belangrijkste vereisten 
voor adequate verwarming zijn dat de vermogensafgifte aan het weefsel ten 
eerste, voldoende is om warmteafvoer, bijvoorbeeld via het bloed, te 
compenseren en ten tweede, dat deze met een voldoende hoge ruimtelijke 
resolutie te regelen is, lOdat een min of meer homogene temperatuurverdeling 
bereikt kan worden. 
Het hier beschreven onderzoek werd mogelijk gemaakt door de financiiile steun 
van de Nederlanse Kanker Bestrijding (Koningin Wilhelmina Fonds) 
De mogelijkheden en beperkingen van het MECS-IHT systeem zijn onderzocht, 
waarbij de nadruk is gelegd op de effectiviteit van de vermogensafgifte aan het 
weefsel en op de homogeniteit van de temperatuurverdeling. Verder is het 
systeem ge',ntroduceerd in de kliniek en is er een compacte versie ontwikkeld 
voor IHT bij kleine proefdieren. 
2. Een interstitieel hyperthermiesysteem voor kleine dieren 
Om het effect van interstitiiile hyperthermie gecombineerd met interstiti;;le 
radiotherapie op een tumor in de flank van een rat te bestuderen, is een 4-
kanaals "current-source" IHT-systeem ontwikkeld. Dit systeem uit 4 verwar-
mings modules bestaande uit een 27 MHz generator, een elektrode en een 
elektrisch netwerk, dat dient om de impedantie van de elektrode plus rat aan 
te passen aan die van de generator en zo vermogensreflectie te minimaliseren. 
De 27 MHz stroom loopt tussen de elektrodes en een uitwendige aarde-plaat 
onder de rat. De temperatuur wordt in iedere elektrode gemeten met een 
enkelpunts-thermokoppelthermometer en in een 7-punts-thermometer 
loodrecht op de elektrodes. Dankzij RF-filters, gebaseerd op toroiden om een 
ferrietkern, is het mogelijk om temperaturen te meten tijdens het verwarmen, 
zonder verstoring door het 27 MHz elektromagnetische veld. Dit IHT-systeem 
is gebruikt voor de behandeling van diverse tumoren met volumes van 1500 
tot 2000 mm3 . De gewenste minimum temperaturen (44-46°C), gemeten aan 
de rand van lO'n tumor, werden bereikt binnen 4-10 minuten. Dankzij een 
duidelijk presentatie van de temperatuurgegevens en het geringe aantal 
applicatoren is het mogelijk de minimum temperatuur gedurende ten minste 2 
uur binnen ±0.5°C rond de streefwaarde te houden, d.m.v. handmatige 
regeling van de elektrodevermogens. 
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3. Effectieve vermogensafgifte aan het weefsel 
Een belangrijke voorwaarde voor het bereiken van een bepaalde temperatuur-
verhoging is dat er voldoende vermogen in het weefsel terecht komt. Om na 
te gaan of het MECS-systeem aan deze voorwaarde voldoet is eerst een 
schatting gemaakt van hoeveel vermogen voldoende is. Ten tweede is er 
gekeken naar de efficientie van het energietransport tussen generator en 
weefsel. 
Met behulp van eenvoudig bolvormig tumor model is een schatting gemaakt 
van het vermogen dat nodig is om een bepaalde minimum temperatuur te 
bereiken , als een functie van de tumorafmeting, de elektrodedichtheid en de 
effectieve warmtegeleidingscoefficient (k,,,) van het weefsel. Een representa-
tief voorbeeld voor de klinische praktijk is een implantaat met 2 cm lange 
elektrodes in katheters die 1.5 cm uit elkaar liggen. Om in dit geval een 
minimum temperatuur te kUnnen bereiken aan de rand van een goed door-
bloedde (k,,, = 3 Wm" °C) tumor met een diameter van 4 cm is een effectief 
vermogen per elektrode (P,,,) nodig van ongeveer 0.5 W. Omdat het generator 
vermogen per verwarmingskanaal 5 W is, moet, uitgaande van Ben elektrode 
per kanaal, de efficientie van het energietransport dus minimaal 10% 
bedragen. 
De efficientie van het verwarmingssysteem is in hoofdzaak afhankelijk van de 
methode die wordt gebruikt om de impedantie van een elektrode in het weefsel 
aan te passen aan die van de generator. Deze impedantieaanpassing is nodig 
om vermogensreflectie te minimaliseren. In het geval van het MECS-IHT 
systeem worden de elektrode-impedanties getransformeerd naar ongeveer 800 
Ohm door de lengte van de kabel tussen elektrode en generator goed te 
kiezen. Voor een nauwkeuriger transformatie kan verder nog een kleine spoel 
of condensator worden toegevoegd aan de elektrode. De maximale efficientie 
die theoretisch op deze manier gehaald kan worden is, afhankelijk van de 
elektrode impedantie, lO'n 35 tot 45%. Het overige vermogen wordt in de 
kabel geabsorbeerd. In de praktijk zal heteffectieve vermogen echter nog lager 
zijn door verliezen in de applicator. Afhankelijk Van applicator ontwerp en de 
elektrische eigenschappen van het weefsel eromheen kan berekend worden dat 
de applicator-efficiiintie tussen de 60 en 70% zal liggen. Dit betekent dus dat 
de totale efficientie van het energietransport 20-30 % bedraagt. Metingen met 
2 cm lange elektrodes in een zoutoplossing met spier-equivalente elektrische 
eigenschappen laten zien dat het effectieve vermogen per elektrode ongeveer 
1 W is en de efficientie dus ongeveer 20%. Dit komt goed overeen met de 
berekende verwachtte waarde en is voor de meeste praktisch situaties 
voldoende. 
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4. MECS-IHT eigenschappen en temperatuurhomogeniteit 
Een voordeel van IHT is dat, dankzij het grote aantal applicatoren en 
thermometers, de vermogensalgifte aan het weelsel geregeld kan worden op 
een cm-schaal. Oil geeft de mogelijkheid om het gezonde weelsel te sparen en 
om lokale variaties in warmtealvoer, ten gevolge van de heterogeniteit van 
doorbloeding en/ol thermische eigenschappen van het weelsel, te compense-
reno 
Daartegenover staat echter dat de energieabsorptie op een mm-schaal in het 
geval van IHT vrij inhomogeen is. De meeste energie wordt in de eerste 
millimeters weelsel rond de applicatoren geabsorbeerd, wat kan leiden tot 
grote verschillen tussen minimum en maximum temperaturen. Daarom zijn een 
goede temperatuurregeling en behandelingsvoorbereiding voor IHT nog 
belangrijker dan voor uitwendige verwarmingsmethodes. 
De kwaliteit van de temperatuurverdeling hangt ten eerste al van de geometrie 
van de ge'lmplanteerde katheters. De temperatuurinhomogeniteit zal snel 
toenemen als de alstand tussen de katheters groter wordt. Voor de "current 
source" IHT-methode zijn katheteralstanden tot 15 mm nog acceptabel. Met 
deze beperking valt in het algemeen goed te leven, omdat ook in het geval van 
interstitiale radiotherapie alstanden groter dan 15 mm meestal als niet 
adequaat beschouwd worden. 
Een voordeel van de capacitieve koppeling tussen de elektrodes en het weelsel 
is dat de elektrodes zich gedragen stroombronnen waarvan de stroomdichtheid 
langs een elektrode min 01 meer constant is, onalhankelijk van de posities en 
oriantaties van de elektrodes ten opzichte van elkaar. Dit wordt veroorzaakt 
doordat de impedantie van de wand van de katheters relatiel groot is 
vergeleken met de weerstand van het weelsel eromheen en constant is per 
eenheid van lengte. Dit maakt de "current source" verwarmingsmethode 
geschikt voor onregelmatige implantaten, dat wi! zeggen met niet-parallelle 
en/ol gekromde katheters. Een ander voordeel is dat de lengte en de posilie 
van het verwarmde gebied vrij te kiezen zijn. Er moet echter wei opgemerkt 
worden dat homogene verwarming langs een elektrode aileen mogelijk is als 
het omringende weelsel langs die elektrode homogeen is. 
Voor een goede driedimensionale regeling van de vermogensalgilte aan het 
weelsel moet, naast een voldoende kleine alstand tussen de katheters, de 
lengte van de elektrodes beperkt zijn. Dit brengt vaak met zich mee dat er 
meer dan een elektrode per katheter gebruikt moet worden. Momenteel 
worden in klinische toepassingen vaak applicatoren met 2 elektrodes van ieder 
10 mm lang met een tussenruimte van 5 mm gebruikt. In praktijk betekent dit 
dat er meestal een groot aantal elektrodes gebruikt worden waarvan het 
vermogen voor ieder alzonderlijk geregeld moet worden. Handmatige regeling 
kan in dit geval moeilijk en misschien zells gevaarlijk zijn. Daarom is er voor 
het MECS-systeem een eenvoudige algoritme ontwikkeld waarmee de 
vermogens automatisch geregeld kunnen worden op basis van in de elektrodes 
gemeten temperaturen. 
Deveideling vande vermogensabsorpH" in het weefselhangt niet aileen al 
Samenvatting en discussie 129 
van de hoogte van de elektrodevermogens maar ook van de fase ervan. Een 
absorptie patroon kan aanzienlijk veranderen als de fase van een aantal van de 
elektrodes gewijzigd wordt. 
Om de eigenschappen van het MECS-IHT systeem goed te kunnen benutten 
voor het bereiken van een zo homogeen mogelijke temperatuurverdeling is een 
goede voorbereiding van groot belang. Voor dit doel zijn er computerprogram-
ma's beschikbaar waarmee de vermogensabsorptieverdeling en de resulterende 
temperatuurdistributie berekend kunnen worden voor een bepaalde elektrode 
configuratie, mits de elektrische en thermische weefseleigenschappen bekend 
zijn. 
5. Thermometrie 
De bereikte temperatuurverdeling hangt af van enerzijds de enegieabsorptie, 
met andere woorden, van de verdeling van elektrodes, hoogte en fase van hun 
vermogens en elektrische eigenschappen van het weefsel, en anderzijds van 
de warmteafvoer, of wei de thermische eigenschappen van het weefsel. De 
temperaturen gemeten in de elektrodes kunnen in het algemeen gezien worden 
als maximum weefseltemperaturen terwijl de posities van de temperatuurmini-
ma verwacht worden tussen de elektrodes in en aan de rand van het 
doelgebied. De minimum temperaturen kunnen rechtstreeks gemeten worden 
door extra katheters te implanteren voor thermometrie of kunnen geschat 
worden door de temperatuurafval in de applicatoren te bestuderen nadat er 
een of meer zijn uitgezet. 
Wat de nauwkeurigheid van thermokoppel-thermometrie in combinatie met 
MECS-IHT betreft, zijn er twee hoofdoorzaken voor meetfouten (met een 
meetfout wordt hier bedoeld dat de afgelezen temperatuur afwijkt van de te 
meten weefseltemperatuur). Ten eerste, de aanwezigheid van een 27 MHz 
elektromagnetisch veld en ten tweede, het feit dat de thermometers niet direct 
contact maken met het weefsel. 
De goede capacitieve koppeling tussen thermokoppel-thermometers in een 
applicator en de elektrodes (1-5 pF) kan een 27 MHz stroom in de thermokop-
peldraden veroorzaken die resulteert in een verstoring van de uitlezing van de 
thermokoppelspanning en het opwarmen van de thermometer. Een ongestoor-
de meting is mogelijk dankzij speciaal hiervoor ontwikkelde 7-kanaals RF-filters 
of door het RF-vermogen minstens 2 s te onderbreken. 
Meetfouten kunnen ook veroorzaakt worden door de thermische weerstand 
tussen thermokoppel en weefsel, ten gevolge van de tussenliggende kunststof 
en luchtlagen, in combinatie met een temperatuurgradient langs de katheter. 
Tijdens IHT zijn hoge temperatuurgradienten van 1-2°C/mm mogelijk. De 
meetfout die met manganine-constantaan thermokoppels in een standaard 
katheter gemaakt wordt is vergelijkbaar met de fout die gemaakt wordt als de 
thermometer 0.5 mm wordt verschoven. Gezien het feit dat de positionerings-
onzekerheid van een thermometer inhetdoelgebied .inhetalgemeengroteris 
(;0, 1 mm) zijn deze fouten in de temperatuurmeting acceptabel. 
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Echter, de verschillen tussen de temperaturen gemeten in een applicator en de 
te meten weefseltemperaturen net buiten de katheter kunnen aanzienlijk groter 
zijn. Deze verschillen worden veroorzaakt door energieabsorptie in de 
applicator en de katheterwand. 
In het geval van de applicatoren en katheters die klinisch gebruikt worden is 
de temperatuurstijging in een applicator ongeveer twee keer zo hoog als die in 
het weefsel net buiten de katheter. Met behulp van een eendimensionaal 
cilindrisch model is deze meetfout onderzocht als functie van de dialectrische 
eigenschappen van het kathetermateriaal, van de relatieve vermogensabsorptie 
in de applicator en van de thermische eigenschappen van het omringende 
weefsel. Met behulp van het model kan slechts een kwalitatieve beschrijving 
van deze meetfout gegeven worden. Voor een nauwkeurige berekening van de 
fout in klinische situaties is een uitbreiding van het model naar drie dimensies 
vereist. Een methode om de maximum weefseltemperatuur te schatten is door 
de temperatuurafval in een applicator te bestuderen nadat het vermogen is 
uitgezet. In een spier-equivalent agarfantoom is de temperatuur in de applicator 
na ongeveer 5 s nadat het vermogen is uitgezet, gelijk aan de maximum 
weefseltemperatuur net voordat de applicator werd uitgezet. 
6. Thermometrie tijdens MECS-IHT bij hersentumoren 
In de Daniel den Hoed kliniek zijn 7 patianten met hooggradige (III/IV) glioma's 
behandeld met IHT in combinatie met pulsed-dose-rate interstitiale radiothera-
pie (PDR-IRT). Op de eerste hele bestralingsdag, met 4 IRT-fracties met een 
interval van drie uur, werden drie warmtefracties van ieder 2 uur gegeven 
tussen de bestralingen in. De doelvolumes (diameter: 1-4 cm) werden 
verwarmd met 1 tot 9 applicatoren met ieder twee 1 cm lange elektrodes. De 
applicatoren werden in nylon katheters geschoven die met een onderlinge 
afstand van ongeveer 1 cm in het doelgebied werden germplanteerd. De 
temperatuur werd gemeten met 7-punts thermokoppel-thermometers in de 
applicatoren en soms in niet voor verwarming gebruikte katheters. Voor 
temperatuurmeting werd het vermogen periodiek onderbroken. De temperatuur 
in de elektrodes werden door middel van een automatische regeling op een 
ingestelde waarde gehouden. Deze streeftemperatuur werd handmatig 
langzaam verhoogd totdat de gewenste minimum temperatuur van 40°C in het 
doelgebied was bereikt. Er werden twee methodes gebruikt om deze minimum 
temperaturen te schatten. Of wei, door het meten van de temperatuur aan de 
rand van het doelvolume in een niet voor verwarming gebruikte katheter. 
Of wei door te meten in een van de applicatoren die tijdelijk werd uitgescha-
keld. Na ongeveer 1 minuut geeft de applicatortemperatuur een goede 
schatting van de lokale minimum temperatuur. De bereikte temperatuurverde-
lingen waren vrij homogeen. De temperatuur in het grootste deel van het 
doelvolume lag tussen 40 en 43°C. Lokaal rondom de elektrodes werden 
temperaturen tot 46°Cgevonden. 
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7. Toekomstige ontwikkelingen en discussie 
Met het MECS-IHT svsteem en een alstand van 1 cm tussen de katheters 
kunnen hersentumoren verwarmd worden tot de gewenste minimumtempera-
tuur van 40°C. Er zijn echter situaties te bedenken waarbij voldoende 
verwarming een stuk moeilijker wordt. Bijvoorbeeld als er een hog ere minimum 
temperatuur nodig is, als de vermogensalgifte aan het weelsel minder effectiel 
is 01 als de warmtealvoer groter is dan in het geval van de hersenbehandeling. 
De vermogensalgifte per eenheid van volume neemt onder andere al naarmate 
de elektrodes verder uit elkaar liggen. Voor implantaten in de tongbasis zijn 
alstanden tussen de katheters van meer dan 1.5 cm niet uitzonderlijk. Het in 
te stellen vermogen wordt soms beperkt door warmt~-gerelateerde pijn, met 
als mogelijk gevolg een tekort aan vermogen in andere delen van het 
doelvolume. Dit probleem kan niet opgelost worden met behulp van een 
generator die meer vermogen levert 01 door een ellicientere warmtealgifte van 
de applicatoren. Om pijn te voorkomen moet de maximum weelseltemperatuur 
laag blijven. In de tong bijvoorbeeld is 45°C in het algemeen nog te te 
verdragen maar neemt de kans op pijn snel toe als het weelsel warmer wordt. 
Het is dus van belang om te streven naar een zo homogeen mogelijke 
temperatuurverdeling, zeker naarmate de gewenste minimum temperatuur 
toeneemt. Wat dit betreft kan het MECS-IHT svsteem goed concurreren met 
andere IHT-svstemen. De rechtstreekse vermogensalgifte aan het weelsel op 
enige alstand van de katheters is een voordeel ten opzichte van verwarming 
via warmtegeleiding aileen zoals in het geval van de zogenaamde hot source 
IHT -svstemen (Ierromagnetische zaadjes, warm-water-applicatoren, weer-
standsapplicatoren). Verder is, vergeleken met IHT-svstemen die gebaseerd zljn 
op microgoll antennes 01 galvanisch gekoppelde RF-elektrodes, het verwarmde 
gebied langs een applicator minder alhankelijk van lactoren als applicatoralme-
ting, insteekdiepte en kathetergeometrie. 
De homogeniteit van de verwarming met het MECS-svsteem kan echter nog 
verder verbeterd worden. Ten eerste, door de elektrodedichtheid te vergroten, 
door de alstand tussen de katheters te verkleinen en/ol door het aantal 
elektrodes per eenheid van lengte katheter te verhogen. Ten tweede, zal de 
vermogensabsorptieverdeling en dus de temperatuurverdeling minder 
heterogeen worden als er kathetermaterialen gebruikt worden met een lage 
dielektrische absorptie zoals tellon 01 polvethvleen. Ten derde, kan de 
homogeniteit van de stroomdichtheidsverdeling nog verbeterd worden als de 
elektrodes zo worden aangesloten dat de vermogenslases van buur-elektrodes 
zoveel mogelijk tegengesteld zijn. Ten slotte, kan overwogen worden om 
katheters met een grotere diameter te gebruiken (de vermogensabsorptie 
neemt namelijk al met 1 /r') en/ol om de applicatoren met water 01 lucht te 
koelen. Hierdoor zouden de hoge temperaturen net rond de elektrodes gedrukt 
kunnen worden. 
Methodes om de homogeniteit van de temperatuurverdeling te verbeteren 
hebben vaak als nadeel dat de effectieve vermogensalgifte aan het weelsel 
afneemt. VergtdtenVah deelektrddedlt:tnheld is de ehlgemanlerdmzowelde 
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ruimtelijke verdeling als de grootte van de vermogensabsorptie te verbeteren. 
Dit houdt in dat er meer katheters ge'implanteerd moeten worden, maar er is 
een limiet aan het aantal katheters dat een patient kan verdragen. 
Het effectieve vermogen per elektrode kan vergroot worden door 6f het 
aangeboden vermogen 6f de verwarmingsefficientie te vergroten. De eerste 
optie kan met het huidige MECS-systeem gerealiseerd worden door een 
elektrode aan meer dan een kanaal van het verwarmingssysteem aan te 
sluiten. Het is duidelijk dat er dan minder elektrodes gebruikt kunnen worden 
en dus het maximaal te behandelen doelvolume en/of de homogeniteit van de 
temperatuurverdeling kleiner wilen zijn. De efficientie van de applicatoren kan 
mogelijk nog iets verbeterd worden door aanpassingen van het applicator-
ontwerp, maar de winst hiervan zal marginaal zijn. Een meer substantiele 
efficientiewinst kan verkregen worden door een andere methode te kiezen om 
de applicatorimpedantie aan de generatorimpedantie aan te passen. Ais de 
applicatorimpedantie bijvoorbeeld wordt getransformeerd naar 200 in plaats 
van naar 800 Ohm, dan lOU de verwarming ongeveer twee keer lo efficient 
worden. Hierbij moet wei opgemerkt worden dat bij transformatie naar 200 
Ohm, de efficientie meer zal varieren bij eventuele variaties van de applicato-
rimpedantie en dat de voor impedantieaanpassing benodigde inductie groter is 
en daardoor meer energie zal absorberen. 
Met het huidige MECS-systeem zijn er situaties denkbaar waarin er onvoldoen-
de vermogen beschikbaar is. Er zijn echter geen fundamentele beperkingen aan 
het aantal verwarmingskanalen of aan het vermogen per kanaal, dus uit 
technisch oogpunt zijn er geen beperkingen voor het maximaal verwarmbare 
volume of de te bereiken temperatuur. 
Het onderzoek beschreven in dit proefschrilt heelt vooral betrekking op de 
kwaliteit van de temperatuurverdeling. Eventuele toekomstige studies wilen 
meer gericht zijn op dosis-effect relaties. Hyperthermie is in het algemeen meer 
effectief indien het gelijktijdig met radiotherapie wordt toegepast. Voor deze 
toepassing lOU het interessant zijn om de katheters te integreren met holle 
MECS-IHT applicatoren waarin ruimte is voor de radioactieve IRT-bronnen. 
Daarbij lOU het meten van de maximum weefseltemperaturen verbeterd 
kunnen worden door de thermokoppel-thermometers te bevestigen aan de 
buitenkant van deze MECS-IHT-katheters. 
In principe kan MECS-IHT nog verder verbeterd worden. In de meeste situaties 
is dit echter niet strikt noodzakelijk om adequaat te kunnen verwarmen. 
Daarom is het aileen te rechtvaardigen om meer mankracht en middelen in de 
verdere ontwikkeling van MECS-IHT te steken als er voldoende klinische 
toepassingsmogelijkheden v~~r IHT zijn. In het algemeen is IHT een behandel-
optie mits 1) IRT deel uitmaakt van de bestaande standaardbehandeling en 2) 
als het verwachte resultaat van die standaardbehandeling onbevredigend is 
(bijvoorbeeld een lokale controle van de ziekte van minder dan 60 II 70%). 
Implantatie van katheters aileen voor IHT of het toevoegen van IHT met als 
doel de IRT-dosis verlagen zonder verlies van effect maar met minder 
stralingsbijwerkingen, zijn ook mogelijkheden. Deze opties zijn echter voorlopig 
nognietalgemeengeaeeepteerdzolang·IHTnogeenexperimentele·behande-
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ling is. De enige manier om aan te tonen dat IHT in combinatie met radiothera-
pie wei of niet effectief is, is door middel van een gerandomiseerd onderzoek. 
Daarom lOU de derde eis voor het toepassen van IHT moeten zijn dat de 
resultaten evalueerbaar zijn binnen een gerandomiseerde studie. Het belangrijk-
ste probleem hierbij is dat het aantal patienten per jaar dat aan de eerste twee 
voorwaarden voor IHT voldoet meestal te laag is om binnen een redelijke tijd 
een zinvol antwoord te krijgen op de effectiviteitsvraag. Afhankelijk van de 
uiteindelijke winst ten gevolge van IHT varieert het benodigde aantal patienten 
voor een statistisch significant resultaat van enige tientallen tot een paar 
honderd. In de Daniel den Hoed Kliniek is de frequentie waarmee mogelijke 
IHT-indicaties lOa Is hooggradige (IIIIIV) glioma's (0% lokale controle) en grote 
(T3iT 4) tumoren in de tong basis (ongeveer 30% lokale controle) voorkomen, 
ongeveer 0-5 respectievelijk 5-10 patienten per jaar. Het probleem van lage 
aantallen, voor een studie in aanmerking komende, patienten is echter niet 
uniek in de oncologie en wordt vaak opgelost door de studie met meerdere 
behandelcentra samen uit te voeren. 
Op dit moment, geven de goede resultaten van recente gerandomiseerde 
hyperthermie studies en de goede verwarmingsresultaten van het MECS-IHT 
systeem bij hersentumoren aanleiding om nieuwe gerandomiseerde IHT-studies 
te starten en MECS-IHT behandelingen verder te verbeteren. 
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Dankwoord 
"Wat in het vat zit verzuurt niet!" Oat zal wei, maar een beetje blij dat het 
boekje nu gedrukt is ben ik toch weI. Het is mogelijk dat de zuurgraad toch 
enigszins verhoogd is, maar wie het waagt om na dit dankwoord nog verder 
te lezen zal ontdekken dat dit in de hyperthermie juist een plus punt is. Aile 
medeplichtigen aan dat wat aan dit proefschrift voorafging, en dat zijn er heel 
wat, wil ik graag bedanken. Slechts een aantal hoofdschuldigen zal ik 
hieronder bij naam noemen. 
Toen ik in 1991 bij de Daniel den Hoed Kliniek kwam solliciteren voelde ik me 
meteen op mijn gemak. Gerard van Rhoon deed wei zijn best om mij grondig 
aan de tand te voelen maar Inger-Karine (toen nog) Deurloo deed al zijn 
pogingen stranden. Ongeveer een week later zat ik in een luxe hotel mij te 
verdiepen in de basisbeginselen van de oncologie en ik kan u verzekeren dat 
valt niet mee na een jaartje dienstplicht. Eenmaal, in "huis" kwam ik terecht 
in de roze zone naast mijn lotgenoten van photodynamische therapie (PDT). 
Net als zij deed ik namelijk niets met ioniserende straling dus een plaatsje op 
de afdeling Klinische Fysica was iets te hoog gegrepen (twee verdiepingen om 
precies te zijn). Gezien het onderwerp van mijn onderzoek "interstitiiile 
hyperthermie (IHT)" begreep ik dat ik eigenlijk bij de afdeling Hyperthermie 
moest zijn. Bijna goed. Ik bleek namelijk geen hyperthermist, maar zo'n 
"interstitiiile" te zijn. Het ligt daarom voor de hand om allereerst mijn "soort" 
te bedanken. 
Inger-Karine (tegenwoordig) Kolkman-Deurloo, collega Veni Vidi Fysicus en 
mijn eerste kamergenoot. Sinds die eerste dag tot op heden heb ik jouw 
oprechte belangstelling in mijn welbevinden, op het werk maar ook prive, zeer 
kunnen waarderen. Andries Visser, man van wine(gums)en klassieke muziek. 
Rap, . .jekunthet nietaanhorenmaar jewas hetwelalsik jehulpnodighad, 
lets moest niet, maar was wenselijk en dat maakte je voor mij een goede 
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begeleider. Bart Kanis, je hebt wat moeten afzien als je mij weer eens zag 
solderen. Co-auteur van elk artikel in dit proefschrift en in een glansrol als 
mijzelf tijdens mijn bruiloft. Wie kan er meer geschikt zijn als paranimf dan jij. 
Verder heb ik goede herinneringen aan al die keren dat we rond de Kandinski 
van Hyperthermie de problemen van de wereld zaten op te lossen. Aile 
aanzittenden wil ik onder andere hiervoor bedanken. Cobi van der Zee, de 
moeder van de afdeling (en eigenlijk ook van de hyperthermie familie in heel 
Europa). Je wetenschappelijke carriere is ontzagwekkend maar ik heb nog 
meer respect voor hoe je met patianten omgaat. Gerard van Rhoon, optimist 
tot op het bot. Meer dan eens heb je in mijn ogen doodlopende sporen weer 
verbonden met een uitgebreid net van mogelijkheden. Paul Rietveld, zonder 
jouw was het vat nog wei even dicht gebleven. Na een paar weken van 
opmerkingen, telefoontjes en mailtjes, heb ik eieren voor mijn geld gekozen en 
de EUR gebeld om een promotiedatum af te spreken. Ook wil ik je bedanken 
voor je vele praktische houtje-touwtje-knip-en-plak oplossingen voor 
experimenteerprobleempjes. Pia Broekmeyer en Lia Verloop jullie hebben mij 
geleerd dat het behandelen van patianten datgene is waardoor een 
hyperthermist zich onderscheid van een interstitiale. Ik hoop dat ik nu ook een 
klein beetje een hyperthermist geworden ben. Ad (paddestoel) van de Berg, 
jouw kennis van de hyperthermie literatuur was indrukwekkend. Susanne van 
de Ploeg, Saskia van de Merwe, Jacqueline Peer, Lucina de Graaf en Jorine 
Juffermans bedankt voor jullie opgewekte humeur. Joop Stakenborg, we 
missen jouw hoog-frequente begaafdheid. Inge Dijkstra en Paula Groot, 
bedankt voor jullie werk aan het uiterlijk van het boekje. Ali Ameziane, dankzij 
jouw kan ik ook nu nog iets vinden in het lab. Tot slot, Isabelle Conradus, 
Gerton Kampmeier, Arie Hobbel, Leila Van der Voet en Paul Knops bedankt, 
omdat jullie als praktikant een belangrijke schakel waren tussen veel ideean en 
de realisatie daarvan. leder van jullie kan zijn werk terugvinden in dit 
proefschrift. 
Het door de Nederlandse Kankerbestrijding gefinancierde (waarvoor dank) 
onderzoeksproject bezat naast de in dit boekje beschreven technische tak, een 
minstens zo interessante radiobiologische component. ledereen die bijdroeg 
aan het altijd boeiende wekelijkse projectoverleg wil ik hiervoor bedanken. 
Christel van Hooije, jij hebt me laten zien hoe je bestralingsexperimenten met 
ratten op een ethisch verantwoorde manier kunt uitvoeren. Bedankt ook voor 
jouw hulp bij de in vivo tests van apparatuur, die een essentiale tussenstap 
vormde op weg naar de klinische introductie van IHT. 
Zodra het onderzoek praktisch begon te worden (lees: er patianten behandeld 
konden gaan worden) nam het aantal mensen dat er bij betrokken was 
exponentieel toe. Dim Noteboom, Dick Sipkema, Conny de Pan en hun 
collega's van de afdeling brachytherapie, Elly Korevaar en de verpleging van 
AO en de radiotherapeuten waaronder Peter Levendag en Peter Nowak, allen 
bedankt voorhet vertrouwen ... 
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Verder wil ik nog bedanken de medewerkers van Medische Fotografie en Hans 
Vuik in het bijzonder voor je "vandaag brengen, gisteren klaar" principe en de 
vaklui uit de Instrumentmakerij waar we helaas het vakmanschap en de humor 
van Dick Van Sluis moeten missen. 
Wat Klinische Fysica betreft is alles goedgekomen. Aile overgebleven IHT-ers 
(en ook de PDT-ers) van weleer huizen tegenwoordig twee verdiepingen hoger. 
Jullie allemaal bedankt voor de goede sfeer en de leuke SOPs en SOEPs die ik 
met jullie overleefd heb. Het feit dat er bij jullie de laatste tijd lustig op los 
gepromoveerd wordt heeft ongetwijfeld bijgedragen aan de afronding van mijn 
boekje. 
Het mag duidelijk zijn dat er vee I afdelingen in huis bij het onderzoek betrokken 
zijn geweest met als gunstig bijeffect vrijwel onbeperkt gebak eten. 
In het Academisch Ziekenhuis Utrecht heb ik weliswaar minder gebak gegeten 
maar de samenwerking met Hans Crezee, Jan Lagendijk, John van de Koijk, 
Jacob de Bree, Hugo Kroeze en Cees Ligtvoet was aangenaam en heeft flink 
bijgedragen aan de inhoud van dit boekje. 
Op dit moment staat het IHT -onderzoek al weer enige tijd op een laag pitje, het 
verwarmingssysteem wordt elders nuttig gebruikt, en nu is het proefschrift ook 
nog at. 
Toch zal ik altijd een beetje een interstiiile blijven. 
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